ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0061333;renal tubule morphogenesis;6.0;0.7192862368539868;0.682763431017138;8.801845679307654;32.20947323359611;6.943860283624253;0.0010780220824845236;0.6782296504172152;[MEF2C, TACSTD2, LGR4]
GO:0060244;negative regulation of cell proliferation involved in contact inhibition;6.0;1.0;0.8231203125901445;9.628524252492122;46.9815665635761;8.390779266560578;0.001572430752218078;0.7522251544931926;[PAK1, DACH1]
GO:2000483;negative regulation of interleukin-8 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.9724324201893;7.8311634786251565;0.02523477878196853;0.8157270763441555;[ANXA1, PTPN22, TLR6]
GO:1901222;regulation of NIK/NF-kappaB signaling;7.0;0.8436909121759173;0.7727648213451592;9.34084218004034;45.070113835906206;5.223196736079928;0.001508456149618737;0.6180338892438164;[PTPN22, TNF, HAVCR2, ACTN4, IL1B, CHI3L1, TLR7, TLR6, TLR4, TLR2, NLRP3, CCL19, TNFSF14, TNFRSF10B, NFKBIA, NLRP12, IL18R1]
GO:1901224;positive regulation of NIK/NF-kappaB signaling;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;238.82315740091596;5.572381008289503;0.007993196151321231;0.6599718239061428;[TNF, HAVCR2, ACTN4, IL1B, CHI3L1, TLR7, TLR6, TLR4, TLR2, CCL19, TNFSF14, TNFRSF10B, NLRP12, IL18R1]
GO:1900015;regulation of cytokine production involved in inflammatory response;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;49.77457630453619;6.311337724880743;0.0016659102747024386;0.6736814700148209;[IL1R2, MAPK14, CD6, TLR6, TLR4, MYD88, IL17A]
GO:1900017;positive regulation of cytokine production involved in inflammatory response;8.0;1.0;0.875;9.628524252492122;226.66426644256094;7.004484905440688;0.0075862490132365176;0.7332096838060964;[CD6, TLR6, TLR4, MYD88, IL17A]
GO:0060368;regulation of Fc receptor mediated stimulatory signaling pathway;6.0;0.8436909121759173;0.7449657686781032;9.446202695698167;67.47621599979578;7.9853141584524145;0.0022583682248613433;0.7314896500084853;[LYN, CSK]
GO:0061337;cardiac conduction;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;31.820364139744015;5.9928839937622085;0.0010649989512887435;0.6573957313958061;[DSP, MEF2A, JUP, KCNE3, CAV1, KCNA5, PLN, KCNQ1]
GO:0060369;positive regulation of Fc receptor mediated stimulatory signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.577230958104572;294.1477435792768;8.390779266560578;0.009844860261815976;0.7800242071602487;[LYN]
GO:0002244;hematopoietic progenitor cell differentiation;4.0;0.811012628672052;0.655506314336026;8.935377071932177;21.066225782797595;5.395046993006588;7.050676185779127E-4;0.5259029541176994;[TNFRSF13B, ESCO2, KIT, HOXB4, HOXB3, PLD4, JAM3, TGFB1, ACE, INHBA, PTPRC, PTPN6]
GO:0000188;inactivation of MAPK activity;13.0;0.8436909121759173;0.8844004208555951;9.558319993818873;2610.871803759405;6.518977089658987;0.08738352963975493;0.7959357562962344;[DUSP2, DUSP1, CAV1, DUSP6, PPP2R1A]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[, LRRK2, TNF, GHR, PROK2, TNFSF11, MAP4K1, MAP2K2, SYK, DUSP6, IL1B, KIT, TLR4, C5AR1, FPR1, CXCR4, TGFA, IQGAP3, NTF3, CCL19, DRD4, MAP2K6, EGF, MAPK14, CD40LG, CSPG4, PKN1]
GO:0002479;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;6.0;1.0;0.8231203125901445;9.628524252492122;33.24930607151726;6.518977089658987;0.0011128243517809471;0.6565011041187423;[CHUK, CD36, FCGR1B]
GO:0002237;response to molecule of bacterial origin;4.0;0.6873818243518346;0.5936909121759173;8.741221057491218;31.746667436368902;4.018171853803189;0.0010625323889495053;0.45548949546759565;[EDNRB, MEF2C, SLC11A1, SLPI, ABCB4, MGST1, KLRK1, S100A14, ELANE, ABCA1, JUN, FZD5, PPBP, CD24, CTSG, CCR7, CD36, CCR5, HAVCR2, ARG1, PDCD1LG2, FOS, TLR1, IL1B, TLR6, TLR4, TLR2, PTGER2, PTGS2, IL12RB2, GCH1, CCL20, NR1H2, CARD9, LILRB1, LILRB2, PF4, CD86, CD80, CXCL13, PYCARD, GHSR, CD96, CD180, F2R, KMO, ADAM9, S100A8, CD274, C5AR1, LY96, CSF2RB, TNFRSF11A, STAP1, NLRP3, DEFA4, TNFRSF10C, TNFRSF10B, DEFA1, SELE, NFKB1, CXCL10, CXCL11, ALPL, CXCL6, CXCL9, HMGB2, TNFAIP3, CXCL1, TREM2, FASLG, PTPN22, CXCL3, CXCL2, CXCL5, ALAD, PDE4B, PTGIR, CHUK, IRAK3, TNFRSF1B, CX3CR1, CEBPE, CNR1, CCL2, MAPK14, CD6, LTBR, FCGR2B]
GO:0071498;cellular response to fluid shear stress;4.0;0.7980440201809971;0.6490220100904985;9.271849308553389;39.92524609926753;6.8867018697843045;0.0013362620565537933;0.6021862538851576;[MEF2C, PTGS2]
GO:0006958;complement activation, classical pathway;8.0;1.0;0.875;9.628524252492122;171.02669507306572;4.7081694254602375;0.005724109570062889;0.6157760033703056;[, IGHM, CR2, CR1, IGHG1, IGKC, IGLV1-44, TRBC1, IGHD, IGHA1, IGKV3-20]
GO:0071374;cellular response to parathyroid hormone stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;109.38485831558611;7.57984905034425;0.003661012767841448;0.710754145523778;[MEF2C]
GO:0071375;cellular response to peptide hormone stimulus;7.0;0.7369933605727446;0.7194160455435727;9.117698628726131;386.0268190343683;4.727217620430932;0.012919970231498398;0.5926694942041391;[CYFIP1, AKT1, PRKACB, MEN1, GHSR, LHCGR, ARG1, GLP2R, POR, CEACAM1, ADCY9, PRKAR1B, SLC30A10, FOXO1, PAK1, PRKAR2B, FYN, CSK, TGFB1, CAV1, CDC6, SORBS1, TSHR, NFKB1, NR4A2, NR4A1]
GO:0000060;protein import into nucleus, translocation;9.0;1.0;0.896240625180289;9.628524252492122;93.4429707305496;6.444869117505266;0.0031274521371376313;0.7258315315665724;[TGFB1, PHB2, TNF, NFKBIA, POLA2, BCL6, IFNG, AKT1, RAN]
GO:2000111;positive regulation of macrophage apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;256.05226485460065;8.67846133901236;0.008569838872606032;0.8400575416471059;[MEF2C]
GO:2000353;positive regulation of endothelial cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.82178199018807;6.943860283624253;0.00434501821119318;0.7513499630073597;[FASLG, CD40LG, CCL2, PLCG1]
GO:2001205;negative regulation of osteoclast development;10.0;1.0;0.9152410118609203;9.628524252492122;1250.359070569308;8.16763571524637;0.041848392841848644;0.8329342821725234;[LILRB1, LTF]
GO:2000473;positive regulation of hematopoietic stem cell migration;8.0;1.0;0.875;9.628524252492122;201.08518903965808;9.083926447120524;0.006730140312236458;0.839552420951524;[PTPRC, CCR2]
GO:0051403;stress-activated MAPK cascade;10.0;0.811012628672052;0.8207473261969463;9.451593544333043;288.8226961090722;5.500407508664414;0.009666635715219814;0.696532107649126;[TNF, CHUK, MAPK14, NFKB1]
GO:0050798;activated T cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;53.24038617789342;8.390779266560578;0.0017819078121373234;0.7800242071602487;[FYN]
GO:2001202;negative regulation of transforming growth factor-beta secretion;10.0;1.0;0.9152410118609203;9.628524252492122;670.9356820924863;9.083926447120524;0.02245561347672384;0.8797934328124444;[LILRB1]
GO:2000491;positive regulation of hepatic stellate cell activation;6.0;1.0;0.8231203125901445;9.628524252492122;58.82470762909909;8.390779266560578;0.001968810025546158;0.7522251544931926;[PDGFRB, MYB, RPS6KA1]
GO:0035397;helper T cell enhancement of adaptive immune response;8.0;0.8933024483968273;0.8216512241984136;9.4949928598676;141.16491257062583;9.777073627680469;0.004724662583565679;0.875;[CD4]
GO:2000010;positive regulation of protein localization to cell surface;7.0;1.0;0.8509193652572005;9.628524252492122;73.70707873031733;7.004484905440688;0.002466909593039506;0.7091290490632969;[FCER1G, TNF, AKT1, CD247]
GO:2000251;positive regulation of actin cytoskeleton reorganization;9.0;1.0;0.896240625180289;9.628524252492122;130.7363647434596;6.8867018697843045;0.004375628472874139;0.7484268790654467;[NRP1, HCK, NTF3, STAP1, TEK]
GO:0036120;cellular response to platelet-derived growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.781341354126479;0.003262744749111514;0.6699184248047958;[PDGFRB, PDGFD, FYN]
GO:0006974;cellular response to DNA damage stimulus;4.0;0.5696777571895439;0.534838878594772;7.469040003138749;28.997869804256865;3.161008442547652;9.705326059599744E-4;0.4116541187538124;[SMC3, AKT1, SFN, BARD1, LYN, PLK2, CDKN1A, CHAF1B, CHAF1A, CTLA4, UNG, GTF2H1, TNF, PYCARD, RUVBL1, MACROD2, MEN1, MSH6, MSH2, BLM, FOXO1, MAP2K6, COPS5, BCL6, CNOT3, MCM7, EXO1, RFC5, RFC3, RFC4, RFC1, RFC2, SMC1A, TNFRSF1B, RBBP8, POLR2E, POLR2I, POLR2J, E2F7, POLR2K, POLR2L, RAD50, RAD51, MNDA, SMARCAL1, CCNH, CHEK1, ESCO2, MIF, POLA1, BRCA2, RAD51C, SGK1, PCNA, RAD54B, RPA1, MLH1, RPA3, DCLRE1A, PSMD14, HMGA1, JMY, TOPBP1, BCL2A1, TAF9, POLD3, POLD1, MAPK14, POLE2]
GO:0002374;cytokine secretion involved in immune response;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;8.67846133901236;0.004587596526932657;0.8590579283277371;[NLRP3, TLR2]
GO:0006975;DNA damage induced protein phosphorylation;8.0;1.0;0.875;9.628524252492122;212.05375489921127;7.697632086000634;0.007097248340487313;0.7686572628545723;[CHEK1, MAP2K6]
GO:0048012;hepatocyte growth factor receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;7.292166977892469;0.0010376185600805164;0.747921758369865;[NRP1, PAK1, STMN1]
GO:0051412;response to corticosterone;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;159.4387911184404;6.7325511899570465;0.0053362728531380675;0.719302980950052;[CDKN1A, AVPR1A, FOS]
GO:0000077;DNA damage checkpoint;8.0;0.811012628672052;0.780506314336026;9.456673995565463;85.75736069739153;5.486614186532078;0.002870221685927797;0.655585704652903;[BLM, CHEK1, TOPBP1, MAPK14, MSH6, MSH2]
GO:0048010;vascular endothelial growth factor receptor signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.186691500213083;31.002284443533863;5.572381008289503;0.0010376185600805164;0.6599718239061428;[CYFIP1, NRP1, NRP2, NCF4, NCKAP1L, FYN, MAPK14, PTK2]
GO:0051770;positive regulation of nitric-oxide synthase biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.28763043943843;7.069023426578259;0.0049295844405465;0.7124295520356204;[CCL20, LRRK2, FCER2, CCL2, TLR4, TLR2, MAP2K6]
GO:0006606;protein import into nucleus;9.0;0.8933024483968273;0.8428918493787028;9.551563211355994;277.5355368998559;5.288437257948329;0.009288864654271135;0.6666915524892495;[NUP107, CSE1L, NUP62, NUP133, SYK, TSC2, MMP12, NUP54, NUP85, NUP88, RANBP2, RANBP1, NUP155, NUP35, RAN]
GO:0048013;ephrin receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;5.395046993006588;0.0010376185600805164;0.6509029541176994;[EPHB1, AP2M1, MMP9, EPHA3, SDC2, PAK1, FYN, LYN, PTK2]
GO:0071364;cellular response to epidermal growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.088194173566533;0.003262744749111514;0.63447084575632;[MCM7, AKT1, PLCG1, PAX2]
GO:2000484;positive regulation of interleukin-8 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.5029195149353;7.069023426578259;0.02521906460756386;0.7767511986393403;[F2R, TLR1, CD2, PYCARD, FFAR2, CD58, CD244, TLR2]
GO:0035026;leading edge cell differentiation;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;24.20171999872632;9.083926447120524;8.100097882234571E-4;0.7547934328124444;[JUN]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[CD86, CD80, TNF, FGF5, TNFSF11, CCR7, PDGFRB, GAB1, BTC, LCK, KIT, CHI3L1, HBEGF, ENG, CD19, FYN, CCL19, ICOS, TGFB1, TRAT1, EGF, PTK2, LIN28A, CD28, NOX4, TEK]
GO:0043923;positive regulation by host of viral transcription;11.0;1.0;0.9324289523296623;9.628524252492122;272.30213926078306;6.943860283624253;0.009113707545043459;0.7875382901567328;[JUN]
GO:0043922;negative regulation by host of viral transcription;11.0;1.0;0.9324289523296623;9.628524252492122;272.3838172918008;7.292166977892469;0.009116441235236167;0.8053507106995271;[JUN, CCL5, CCL4]
GO:0060025;regulation of synaptic activity;7.0;1.0;0.8509193652572005;9.628524252492122;30.61939422688933;8.67846133901236;0.001024803569108247;0.7947362817240173;[MEF2C]
GO:1900271;regulation of long-term synaptic potentiation;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;41.65758488823441;6.193554689224359;0.0013942418768168238;0.6917386748366816;[CX3CR1, LILRB2, NRGN]
GO:1904753;negative regulation of vascular associated smooth muscle cell migration;9.0;1.0;0.896240625180289;9.628524252492122;245.4091710939714;7.9853141584524145;0.008213624102600289;0.8046099625986299;[MEF2C, MYOCD, TPM1]
GO:1904754;positive regulation of vascular associated smooth muscle cell migration;9.0;1.0;0.896240625180289;9.628524252492122;244.58802208207217;7.212124270218933;0.008186140984158152;0.7650689957573628;[DOCK5, PAK1]
GO:0002221;pattern recognition receptor signaling pathway;10.0;0.6467165523344657;0.7385992880281531;8.89455507741192;408.2729656680319;5.049685808968129;0.01366452873909497;0.6734821789659555;[ITGAM, TNFAIP3, CTSS, FFAR2, CD36, HAVCR2, CHUK, CD180, IRAK3, TLR1, BTK, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, S100A8, TLR2, COLEC12, UNC93B1, LY96, HSPD1, CLEC7A, S100A14, MAP2K6, NFKBIA, MARCO, MYD88]
GO:0002223;stimulatory C-type lectin receptor signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;628.1099736002739;5.618190544320798;0.02102227555412486;0.7197434780388068;[ICAM2, PAK1, KLRK1, FYN, MUC15, PRKACB, LYN, FCER1G, CHUK, SYK, CARD9, NFKB1, CLEC4D, CARD11]
GO:0042832;defense response to protozoan;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;69.6526388451159;6.832634648514029;0.0023312111388408135;0.6725415662651573;[ARG1, SLC11A1, DEFA1, CLEC7A, PF4]
GO:0002455;humoral immune response mediated by circulating immunoglobulin;7.0;1.0;0.8509193652572005;9.628524252492122;48.293467131004675;8.390779266560578;0.001616338883576055;0.7800242071602487;[EXO1, HLA-DQB1]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[ORM1, F13A1, LAMP2, CD36, ACTN1, ANXA5, ACTN4, F5, PECAM1, TLN1, VCL, STXBP2, FLNA, LYN, TGFB1, EGF, LHFPL2, PPBP, CD9, PF4]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[IL5RA, TNF, FGF5, TNFSF11, MEN1, PDGFRB, MEF2A, MEF2C, MAP2K2, PAQR3, BTC, CSF2RB, IQGAP3, RASGRP4, SPTA1, MAP2K6, TGFB1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, MAP4K1, CHUK, DUSP6, IL1B, KIT, HBEGF, IL2RG, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, IL2RB, TEK]
GO:0002578;negative regulation of antigen processing and presentation;5.0;0.6913464685778243;0.6359142461498324;8.48339194818912;38.82783361315856;7.8311634786251565;0.0012995326482508427;0.6907270763441554;[LILRB2, FCGR2B, HLA-DOA, HLA-DOB]
GO:0006933;negative regulation of cell adhesion involved in substrate-bound cell migration;6.0;1.0;0.8231203125901445;9.628524252492122;40.059981433445344;8.67846133901236;0.0013407715269347963;0.7669372290569613;[PTPRC]
GO:0071277;cellular response to calcium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;5.433268205826786;0.0026274528238337297;0.6009779013089371;[CPNE8, NLGN1, CPNE5, PHB2, KCNH1, MEF2A, MEF2C, JUN, FOS, TUBG1]
GO:0048146;positive regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.74573076450893;5.825829909099042;0.0021335122412550348;0.6210535250702663;[CDKN1A, PDGFD, MYB, PDGFC, PDGFRB, JUN, TGFB1, CDC6, MIF, BTC, NDUFS4]
GO:0071276;cellular response to cadmium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;6.139487467954083;0.0026274528238337297;0.6370939872166814;[JUN, GSN, CHUK, FOS, MMP9, AKT1]
GO:0006816;calcium ion transport;8.0;0.6696747006330769;0.7098373503165385;8.690254613899192;35.67391733828006;4.3132418226548594;0.001193973908871026;0.5955793873968269;[DENND5B, PHB2, SLC8A1, CTGF, F2R, CACNA2D3, CALCRL, PSEN2, CACNA1F, CORO1A, CCR1, CAV1, BSPRY, PTPRC, ATP2A3, FASLG, JPH2, CCR7, CCR5, TRPC7, TRPC3, TRPC1, TMEM37, LCK, XCL1, SLC24A2, SLC24A1, SLC24A4, CCL8, PLN, CCL5, FYN, CCL19, RAMP1]
GO:2000379;positive regulation of reactive oxygen species metabolic process;6.0;0.7763722522362496;0.7113064387082693;9.253830803050711;112.71770282919289;5.299736813202263;0.0037725600743465397;0.5941490996802742;[CDKN1A, PID1, ITGAM, TNF, AKT1, CD36, CD177, PDGFRB, DNM2, IFNG, IL1B, AGTR1, TLR6, TLR4, FPR2, PTGS2, GNAI2, KLRK1, TGFB1, AGXT2, MAPK14, NOX4, PTX3]
GO:0033194;response to hydroperoxide;4.0;0.7980440201809971;0.6490220100904985;9.34084218004034;25.335607989987928;6.781341354126479;8.479599988580431E-4;0.5967981122146513;[CHUK, MGST1, CD36]
GO:0034162;toll-like receptor 9 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;7.004484905440688;0.013811191226989502;0.8063299963962409;[UNC93B1, TLR8, TLR7, MYD88, HAVCR2]
GO:2001240;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand;10.0;1.0;0.9152410118609203;9.628524252492122;570.2036429558796;6.221725566191056;0.019084202779771145;0.7334203466557586;[CX3CR1, TNF, IL1B, AKT1, FYN, PF4]
GO:0034166;toll-like receptor 10 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;9.777073627680469;0.013811191226989502;0.9481203125901445;[TLR10]
GO:1900165;negative regulation of interleukin-6 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;618.5369298683007;7.8311634786251565;0.020701874395595732;0.8157270763441555;[BANK1, PTPN22]
GO:0060252;positive regulation of glial cell proliferation;9.0;0.8933024483968273;0.8428918493787028;9.587702257971866;465.4406966640378;7.292166977892469;0.015577881247913653;0.769162383550154;[LYN, MYB]
GO:1904646;cellular response to amyloid-beta;7.0;1.0;0.8509193652572005;9.628524252492122;273.93391051768003;6.518977089658987;0.009168321460513012;0.6843001567857983;[LRP1, FPR2, ADRB2, GRM5, CD36, TLR6, FCGR2B, TLR4]
GO:1904645;response to amyloid-beta;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;46.101821680530804;6.409777797693995;0.001542986482701544;0.6509166472493662;[LRP1, FPR2, ADRB2, GRM5, FYN, CD36, TLR6, FCGR2B, TLR4]
GO:0002230;positive regulation of defense response to virus by host;8.0;1.0;0.875;9.628524252492122;73.08237040089334;6.599019797332524;0.0024460011674546805;0.712474179321389;[LILRB1, IL12RB1]
GO:0002587;negative regulation of antigen processing and presentation of peptide antigen via MHC class II;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;144.69507589410327;9.083926447120524;0.004842813973061743;0.8154717862087246;[HLA-DOA, HLA-DOB]
GO:0002467;germinal center formation;5.0;1.0;0.7902410118609202;9.628524252492122;29.459500770284833;7.697632086000634;9.859829789520339E-4;0.6838982747154925;[MEF2C, BCL6, CXCL13]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[CHEK1, AKT1, IL1B, TLR8, TLR7, TLR5, TLR4, ENG, PTGS2, TGFB1, TNFSF14, TNFRSF10B, NFKB1, LTBR, MYD88]
GO:0072112;glomerular visceral epithelial cell differentiation;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;72.77032193269073;7.8311634786251565;0.002435557186049328;0.7514054297404357;[BASP1, CD24]
GO:0006948;induction by virus of host cell-cell fusion;8.0;1.0;0.875;9.628524252492122;77.37443216443229;9.777073627680469;0.0025896526120755235;0.875;[CD4]
GO:2000144;positive regulation of DNA-templated transcription, initiation;11.0;0.8933024483968273;0.8790801765280758;9.604426700913061;1600.8530134724567;6.444869117505266;0.05357910968674749;0.7620198587159455;[JUN, PSMC6, PSMC2]
GO:2001235;positive regulation of apoptotic signaling pathway;8.0;0.6997970393407541;0.724898519670377;9.176539128749065;291.4603159253591;4.6590798152637145;0.009754914476767216;0.6132655584219551;[PYCARD, PPP2R1A, MAL, ATF3, S100A8, NACC2, TP53BP2, SFN, TNFSF12, CAV1, INHBA, ITM2C, PLEKHF1, CTSH, MMP9, LCK, GSN, BIK, G0S2, PPP1CA, LTBR]
GO:0038116;chemokine (C-C motif) ligand 21 signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;32.49393932031223;9.777073627680469;0.0010875429064040555;0.875;[CCR7]
GO:0038115;chemokine (C-C motif) ligand 19 signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;32.49393932031223;9.777073627680469;0.0010875429064040555;0.875;[CCR7]
GO:0038110;interleukin-2-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.379178354882098;0.00101047745553359;0.728290889492758;[SYK, IL2RB, IL2RG]
GO:0002281;macrophage activation involved in immune response;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;81.79914540449643;7.379178354882098;0.0027377437822370863;0.7004918368257019;[CX3CR1, SUCNR1, SYK, HAVCR2]
GO:0006882;cellular zinc ion homeostasis;10.0;1.0;0.9152410118609203;9.628524252492122;329.3407122754199;6.375876246018314;0.011022737252460356;0.7413036195908642;[ATP7B, LCK]
GO:1900454;positive regulation of long term synaptic depression;9.0;1.0;0.896240625180289;9.628524252492122;54.16329535062315;8.16763571524637;0.0018127967515842568;0.8139338954918922;[LILRB2]
GO:0002283;neutrophil activation involved in immune response;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;82.20461051260416;3.594988720963838;0.002751314334510546;0.5347672556313635;[CDA, CYFIP1, ABCA13, C3AR1, RNASE3, RNASE2, BIN2, PADI2, FPR1, FPR2, NCKAP1L, ELANE, JUP, AZU1, LYZ, TCN1, SIGLEC9, PYGL, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, PTAFR, ALOX5, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, BRI3, HVCN1, GPR84, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, ITGAM, FCAR, ALAD, FCGR3B, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, TTR, FCGR2A, P2RX1, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CCT2, FCER1G, MME, SYK, RHOG, CEACAM1, CEACAM6, TLR2, LILRA3, CXCR1, CXCR2, CD58, CCT8, LILRB2, LILRB3, QPCT, CD68, CD97, CHRNB4, CD93, OSCAR, DOK3, PRTN3, VCL, PSMD14, C5AR1, MGAM, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0006887;exocytosis;6.0;0.6696747006330769;0.657957662906683;8.375761283996754;37.082880499217325;3.1596706497059923;0.0012411306378830758;0.4847060165558207;[, CDA, CYFIP1, ABCA13, C3AR1, RNASE3, RNASE2, BIN2, PADI2, FPR1, FPR2, NCKAP1L, ELANE, LYN, JUP, AZU1, LYZ, TCN1, SIGLEC9, PYGL, OLR1, ANXA3, ARG1, NFAM1, ANXA5, F5, PSMA5, PSMA2, SERPINB10, PTAFR, ALOX5, FLNA, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, PF4, HP, F13A1, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, BRI3, HVCN1, LIN7A, GPR84, CORO1A, ATP8B4, DEFA4, DEFA1, NFKB1, COPS5, PTPRC, LCN2, LAT, ITGAM, FCAR, ALAD, FCGR3B, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, CCL8, TTR, CCL5, FCGR2A, P2RX1, VPS41, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, ACTN1, SLC11A1, ACTN4, MIF, CHIT1, SLPI, CRISPLD2, TLN1, LLGL2, STXBP2, MGST1, CCR1, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CCT2, FCER1G, MME, RHOG, LAT2, HCK, CEACAM1, CEACAM6, KIT, TLR2, LILRA3, STX11, PAK1, CXCR1, CXCR2, CD58, CCT8, LHFPL2, LILRB2, LILRB3, QPCT, CD68, CD97, CHRNB4, CD93, OSCAR, DOK3, PRTN3, VCL, PSMD14, C5AR1, MGAM, TGFB1, SYT2, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, MMP8, SYNGR3, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, EGF, MAPK14, CD9, S100P, PTX3]
GO:0060326;cell chemotaxis;5.0;0.6393367784920305;0.6099094011069355;8.152617732682543;30.286927728949156;4.458953633836253;0.0010136762146226118;0.5182721080578558;[CSF3R, CXCL13, CXCL16, LGALS3, EDNRB, CCRL2, C3AR1, TNFSF11, IL6R, EPHB1, PDGFRB, CXADR, HOXB9, BIN2, AGTR1, PRKCQ, S100A8, CALCA, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, CORO1A, NUP85, NCKAP1L, CCR10, CCR1, EGR3, AZU1, DEFA1, PPBP, NR4A1, CXCL10, CXCL11, CXCL12, NRP1, CXCL6, CXCL9, HMGB2, CXCL1, CXCL3, CXCL2, CXCL5, CCR9, PDE4B, FFAR2, CCR7, CCR6, CCR5, CCR2, ANXA1, FCER1G, SYK, RHOG, GAB1, IL1B, KIT, XCL1, HBEGF, CX3CR1, CCL13, CXCR5, CXCR4, CXCR6, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL20, PF4]
GO:0030866;cortical actin cytoskeleton organization;6.0;0.7671156992804218;0.7066781622303554;9.117698628726131;53.946853691669205;6.088194173566533;0.0018055526440439148;0.63447084575632;[TNF, RACGAP1, NCKAP1L, TLN1, LLGL2]
GO:0050871;positive regulation of B cell activation;8.0;0.7436939687323844;0.7468469843661922;9.117698628726131;160.32529438548238;4.695669262696007;0.00536594331968482;0.6151367444652258;[, IGHM, CDKN1A, TFRC, TNFSF13B, IGHG1, TRBC1, MEF2C, SYK, FCRL3, MIF, MSH6, MSH2, BTK, IGHD, CARD11, UNG, IGKC, INPP5D, NCKAP1L, IGHA1, TGFB1, MLH1, BST1, PTPRC, BCL6, CD28, CD320]
GO:0032928;regulation of superoxide anion generation;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;29.554879433861746;6.781341354126479;9.891752169867288E-4;0.6977174774718518;[TGFB1, ITGAM, SYK, FPR2, GNAI2, CD177]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[PYCARD, IFNA14, IFNA16, RNASE6, RNASE2, IFNA10, NLRP3, IFNA21, AZU1, DEFA1, CXCL10, PTPRC, IFNA5, IFNA4, IFNA7, CXCL9, IFNA2, IFNA8, IFNG, TLR8, TLR7, UNC93B1, SAMHD1, CARD9, LILRB1]
GO:0019722;calcium-mediated signaling;7.0;0.7192862368539868;0.710562483684194;8.712233520617966;27.814661162170232;4.835431205071165;9.309316775279788E-4;0.598203541955087;[MCTP1, LRRK2, SLC8A1, GRM5, EDNRB, CCRL2, CCR9, TNFSF11, CCR7, CCR6, CCR5, CCR2, AVPR1A, ATP1B1, LAT2, BTK, AGTR1, CX3CR1, CXCR5, CXCR4, FPR2, CXCR6, PLN, CXCR1, CXCR2, DMD, PLCG1, CCR10, CCR1, CCL20, AZU1, SELE, LAT]
GO:0051603;proteolysis involved in cellular protein catabolic process;6.0;0.6519675769143192;0.6491041010473041;8.270400768338927;49.64990487012002;3.4509241545253704;0.001661737633989536;0.49960073433695684;[, HACE1, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, USP9Y, PSMC6, PSMC2, WFS1, HM13, RNF24, SKP2, CTSS, CTSH, RANBP2, RANBP1, PSMD14, TNFAIP3]
GO:0051966;regulation of synaptic transmission, glutamatergic;7.0;0.811012628672052;0.7564256795932265;9.405380701177911;30.61939422688933;5.528578385631111;0.001024803569108247;0.6336511210035629;[MEF2C, NLGN1, LRRK2, GRIK3, PTGS2, KMO, GRM5, CNR1, TNR]
GO:2001244;positive regulation of intrinsic apoptotic signaling pathway;9.0;0.7671156992804218;0.7797984748205;9.413412872875176;596.4251749563025;5.75172193694532;0.019961813857978603;0.6903839525180965;[PLEKHF1, NACC2, CAV1, LCK, ATF3, S100A8]
GO:0031953;negative regulation of protein autophosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;780.3281191277907;7.379178354882098;0.026116879897493853;0.7926125360964777;[NLRP12, JUN, CAV1, ENG]
GO:0019724;B cell mediated immunity;5.0;0.7307253602413294;0.655603691981585;8.8813098506619;29.48574010893193;6.8867018697843045;9.868611860026806E-4;0.6424272657460779;[FCER1G, SLA2, HSPD1, MSH2, EXO1, INPP5D, TLR8, FCGR2B, IL13RA2, HLA-DQB1]
GO:0030501;positive regulation of bone mineralization;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;171.85898464291293;6.221725566191056;0.005751965552953692;0.6690987000520388;[MEF2C, TGFB1, ADRB2, SLC8A1, LTF]
GO:0051963;regulation of synapse assembly;6.0;0.7090535922965819;0.6776471087384355;9.0306872517365;59.898395703774696;5.322726331426962;0.002004745399149018;0.5953247847114072;[ROBO2, NLGN1, AMIGO3, FLRT2, SLITRK6, EPHB1, GHSR, MEF2C, LRRN3, PTK2, TLR2]
GO:0051964;negative regulation of synapse assembly;7.0;0.8259837884571596;0.7639112594857803;9.437469015729413;219.30269939314178;7.9853141584524145;0.007339863989072673;0.7592887026755414;[ROBO2, PTK2, TLR2]
GO:0014033;neural crest cell differentiation;5.0;0.8653626801206646;0.7229223519212526;9.271849308553389;46.51447820026907;7.9853141584524145;0.001556797725050427;0.6986103492792611;[MEF2C]
GO:0002292;T cell differentiation involved in immune response;7.0;0.7586651285174919;0.7302519295159464;9.260799472366804;150.83672260445746;6.686031174322154;0.00504836936133411;0.692843310444282;[FCER1G, CLEC4D, IL18R1]
GO:1902523;positive regulation of protein K63-linked ubiquitination;12.0;0.9326813400603323;0.9144609826203107;9.593432932680852;695.4271152056829;8.67846133901236;0.02327531970216374;0.8919372290569614;[PTPN22]
GO:1901796;regulation of signal transduction by p53 class mediator;7.0;0.7192862368539868;0.710562483684194;9.117698628726131;45.070113835906206;4.948759890378168;0.001508456149618737;0.6039991761920099;[CHEK1, AKT1, MIF, TAF9, TP53BP2, MAPK14, JMY]
GO:1903974;positive regulation of cellular response to macrophage colony-stimulating factor stimulus;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;111.61630484940933;8.67846133901236;0.0037356972751570123;0.7947362817240173;[TLR4, TLR2]
GO:1904706;negative regulation of vascular smooth muscle cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;80.8833163751231;6.8867018697843045;0.0027070918088165762;0.7031056191423581;[MEF2C, CDKN1A, MYOCD, TPM1]
GO:1900227;positive regulation of NLRP3 inflammasome complex assembly;7.0;1.0;0.8509193652572005;9.628524252492122;140.3817219977405;7.9853141584524145;0.004698449899916962;0.7592887026755414;[CD36, TLR6, TLR4]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[SCARB2, TFRC, HP, CXCL16, AP2M1, CUBN, CALCRL, FPR2, ADRB2, IGLV1-44, IGHA1, MSR1, CD163, CAV2, CAV1, LRP1B, MARCO, IGKV3-20, LRP12, ASGR1, ASGR2, CD36, FCER1G, SYK, DNM2, CEACAM1, COLEC12, LRP1, LRP2, DLL1, IGKC, CXCR1, CXCR2, FCGR1B, LILRB1, CD6, CD9, FCGR2B, RAMP1]
GO:0032913;negative regulation of transforming growth factor beta3 production;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;85.63944001314535;9.777073627680469;0.002866274986747803;0.8509193652572005;[CD24]
GO:0071560;cellular response to transforming growth factor beta stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;5.788089581116195;0.003262744749111514;0.6191234829421188;[CX3CR1, EPB41L5, PDGFD, FYN, MEF2C, TGFB1, ARG1, CAV1, NOX4, XCL1]
GO:0051973;positive regulation of telomerase activity;9.0;0.9326813400603323;0.8625812952104552;9.600353375525426;952.4250073221435;6.193554689224359;0.031876807868214944;0.7129793000169707;[CCT4, CCT2, GRHL2, PRKCQ]
GO:0070233;negative regulation of T cell apoptotic process;10.0;0.8259837884571596;0.8282329060895002;9.370695143190021;155.57980234840144;6.7325511899570465;0.005207115971869279;0.7595439928109722;[BLM, SLC46A2, CCL5, PRKCQ]
GO:2001016;positive regulation of skeletal muscle cell differentiation;9.0;0.8653626801206646;0.8289219652406215;9.541512875502493;376.2972035421309;7.9853141584524145;0.01259432875705866;0.8046099625986299;[MEF2C]
GO:2000045;regulation of G1/S transition of mitotic cell cycle;8.0;0.7436939687323844;0.7468469843661922;9.040737587590003;58.63952701093024;4.821246570079209;0.0019626121969077833;0.6215587738047448;[AKT1, NACC2, SFN, PLK2, CDC6, CNOT3, EZH2, CDKN1A, ANXA1, PCNA, KCNA5, GPNMB, CCL2, E2F7, CDKN2C, PTPN6]
GO:0050766;positive regulation of phagocytosis;8.0;0.7671156992804218;0.7585578496402109;9.34084218004034;175.32691305650852;5.825829909099042;0.005868033996023792;0.6729332124801218;[SIRPG, TNF, SIRPB1, PYCARD, STAP1, CCL2, NCKAP1L, CD36, FCER1G, SLC11A1, AZU1, DNM2, IL1B, PTX3, FCGR2B]
GO:0072659;protein localization to plasma membrane;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.42666064804821;4.677207199856271;0.002189771451718415;0.5623129063031725;[PLEKHF1, TNF, CDH1, FCER1G, GOLPH3L, ATP1B1, PKP3, TSPAN33, FLNA, TSPAN5, JUP, RAMP1]
GO:0050764;regulation of phagocytosis;7.0;0.6873818243518346;0.6946102774331178;9.05316010758856;47.10255867462412;5.4730085344763;0.0015764802492890249;0.6308092762312435;[SIRPG, TNF, SIRPB1, PYCARD, CD36, FCER1G, SYK, SLC11A1, DNM2, FGR, HCK, IL1B, PRTN3, TLR2, STAP1, CCL2, NCKAP1L, CSK, TGFB1, AZU1, PTX3, FCGR2B]
GO:0050765;negative regulation of phagocytosis;8.0;0.8436909121759173;0.7968454560879586;9.503361109538115;175.4194889364855;7.069023426578259;0.005871132427413739;0.7365101867784198;[TGFB1, PRTN3, CSK, FCGR2B, TLR2]
GO:0060100;positive regulation of phagocytosis, engulfment;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;308.80984280932773;7.57984905034425;0.010335587528013168;0.7838744581139225;[STAP1, NCKAP1L, CD36]
GO:0014003;oligodendrocyte development;5.0;1.0;0.7902410118609202;9.628524252492122;34.09911675737102;6.558197802812269;0.001141266750656509;0.6256275524841266;[LYN, EIF2B3, TGFB1, GSN, CD9]
GO:2001275;positive regulation of glucose import in response to insulin stimulus;9.0;1.0;0.896240625180289;9.628524252492122;210.7203529833852;6.832634648514029;0.00705262057834843;0.7456618788553018;[PAK1, SORBS1]
GO:1902895;positive regulation of pri-miRNA transcription by RNA polymerase II;12.0;1.0;0.9481203125901445;9.628524252492122;1721.2385553242598;6.599019797332524;0.0576083054325737;0.7855944919115336;[JUN, TGFB1, KLF5, PRL, FOS]
GO:0046037;GMP metabolic process;10.0;0.8259837884571596;0.8282329060895002;9.548481544818586;1315.1089846810005;6.7325511899570465;0.04401551419602758;0.7595439928109722;[MPP1, PRTFDC1, CARD11]
GO:0090073;positive regulation of protein homodimerization activity;6.0;1.0;0.8231203125901445;9.628524252492122;47.416497719221994;7.57984905034425;0.0015869875065849188;0.710754145523778;[MEF2C]
GO:0002378;immunoglobulin biosynthetic process;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;39.16312370347755;9.083926447120524;0.0013107545058323288;0.7547934328124444;[PTPRC]
GO:1904707;positive regulation of vascular smooth muscle cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;80.75549718811011;6.444869117505266;0.0027028138156570515;0.6805102716434839;[JUN, MMP9, TNF, GNAI2, PAK1]
GO:0045078;positive regulation of interferon-gamma biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.212124270218933;0.027942676825076673;0.7438283705770736;[TLR8, TLR7]
GO:0045077;negative regulation of interferon-gamma biosynthetic process;8.0;1.0;0.875;9.628524252492122;836.0204953067102;8.390779266560578;0.027980853608317785;0.8041048419030481;[LILRB1, INHBA]
GO:0071479;cellular response to ionizing radiation;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;48.660440229648614;5.602686357784832;0.0016286211429333208;0.6096419534788213;[CDKN1A, BLM, FIGNL1, EGR1, TGFB1, MAPK14, DNM2, RAD51, NOX4]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[PID1, PYCARD, TCL1A, AKT1, CHUK, CHI3L1, XCL1, CCL13, CALCA, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, CCL23, CCL20, MAPK14, NFKB1]
GO:0050777;negative regulation of immune response;5.0;0.5193749703860713;0.549928497053956;7.293149336675085;78.83017544275083;4.909539177224887;0.0026383750295169523;0.5413150737011212;[IFNA2, TNFAIP3, TNF, LGALS3, CTLA4, IL13RA2, CCR2, HAVCR2, CD96, CR1, ANXA1, ARG1, SERPINB9, IRAK3, MMP12, CEACAM1, XCL1, CLEC12B, INPP5D, LYN, TGFB1, NR1H2, LILRB1, PTPRC, BCL6, PTPN6, FCGR2B]
GO:0038202;TORC1 signaling;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;27.12151398160788;7.697632086000634;9.077326651865194E-4;0.7445766281117727;[CARD11]
GO:0140052;cellular response to oxidised low-density lipoprotein particle stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;56.74958382123113;8.16763571524637;0.0018993574991869968;0.7408135829017477;[CD36, TLR6, TLR4, MYD88]
GO:0060333;interferon-gamma-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.514393750639154;0.00101047745553359;0.6329257181104212;[CIITA, HLA-DPA1, HCK, IFNG, HLA-DQB1, PTAFR, NCAM1, FCGR1B, HLA-DQA1, HLA-DRB4, HLA-DPB1, HLA-DRA, HLA-DRB1]
GO:1903997;positive regulation of non-membrane spanning protein tyrosine kinase activity;12.0;1.0;0.9481203125901445;9.628524252492122;2433.420620421529;7.9853141584524145;0.0814443982291329;0.8564896500084854;[STAP1, FYN]
GO:0060338;regulation of type I interferon-mediated signaling pathway;7.0;0.8653626801206646;0.7836007053175329;9.503361109538115;103.51609522721039;6.481236761676141;0.003464590548817385;0.6823701146576509;[MMP12, PTPN6]
GO:1903753;negative regulation of p38MAPK cascade;12.0;1.0;0.9481203125901445;9.628524252492122;1764.046878661414;8.16763571524637;0.0590410614896785;0.8658135829017477;[PTPN22]
GO:0048469;cell maturation;3.0;0.6954798709641801;0.5458602480722345;8.242229891372231;25.22197897315013;4.886724499458715;8.441569379239579E-4;0.4480276307483924;[CDKN1A, BRCA2, ROPN1L, FBXO5, HOXA5, RUNX2, BTK, CCL19, FZD5, NR4A2, SLC26A8, PLP1, SLC26A3]
GO:1901216;positive regulation of neuron death;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;58.38287487682085;5.370354380416217;0.001954022280951067;0.5977604853516485;[ITGAM, FASLG, MYB, FOS, KMO, IL1B, TLR6, TLR4, TP53BP2, FYN, EGR1, JUN, EIF2S1, FCGR2B, UBE2M]
GO:0002399;MHC class II protein complex assembly;7.0;1.0;0.8509193652572005;9.628524252492122;45.61567929762514;9.777073627680469;0.0015267157346454312;0.8509193652572005;[HLA-DMB]
GO:0060337;type I interferon signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.587418885654044;0.00101047745553359;0.6366602269110988;[IFNA5, IFNA4, IFNA7, IFNA2, SAMHD1, IFNA8, IFNA21, EGR1, IFNA14, IFNA16, MYD88, IFNA10]
GO:0070371;ERK1 and ERK2 cascade;10.0;1.0;0.9152410118609203;9.628524252492122;233.3964595037646;6.481236761676141;0.007811569456414605;0.7466917612613706;[MAP2K2, EGF, IQGAP3, TNFSF11, CTSH]
GO:0050663;cytokine secretion;9.0;0.6056485694559711;0.6990649099082746;8.227631091951078;133.331941423656;5.9928839937622085;0.004462500088492957;0.7027169913188946;[NLRC4, NLRP3, CCR7, ITGB6, CD36, CCL19, LYN, ABCA1, LILRB1, CHI3L1, LCP2, TLR6, TLR4, CARD11, TLR2]
GO:0090090;negative regulation of canonical Wnt signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.283683766200392;236.99226377157444;4.932886541221878;0.00793191778924446;0.6272680471207706;[TLE4, AES, PFDN5, FOXO1, EGR1, CAV1, TMEM64, MAPK14]
GO:0045086;positive regulation of interleukin-2 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.292166977892469;0.027942676825076673;0.747921758369865;[CD86, CD4, CD80, IL1B, CD28, PRKCQ, CD3E, CARD11]
GO:0070372;regulation of ERK1 and ERK2 cascade;10.0;0.8653626801206646;0.8479223519212526;9.541512875502493;158.98679164778278;4.069963362931594;0.0053211448376282704;0.623379127513894;[PHB2, TNF, CTGF, PYCARD, TNFSF11, EPHB1, PDGFRB, F2R, MIF, ATF3, EPHA3, C5AR1, FPR2, TNFRSF11A, SLC30A10, PKHD1, PDGFD, PDGFC, LYN, CCR1, JUN, TGFB1, MARCO, NOX4, NRP1, PTPRR, TREM2, PTPN22, CCR7, CD36, HAVCR2, SYK, DUSP1, DUSP6, CEACAM1, IL1B, KIT, CHI3L1, XCL1, TLR4, CCL13, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CSK, CCL19, CCL18, CCL23, CCL20, TIE1, CD4, NLRP12, PTPN6, TEK]
GO:0045084;positive regulation of interleukin-12 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;8.16763571524637;0.027942676825076673;0.7926932703116032;[TLR4]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CD86, CXCL6, CXCL9, CD80, HMGB2, TNFAIP3, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, PYCARD, EDNRB, PDE4B, CTSG, CD36, CCR5, HAVCR2, GHSR, MEF2C, ARG1, CD180, PDCD1LG2, TNFRSF1B, IL1B, ADAM9, TLR4, CX3CR1, CD274, CEBPE, KLRK1, STAP1, NLRP3, CCL2, ABCA1, CCL20, NR1H2, DEFA4, LILRB1, DEFA1, LILRB2, PPBP, MAPK14, NFKB1, CXCL10, CXCL11, PF4]
GO:0070375;ERK5 cascade;10.0;1.0;0.9152410118609203;9.628524252492122;233.3964595037646;9.083926447120524;0.007811569456414605;0.8797934328124444;[MEF2A]
GO:0006509;membrane protein ectodomain proteolysis;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;50.748517158788495;6.781341354126479;0.0016985071986044009;0.6977174774718518;[PSEN2, ADAM9, PRTN3, PRKCQ, RBMX]
GO:0071223;cellular response to lipoteichoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;155.87545856417063;7.474488534686424;0.005217011319337755;0.7053660038532718;[CCL20, TREM2, CD36, MAPK14, TLR2]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, SLA2, LGALS3, TRBC1, RNASE6, RNASE3, MIF, SLPI, BTK, PADI4, TRIM10, NAIP, LY9, KLRK1, SLAMF7, IGHA1, LYN, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, PTK2, MARCO, VNN1, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, LILRA5, IGKC, CARD9, KIR3DL1, LGR4, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, CLEC4D, S100A8, IFNA10, BLK, LY96, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, DEFA1, BMX, NFKB1, LCN2, KLRD1, ITGAM, KIR3DS1, CRISP3, HMGB2, TREM2, TREM1, SIRPB1, CR2, CR1, CHUK, FGR, ZAP70, LCK, LTF, COLEC12, UNC93B1, HIST1H2BK, NLRC4, FYN, CSK, CD6, PTX3, PTPN6, CD244]
GO:0070373;negative regulation of ERK1 and ERK2 cascade;11.0;1.0;0.9324289523296623;9.628524252492122;1180.902522994834;5.6339389012889365;0.039523744701365535;0.7205488497465309;[PTPRR, CSK, LYN, DUSP1, DUSP6, NLRP12, TLR4, ATF3]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, PYCARD, TNFSF11, EPHB1, PDGFRB, F2R, MIF, EPHA3, C5AR1, FPR2, TNFRSF11A, SLC30A10, PDGFD, PDGFC, CCR1, JUN, TGFB1, MARCO, NOX4, NRP1, TREM2, PTPN22, CCR7, CD36, HAVCR2, IL1B, KIT, CHI3L1, XCL1, CCL13, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL20, TIE1, CD4, TEK]
GO:0030838;positive regulation of actin filament polymerization;11.0;0.7866048967936545;0.8257314007264895;9.456673995565463;459.92540939869633;5.2552850506314295;0.01539328954657896;0.7011844742147011;[CYFIP1, LMOD1, PYCARD, CCR7, HCK, PFN1, NCKAP1L, VASP, GSN, JMY]
GO:0045088;regulation of innate immune response;6.0;0.4673148936341128;0.556777759407201;6.780712109014753;42.469229973879315;3.8881956693475885;0.0014214069074002054;0.52196281994017;[ICAM2, PRKACB, BTK, KLRK1, S100A14, LYN, SH2D1A, MARCO, CTSS, FFAR2, MUC15, CD36, HAVCR2, FCER1G, SYK, ARG1, FCRL3, SERPINB9, MMP12, TLR1, NCR1, HCK, CEACAM1, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, PAK1, NR1H2, CARD9, LILRB1, LGR4, PYCARD, IL18RAP, CD96, LAG3, CD180, CLEC4D, S100A8, CARD11, LY96, CLEC7A, MAP2K6, CAV1, NFKB1, NFKBIA, MYD88, ITGAM, HMGB2, TNFAIP3, PTPN22, CR1, CHUK, IRAK3, FGR, IFNG, LTF, COLEC12, UNC93B1, CLEC12B, NLRC4, SAMHD1, HSPD1, CCL5, FYN, PTPN6, FCGR2B]
GO:0071226;cellular response to molecule of fungal origin;5.0;1.0;0.7902410118609202;9.628524252492122;58.24779613319063;9.083926447120524;0.00194950131696474;0.7547934328124444;[SYK, BTK]
GO:0072678;T cell migration;7.0;0.7140352122741334;0.7079369713942671;8.8813098506619;30.235634434558513;6.686031174322154;0.001011959474220325;0.692843310444282;[CXCL9, GPR15, CCL20, DEFA1, CXCL16, CXCL10, ZAP70, CXCL11, CCL2, CCR6, CCR2]
GO:0071345;cellular response to cytokine stimulus;5.0;0.6729672293956388;0.6267246265587396;8.214830917184116;61.59823360834823;3.805811787890007;0.0020616374440603005;0.48487040368196277;[PID1, TFRC, TCL1A, AKT1, TNFSF11, BTK, PADI2, STXBP2, ST3GAL6, EGR1, CCR7, HLA-DPA1, MME, ARG1, TLR4, TLR2, CCL13, CXCR4, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL20, NLRP12, ZYX, IL18R1, IL17A, PYCARD, TLE4, KMO, KIF16B, CALCA, CSF2RB, CORO1A, NFKB1, BSPRY, ALAD, CHUK, CHI3L1, XCL1, MCM2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, MAPK14, CD4, KLF5, PTPN6, RBMX]
GO:0070498;interleukin-1-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.845247994956144;0.00101047745553359;0.6498456195510879;[EGR1, CHUK, IL1R1, IL1R2, IRAK3, NFKB1, NFKBIA, IL1B, MYD88]
GO:0071225;cellular response to muramyl dipeptide;7.0;1.0;0.8509193652572005;9.628524252492122;334.57737126116905;8.16763571524637;0.011198003516026267;0.7686126355688037;[PTPN22]
GO:0071346;cellular response to interferon-gamma;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[HLA-DPA1, KIF16B, XCL1, TLR4, TLR2, CCL13, STXBP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL20, ZYX]
GO:0014005;microglia development;5.0;1.0;0.7902410118609202;9.628524252492122;67.63861772680754;8.67846133901236;0.0022638036645123614;0.7340579283277371;[TSPAN2, TLR2]
GO:0042536;negative regulation of tumor necrosis factor biosynthetic process;8.0;1.0;0.875;9.628524252492122;858.4851481575464;7.9853141584524145;0.0287327253223603;0.7833693374183408;[GHSR, LILRB1]
GO:0045806;negative regulation of endocytosis;7.0;0.7192862368539868;0.710562483684194;9.057979394024509;124.57926064357885;5.8650506222523235;0.004169555739685066;0.6508583268319309;[MCTP1, LGALS3, CSK, TGFB1, NR1H2, CAV1, LILRB1, PRTN3, FCGR2B, EPHA3, TLR2]
GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;5.602686357784832;0.007979625599047746;0.6615216408886768;[CCL5, PDGFD, PDGFC, FYN, PDGFRB, F2R, PTK2, FGR, GH1, KIT, CD28, PTPN6, TEK]
GO:0043507;positive regulation of JUN kinase activity;13.0;0.8653626801206646;0.8952363048279688;9.582714716460828;4931.413721535565;5.459585514144159;0.16504997927558432;0.7417584218576596;[TNF, TNFSF11, MAP4K1, SYK, IL1B, TLR6, TNFRSF11A, PAK1, CCL19, FZD5, CD40LG, PKN1]
GO:0061052;negative regulation of cell growth involved in cardiac muscle cell development;10.0;1.0;0.9152410118609203;9.628524252492122;1870.595370074125;8.16763571524637;0.0626071436098452;0.8329342821725234;[PAK1]
GO:0043508;negative regulation of JUN kinase activity;13.0;1.0;0.9625549647676366;9.628524252492122;4937.625749520049;7.138016298065211;0.16525789026176277;0.8275934502023958;[PTPN22]
GO:1905664;regulation of calcium ion import across plasma membrane;9.0;0.8933024483968273;0.8428918493787028;9.517298617381897;138.2755146586044;8.390779266560578;0.004627957035739618;0.8253454670833372;[FYN]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[, NUP107, TFRC, AKT1, LYN, ABCA1, MMP12, GOPC, CSE1L, AP2M1, ACAP1, SLC27A2, LIN7A, EVI5, TNFSF13B, ITGB6, LCP2, LRP1, LRP2, GOLPH3L, ACTN4, MSR1, EGR2, POLA2, CD24, CD3G, CCR7, CD36, SYK, HSD17B4, STX11, RAMP1, SCARB2, CARD11, NUP155, NASP, NUP62, NUP133, TBC1D9, CHI3L1, NUP54, NUP35, RAN, PHB2, CUBN, NUP85, NUP88, DENND1B, ANXA1, CCL19, TNF, LAMP2, RAB32, CALCRL, BCL6, CCDC22, NLGN1, UNC93B1, NLRC4, RAB21, VPS41, ARFIP1, STXBP2, AHCTF1, TRAM2, XPO1, TMED6, ZDHHC17, RAB33B, TLR6, TLR4, TLR2, RANBP2, RANBP1, LILRB1, CD40LG, NUPL2, GOLT1B, TSC2, ATP1B1, HGS, COPB2, SUCNR1, NLRP3, TGFB1, LRP1B, NFKBIA, TBCK, DNM2, IFNG, HSPD1]
GO:0014063;negative regulation of serotonin secretion;8.0;1.0;0.875;9.628524252492122;272.1012405442988;8.390779266560578;0.009106983645799836;0.8041048419030481;[LILRB1]
GO:0051491;positive regulation of filopodium assembly;9.0;1.0;0.896240625180289;9.628524252492122;200.30665838708023;6.409777797693995;0.006704083591926775;0.7240369598395108;[NRP1, NLGN1, CCR7]
GO:0042770;signal transduction in response to DNA damage;6.0;0.7586651285174919;0.7024528768488905;9.34084218004034;57.72882169830185;5.142344639450834;0.0019321317096756808;0.5861000565951415;[CDKN1A, BRCA2, CHEK1, MIF, PCNA, SFN, E2F7, PLK2, MAPK14, CNOT3]
GO:0043620;regulation of DNA-templated transcription in response to stress;10.0;0.6302958089695718;0.7303889163457062;8.89455507741192;277.5670074981562;5.407625775213448;0.009289917946874546;0.6917872454856517;[CHEK1, RPS6KA1, ATF3, EGR1, JUN]
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;1230.2749798860389;5.618190544320798;0.04117619640118775;0.7197434780388068;[IFNA2, GHR, CCL5, FYN, IL6R, LYN, GH1, IFNG, KIT]
GO:0042535;positive regulation of tumor necrosis factor biosynthetic process;8.0;1.0;0.875;9.628524252492122;857.3444905607055;7.379178354882098;0.028694548539119222;0.7523715242355574;[TLR1, AZU1, TLR4, CCR2]
GO:0031638;zymogen activation;7.0;0.8259837884571596;0.7639112594857803;9.387362195675234;102.5832240862455;6.113511981550823;0.00343336819125881;0.663564652301091;[F11, DHCR24, CTSH]
GO:0032727;positive regulation of interferon-alpha production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;84.40547105694755;6.7325511899570465;0.0028249751562838235;0.6952223462072524;[CHUK, HSPD1, MMP12, TLR8, TLR7, TLR4]
GO:0030307;positive regulation of cell growth;6.0;0.6954798709641801;0.6708602480722345;8.712233520617966;80.64681300048527;4.733648510761223;0.0026991762537066665;0.5651993175676412;[CYFIP1, NRP1, CPNE5, CXCL16, RPS6KA1, AKT1, AVPR1A, S100A8, HBEGF, TAF9, PAK1, SFN, SYT2, CXCL12]
GO:0051365;cellular response to potassium ion starvation;7.0;1.0;0.8509193652572005;9.628524252492122;115.90251486529202;8.67846133901236;0.003879152867050031;0.7947362817240173;[JUN]
GO:0010813;neuropeptide catabolic process;7.0;0.9326813400603323;0.8172600352873667;9.56398573135455;142.40199253781023;9.083926447120524;0.004766066536767652;0.8154717862087246;[CTSH]
GO:0010933;positive regulation of macrophage tolerance induction;7.0;1.0;0.8509193652572005;9.628524252492122;164.43476621900118;9.777073627680469;0.005503483643668157;0.8509193652572005;[IRAK3]
GO:0010815;bradykinin catabolic process;7.0;1.0;0.8509193652572005;9.628524252492122;198.73492378151718;8.16763571524637;0.00665147904914789;0.7686126355688037;[CTSH]
GO:0010936;negative regulation of macrophage cytokine production;8.0;1.0;0.875;9.628524252492122;311.05347994333346;8.16763571524637;0.010410680043746014;0.7926932703116032;[TGFB1, IRAK3]
GO:0032728;positive regulation of interferon-beta production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;84.40547105694755;6.343086423195323;0.0028249751562838235;0.6753050999230941;[HMGB2, TLR8, TLR7, TLR4, TLR2]
GO:0032729;positive regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.6339389012889365;0.002183412136085803;0.6112402100070131;[PTPN22, CD3E, TNF, PYCARD, PDE4B, IL6R, CCR2, HLA-DPA1, HAVCR2, SLC11A1, IL1B, TLR8, TLR7, TLR4, HSPD1, KLRK1, IL12RB1, IL12RB2, FZD5, CD2, HLA-DPB1, IL18R1, CD244]
GO:0032722;positive regulation of chemokine production;6.0;0.7140352122741334;0.6801379187272112;8.734706376470026;66.68357405504983;5.8067817141283475;0.002231839212302133;0.6200793994936333;[TNF, PYCARD, FFAR2, IL6R, HAVCR2, EGR1, AZU1, MIF, IL1B, TLR7, TLR4, TLR2]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[CTSS, HLA-DOA, HLA-DOB, AP2M1, HLA-DPA1, LAG3, FCER1G, DNM2, HLA-DQB1, HLA-DMA, HLA-DMB, RACGAP1, HLA-DQA1, HLA-DRB4, HLA-DPB1, HLA-DRA, FCGR2B, HLA-DRB1]
GO:0032720;negative regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.92712208559752;5.926926025970411;0.002875903446815721;0.6540226378555745;[ORM1, TNFAIP3, PTPN22, GPNMB, HAVCR2, GHSR, LILRB1, IRAK3, BPI, TLR4, GPR18]
GO:0051248;negative regulation of protein metabolic process;6.0;0.4463712279514003;0.5463059265658446;6.752138736570697;129.5306506172274;2.7979283526116596;0.004335274306141412;0.46620649865967934;[PID1, SPINT2, AKT1, SPINT1, PRKAR1B, ATF3, FLRT2, PRKAR2B, SFN, NCKAP1L, ELANE, LYN, JUN, PKIG, CDKN1A, LRRC4, DUSP2, DUSP1, SERPINB9, PAX5, DUSP6, PAX2, HBEGF, ENG, SERPINB10, LRRC19, PTGS2, NTF3, FLNA, DMD, CDKN2C, NR1H2, PKN1, TNF, PYCARD, MEN1, LAG3, FOXO1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, PTPRC, CNOT3, LRRK2, PTPN22, ALAD, HHEX, CR1, TNFRSF1B, NLRC4, FYN, CSK, EIF3E, PTPN6, EDNRB, PPP2R1A, RPS6KA1, FBXO5, IL1R2, PAQR3, MIF, POR, SLPI, NAIP, INPP5D, TNFSF14, ITM2A, ITM2C, PTPRR, CEACAM1, BANK1, IL1B, TLR4, GNAI2, TM4SF20, LILRB1, LILRB2, NLRP12, GHSR, TSC2, TGFB1, CAV1, CRIM1, INHBA, EIF2S1, LIN28A, TNFAIP3, LRRTM4, NUP62, MYOCD, IRAK3, MMP9, LTF, TAF9, SPOCK3, PTX3]
GO:0032600;chemokine receptor transport out of membrane raft;11.0;1.0;0.9324289523296623;9.628524252492122;247.9928586842006;9.777073627680469;0.008300097801077391;0.9324289523296623;[CD24]
GO:2001184;positive regulation of interleukin-12 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.5029195149353;8.67846133901236;0.02521906460756386;0.8590579283277371;[MAPK14]
GO:1905430;cellular response to glycine;7.0;1.0;0.8509193652572005;9.628524252492122;543.0623632319648;9.777073627680469;0.01817580857297763;0.8509193652572005;[FYN]
GO:2001186;negative regulation of CD8-positive, alpha-beta T cell activation;10.0;0.8933024483968273;0.861892236059334;9.551563211355994;305.21353058757757;8.16763571524637;0.010215222194422061;0.8329342821725234;[CD274, LILRB1]
GO:0042307;positive regulation of protein import into nucleus;9.0;0.9326813400603323;0.8625812952104552;9.592156608321247;778.7460608588023;6.063501560976162;0.02606392983099081;0.706328376990269;[LRRK2, PTGS2, CDH1, TGFB1, JUP, MAPK14, IFNG]
GO:0006691;leukotriene metabolic process;7.0;0.7586651285174919;0.7302519295159464;9.193206181234276;59.92630818990423;6.343086423195323;0.002005679604940167;0.6753050999230941;[SYK, CYP4F2, CYP4F3, ALOX5, TLR2]
GO:2001180;negative regulation of interleukin-10 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.9724324201893;8.67846133901236;0.02523477878196853;0.8590579283277371;[LILRB1]
GO:0002092;positive regulation of receptor internalization;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;393.55365953464764;6.599019797332524;0.013171886809326083;0.7337148045016781;[SYK, EGF, NTF3, SELE]
GO:0000902;cell morphogenesis;4.0;0.6260725219892441;0.563036260994622;7.923776160253697;43.26261951924051;4.420487353008457;0.0014479609414792109;0.47606392880653703;[CYFIP1, SPINT2, CDH5, C1GALT1C1, CDH3, CDH1, MEF2C, ACTN1, COL23A1, CLDN3, SLC1A3, EPB41L5, NCKAP1L, ST14, BCL11B, BCL6, NOX4, NRP1, PALLD, PDPN, SLITRK6, FLNA, MAPK14, GRHL2, TEK]
GO:2001183;negative regulation of interleukin-12 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.9724324201893;8.67846133901236;0.02523477878196853;0.8590579283277371;[TLR8, LILRB1]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[CDA, KCNG2, TCL1A, TNFSF11, MIF, OLFM4, CLDN3, BLM, MGST1, CD79B, CD79A, NACC2, VASP, CAV1, CD3G, CD3E, CD3D, ALAD, FCER1G, KCND2, ARG1, NUP54, ACPP, FBP1, COLEC12, NLGN1, HM13, KCNA5, NLRC4, SAMHD1, PLN, GCH1, RAD51, P2RX1, GOPC, CD247, RBMX]
GO:0042663;regulation of endodermal cell fate specification;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;108.59969873383258;8.390779266560578;0.0036347341832379046;0.8041048419030481;[DUSP6]
GO:0042542;response to hydrogen peroxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;79.2907140195247;5.09494240055625;0.0026537888412237636;0.5507966031644187;[HP, TNFAIP3, SLC8A1, IL18RAP, MYB, PDGFRB, ANXA1, DUSP1, ARG1, PAX2, ADAM9, PCNA, KCNA5, FOXO1, PDGFD, JUN, SDC1, EZH2]
GO:0009967;positive regulation of signal transduction;6.0;0.44130843764162375;0.5437745314109563;6.712834686611667;140.23187634019237;2.4492930892588385;0.004693434700611163;0.44837727507861835;[, SLA2, AKT1, ATF3, FPR1, FPR2, SLC30A10, IQGAP3, PDGFD, PDGFC, SFN, LYN, JUN, JAG1, JUP, NOX4, GPR18, EZH2, ARHGAP6, JPH2, GPR37, DUSP6, MMP12, NTF3, FLNA, BIK, LRG1, PKN1, LGR4, CTGF, RUVBL1, MAL, S100A8, LY96, TNFRSF11A, TNFRSF10B, NFKB1, CXCL10, CXCL11, PTPRC, MYD88, LRRK2, FASLG, HHEX, ADAMTS20, ACPP, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, SH2B1, TIE1, PTPN6, FCGR2B, TNFSF11, EPHB1, ACTN4, MIF, BTC, EPHA3, NAIP, TGFA, CD19, TSPAN5, PAG1, CCR1, TNFSF14, TNFSF12, PTK2, CD28, CD24, NRP1, CD3E, CTSH, CCR7, CD36, SYK, GAB1, BANK1, IL1B, KIT, GNAI2, PAK1, PPP1CA, NLRP12, IL18R1, CD86, CD80, IL6R, PDGFRB, CARD11, RASGRP4, CAV2, CAV1, INHBA, GH1, TNFAIP3, GHR, NUP62, MYOCD, MMP9, ELF3, CHI3L1, EGF, MAPK14, CD4, TEK, CYFIP1, PHB2, EPS8, PROK2, SEH1L, ICOS, ELANE, NDFIP2, FZD5, PLK2, HAVCR2, FCRL2, FCRL3, NFAM1, HBEGF, ENG, CCL13, GPNMB, CCL19, CCL18, CCL23, GSN, CCL20, CARD9, G0S2, SULF2, PF4, TNF, FGF5, PYCARD, CDH3, GRAP2, MEN1, MAP2K2, CD180, F2R, ADAM9, NACC2, DRD4, MAP2K6, CSPG4, CCDC22, LAT, PLEKHF1, TREM2, PTPN22, CHUK, LCK, XCL1, NLGN1, CSK, P2RX5, PPP2R1A, SKP2, IL1R1, POR, TP53BP2, SH2D1A, MARCO, ITM2C, IFNA2, PRL, ESM1, MAP4K1, ZDHHC17, TLR1, TLR7, TLR6, TLR5, TLR4, TLR2, CXCR4, SORBS1, CD40LG, F2RL3, GOLT1B, GHSR, C5AR1, ADRB2, STAP1, TGFB1, LIN28A, CXCL9, BLNK, TGFBR3, FGR, ZAP70, IFNG, LTF, DLL1, TRAT1, LTBR]
GO:0098586;cellular response to virus;6.0;0.7763722522362496;0.7113064387082693;8.999915593069748;28.654098265158677;6.375876246018314;9.59026881920657E-4;0.6491829203200885;[CHUK, MAPK14, MMP12, CCL19]
GO:0032715;negative regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.96654663153603;6.166155715036245;0.002174371849661483;0.6384578026126634;[ORM1, TNFAIP3, PTPN22, TNF, INPP5D, NCKAP1L, CSK, HAVCR2, GHSR, IRAK3, NLRP12, BANK1, BPI, TLR4]
GO:0097011;cellular response to granulocyte macrophage colony-stimulating factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;7.57984905034425;0.0027327542132076126;0.710754145523778;[CD4, AKT1]
GO:0051496;positive regulation of stress fiber assembly;11.0;1.0;0.9324289523296623;9.628524252492122;365.07497849775285;5.926926025970411;0.012218730984170163;0.735532224928036;[NRP1, ARHGEF10L, CTGF, PAK1, TPM1, NOX4]
GO:0030890;positive regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.1565706318756;6.063501560976162;0.016940604907709607;0.706328376990269;[CDKN1A, TFRC, TNFSF13B, NCKAP1L, MEF2C, FCRL3, MIF, MSH6, BST1, PTPRC, BCL6, CARD11, CD320]
GO:2001056;positive regulation of cysteine-type endopeptidase activity;11.0;0.7866048967936545;0.8257314007264895;9.510741216835738;564.4496488902071;4.835431205071165;0.018891621776651546;0.6797131290275487;[TNF, CTGF, PYCARD, F2R, S100A8, NLRP3, TNFRSF10B, FASLG, CTSH, LCK, NLRC4, HSPD1, FYN, GSN, HSPE1, NLRP12, P2RX1]
GO:0031623;receptor internalization;7.0;0.7248374789738407;0.7133381047441208;9.201080237665183;64.84818556283533;5.682729065458369;0.0021704104112101165;0.6415343939386686;[CALCRL, LRP1, TFRC, CXCR1, CXCR2, CD36, AP2M1, FCER1G, SYK, CAV1, LILRB1, DNM2, CEACAM1, CD9, RAMP1]
GO:1905563;negative regulation of vascular endothelial cell proliferation;8.0;1.0;0.875;9.628524252492122;108.34661668819432;8.390779266560578;0.0036262637549294456;0.8041048419030481;[MEF2C, CCL2]
GO:0043406;positive regulation of MAP kinase activity;12.0;0.7043150770688792;0.8002778511245842;9.369013057007038;2605.6877929993507;4.201124524534153;0.08721002546492271;0.6629660161470909;[, TNF, PROK2, TNFSF11, PDGFRB, MAP2K2, F2R, MIF, ADAM9, C5AR1, FPR1, TGFA, TNFRSF11A, IQGAP3, PDGFD, PDGFC, ELANE, DRD4, MAP2K6, TGFB1, FZD5, GH1, NOX4, CSPG4, CD24, EZH2, LRRK2, GHR, MAP4K1, SYK, DUSP6, IL1B, KIT, TLR6, TLR4, CXCR4, PAK1, NTF3, CSK, CCL19, EGF, MAPK14, CD40LG, PKN1]
GO:0043647;inositol phosphate metabolic process;6.0;0.7436939687323844;0.6949672969563367;9.280217558223907;87.6170970844922;5.769740442447999;0.002932465389149971;0.618185107137305;[PTAFR, PLD4, IMPA2, INPP5D, PLCG1, MIOX]
GO:0043407;negative regulation of MAP kinase activity;12.0;0.811012628672052;0.8536266269261705;9.539970855150678;2610.1786565788484;5.4730085344763;0.08736033062741366;0.7280102235641875;[PTPN22, PPP2R1A, NUP62, DUSP2, DUSP1, PAQR3, IRAK3, DUSP6, IL1B, LYN, CAV1, PTPN6]
GO:2001198;regulation of dendritic cell differentiation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;68.77525917473399;7.474488534686424;0.0023018460308635697;0.7331650565203278;[TMEM176B, TMEM176A, LILRB1, LILRB2, FCGR2B]
GO:1904355;positive regulation of telomere capping;9.0;0.9326813400603323;0.8625812952104552;9.59462270081644;613.4505056642549;6.943860283624253;0.02053163635497091;0.7513499630073597;[PRKCQ]
GO:2001193;positive regulation of gamma-delta T cell activation involved in immune response;10.0;1.0;0.9152410118609203;9.628524252492122;449.64974642203094;9.777073627680469;0.01504937235424625;0.9152410118609203;[LILRB1]
GO:1905564;positive regulation of vascular endothelial cell proliferation;8.0;1.0;0.875;9.628524252492122;108.29290547333461;7.138016298065211;0.0036244660889050463;0.7400384854347593;[GHSR, PLCG1]
GO:0002062;chondrocyte differentiation;4.0;0.8933024483968273;0.6966512241984136;9.446202695698167;21.066225782797595;6.039404009397101;7.050676185779127E-4;0.5588554019015759;[MEF2C, TGFB1, MAPK14, RUNX2]
GO:2001190;positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell;9.0;1.0;0.896240625180289;9.628524252492122;413.7426732268016;9.083926447120524;0.013847594928669781;0.8607930461318132;[HLA-DMB]
GO:0006661;phosphatidylinositol biosynthetic process;8.0;0.7508913569872202;0.7504456784936101;9.237657943805111;661.808482261977;4.917261223318797;0.022150134312343243;0.6264689676365554;[FGF5, GAB1, INPP5D, BMX]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPIB, MYB, HOXA3, AKT1, HOXA7, HOXA5, MEF2A, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, NKX2-3, JUN, JAG1, JUP, FZD5, PAX5, FOS, PAX2, MMP12, ENG, EPCAM, STAT4, NR1H2, ATAD2, GTF2H1, PSMC6, PSMC2, PF4, PLXND1, TNF, MEN1, FOXO1, NFKB1, CXCL10, COPS5, MAFF, CIITA, HHEX, CHUK, CEBPE, E2F5, E2F7, KLF1, KLF5, POU2AF1, CCNH, RPS6KA1, TNFSF11, DPF3, SLC11A1, EBF1, FLT3LG, RUNX2, BEX1, NHLH2, EGR1, EGR2, EGR3, BCL11B, CD28, PRL, CD3D, RGMA, IL1B, TLR4, TLR2, LILRB1, GRHL2, IL17A, ARID4A, HOXA10, ADRB2, NLRP3, TGFB1, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYOCD, CKAP2, ELF3, TAF9, DLL1, MAPK14, MEIS2, MEIS1, RBMX]
GO:0045824;negative regulation of innate immune response;7.0;0.6240278086381567;0.6629332695762788;8.460919092337061;174.18841360624353;5.970411137910149;0.005829929444006407;0.6562464685024372;[CLEC12B, TNFAIP3, HAVCR2, CD96, CR1, ARG1, NR1H2, LILRB1, SERPINB9, IRAK3, MMP12, CEACAM1]
GO:0043525;positive regulation of neuron apoptotic process;8.0;0.8436909121759173;0.7968454560879586;9.392135474427892;179.36331192335928;5.885253329569843;0.0060031286335741505;0.6759721289664703;[FASLG, MYB, JUN, IL1B, UBE2M]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[NRP1, CHL1, MEF2C, F2R, MSH2, NAIP, LRP1, C5AR1, SLC30A10, CORO1A, NTF3, CCL2, FYN, JUN, WFS1, GABRA5, NR4A2]
GO:0051145;smooth muscle cell differentiation;5.0;0.7763722522362496;0.6784271379790451;8.85533436425864;21.75937296335754;6.7325511899570465;7.282666309192915E-4;0.6345439928109722;[MEF2C, MYOCD, EDNRB]
GO:0030889;negative regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.3396801226706;7.004484905440688;0.016946733417578675;0.7544503089863854;[LYN, TNFRSF13B, PAWR, INPP5D, BTK, CTLA4, MNDA, PKN1, FCGR2B]
GO:0051146;striated muscle cell differentiation;5.0;0.7436939687323844;0.6620879962271125;8.781226392104918;21.75937296335754;5.825829909099042;7.282666309192915E-4;0.5881742243410422;[POPDC3, AKT1, MEF2C, MYOCD, CHUK, SORT1, AVPR1A, MAPK14, NOX4, SIK1]
GO:0032707;negative regulation of interleukin-23 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.96654663153603;9.083926447120524;0.002174371849661483;0.7876727335416686;[TLR4]
GO:0032700;negative regulation of interleukin-17 production;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;65.25422870398782;7.292166977892469;0.002184000309729388;0.6960420709600095;[TGFB1, IFNG, NCKAP1L, TLR4]
GO:2001189;negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell;9.0;1.0;0.896240625180289;9.628524252492122;430.8793777811617;8.67846133901236;0.014421145008071396;0.8400575416471059;[LGALS3, LILRB1, HAVCR2]
GO:0051149;positive regulation of muscle cell differentiation;6.0;0.7090535922965819;0.6776471087384355;8.848365694942547;114.55096530066652;5.346256828837156;0.0038339177194376536;0.5965281354432446;[CXCL9, SMARCD3, MEF2A, MEF2C, MYOCD, TGFB1, TNFSF14, FLT3LG, MAPK14, KIT, ENG]
GO:0030522;intracellular receptor signaling pathway;5.0;0.6547035408479693;0.617592782284905;7.98629651723503;23.17027026302992;4.6122876537569555;7.75488093814194E-4;0.5261136169673617;[SLA2, ACTN4, CCNE1, PADI2, MAP2K6, DEFA1, NR4A2, NFKBIA, NR4A1, TNFAIP3, NR1H2, RAN]
GO:0016358;dendrite development;6.0;0.8259837884571596;0.7361122068187242;9.260799472366804;32.63417926892749;6.343086423195323;0.0010922366112764486;0.647506047256038;[NRP1, CD3E]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[RUVBL1, SKP2, PSMD14, ADRB2, NLRP3, BARD1, NFKBIA, COPS5, TNFAIP3, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, FAM105A, USP9Y, PSMC6, PSMC2, EIF3F]
GO:0043537;negative regulation of blood vessel endothelial cell migration;10.0;0.9326813400603323;0.8815816818910864;9.584072489921288;356.3539069568923;6.311337724880743;0.01192684456815238;0.7380031166185408;[MEF2C, TGFB1, JUP]
GO:0046928;regulation of neurotransmitter secretion;7.0;0.6493065804076676;0.6755726554610344;8.817594036275793;103.1091377978561;5.71663061713405;0.0034509700498948056;0.6432681208679463;[NLGN1, MCTP1, LRRK2, MEF2C, CHRNB4, KMO]
GO:0038124;toll-like receptor TLR6:TLR2 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;8.390779266560578;0.013811191226989502;0.8772251544931927;[CD36, TLR6, TLR2]
GO:0038123;toll-like receptor TLR1:TLR2 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;8.67846133901236;0.013811191226989502;0.8919372290569614;[TLR1, TLR2]
GO:0051281;positive regulation of release of sequestered calcium ion into cytosol;13.0;0.8933024483968273;0.9092061889660501;9.585964638073326;905.0686146861244;6.139487467954083;0.03029183202467376;0.7765286393941734;[CXCL9, TRPC1, F2R, CXCL10, CXCL11, JPH2, CD19, XCL1, PLCG1, F2RL3]
GO:0043536;positive regulation of blood vessel endothelial cell migration;10.0;0.9326813400603323;0.8815816818910864;9.584072489921288;355.43002650478036;5.8067817141283475;0.011895923120858621;0.7122000987644093;[NRP1, PTGS2, AKT1, PLCG1, TGFB1, ANXA1, PLK2]
GO:0045953;negative regulation of natural killer cell mediated cytotoxicity;9.0;0.8653626801206646;0.8289219652406215;9.526741558182179;431.6560499367194;7.379178354882098;0.014447139526158352;0.7736121494158466;[CEACAM1, CLEC12B, LILRB1, SERPINB9, HAVCR2]
GO:0045954;positive regulation of natural killer cell mediated cytotoxicity;9.0;0.8653626801206646;0.8289219652406215;9.526741558182179;431.31665099041965;6.444869117505266;0.014435780148864921;0.7258315315665724;[LAG3, SH2D1A, IL18RAP, KLRK1]
GO:0007517;muscle organ development;4.0;0.7763722522362496;0.6381861261181248;8.753055515138222;27.682183388997124;5.085725745451326;9.264977656821302E-4;0.5100842511328143;[TAGLN, SGCE, BASP1, DMD, MEF2A, MEF2C, EGR3, CXCL10, ITGA7, HBEGF]
GO:0051279;regulation of release of sequestered calcium ion into cytosol;9.0;0.7369933605727446;0.7647373054666613;9.242861771680136;148.50473241193134;5.486614186532078;0.004970319748245178;0.676826329833192;[CXCL9, CORO1A, SLC8A1, JPH2, PLN, CD19, DMD, PLCG1, LYN, TGFB1, TRPC1, F2R, CXCL10, CXCL11, XCL1, PTPN6, F2RL3]
GO:0006306;DNA methylation;9.0;0.7436939687323844;0.7680876095464813;9.253830803050711;389.4685312710283;5.948432231191374;0.01303516124271949;0.7004437261138039;[EHMT2, FOS, EZH2]
GO:0032817;regulation of natural killer cell proliferation;8.0;0.8259837884571596;0.7879918942285797;9.485423408851448;79.99831622737885;7.57984905034425;0.0026774716503199995;0.7626338329336335;[FLT3LG, PTPN22]
GO:0010803;regulation of tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;58.00234281560482;5.734022359845919;0.001941286215318787;0.64415753539903;[TNFAIP3, TNF, PYCARD, CHUK, SYK, TRAF1]
GO:2001199;negative regulation of dendritic cell differentiation;8.0;1.0;0.875;9.628524252492122;349.4674446787805;7.9853141584524145;0.01169636087311766;0.7833693374183408;[TMEM176B, TMEM176A, LILRB1, FCGR2B]
GO:0060045;positive regulation of cardiac muscle cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;720.414482973016;6.641579411751319;0.024111624414165377;0.7548916918429109;[TGFBR3, MEF2C, MAPK14]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[IL5RA, SLA2, FGF5, GRAP2, EPHB1, PDGFRB, MAP2K2, BTC, MELK, BTK, EPHA3, BLK, CSF2RB, MAP2K6, LYN, BMX, PTK2, ITK, GHR, SYK, FGR, ZAP70, HCK, LCK, KIT, HBEGF, FYN, CSK, IL12RB2, EGF, TIE1, WEE1, PTPN6, TEK]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, CCNH, SPIB, MYB, HOXA7, HOXA5, MEF2A, MEF2C, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, NHLH2, EGR1, EGR2, JUN, BCL11B, PAX5, FOS, PAX2, FLNA, GTF2H1, GRHL2, ARID4A, HOXA10, C5AR1, HMGA1, NFKB1, COPS5, MAFF, MYOCD, ELF3, CREB5, CEBPE, TAF9, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, MEIS2, MEIS1, KLF5, POU2AF1, RBMX]
GO:0006006;glucose metabolic process;6.0;0.7090535922965819;0.6776471087384355;8.572471578242808;34.676020684410545;5.040875179285974;0.0011605752059146955;0.5809109036834981;[TNF, HK3, AKT1, NPY1R, FBP1, ATF3, MAPK14]
GO:0009756;carbohydrate mediated signaling;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;23.17027026302992;8.390779266560578;7.75488093814194E-4;0.7193458537639684;[COLEC12, CLEC7A]
GO:0032526;response to retinoic acid;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;43.78950961223322;5.123113277522946;0.0014655954787213788;0.5522372631225753;[PHB2, MYB, CTSH, IGFBP7, LYN, ABCA1, PDGFRB, DUSP1, TIE1, PAX2, EPHA3]
GO:0035914;skeletal muscle cell differentiation;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.845247994956144;7.050676185779127E-4;0.5489262542938873;[EGR1, MEF2C, EGR2, PAX5, FOS, KLF5, MAFF, ATF3]
GO:0033619;membrane protein proteolysis;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;49.64990487012002;6.166155715036245;0.001661737633989536;0.6384578026126634;[HM13, PSEN2, CTSH, TGFB1, NFKB1, ADAM9, PRTN3, PRKCQ, RBMX]
GO:0048167;regulation of synaptic plasticity;7.0;0.6729672293956388;0.6874029799550199;8.567652291806858;39.259689615435484;4.623782033182691;0.0013139864800018823;0.5873797934620173;[MCTP1, NRGN, GRM5, TNR, MEF2C, SORCS3, KIT, CX3CR1, SLC24A2, SLC24A1, NLGN1, PTGS2, EGR2, PLK2, LILRB2]
GO:0030220;platelet formation;5.0;1.0;0.7902410118609202;9.628524252492122;33.79744107268718;6.832634648514029;0.0011311699369806302;0.639662265535933;[MEF2C, ACTN1, NBEAL2, PTPN6]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[CELSR1, CDH3, AP2M1, TLE4, HOXB9, CCNE1, PFN1, APCDD1, FZD5, NR4A2, VANGL1, SDC1, CD24, CDK14, LRRK2, HHEX, AES, EGF, TMEM64, LGR4]
GO:0010613;positive regulation of cardiac muscle hypertrophy;8.0;0.8933024483968273;0.8216512241984136;9.485423408851448;95.57844489853944;6.444869117505266;0.003198924535738274;0.7045909063862833;[MEF2A, TRPC3, PTK2]
GO:0032760;positive regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.9095484537234;5.587418885654044;0.002875315273172136;0.6366602269110988;[ORM1, LRRK2, PYCARD, CD36, CCR2, HAVCR2, FCER1G, MIF, TLR1, TLR4, TLR2, PTAFR, LY96, CCL19, FZD5, CARD9, AZU1, CD2, PF4]
GO:0010976;positive regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;493.1928131726474;4.231896183200907;0.016506719612173492;0.6126599927924817;[SCARB2, CYFIP1, CPNE5, PLXND1, EPHA3, LYN, SYT2, CXCL12, EZH2, ROBO2, NRP1, NLGN1, RAB21, PAK1, CNR1, FYN]
GO:0051209;release of sequestered calcium ion into cytosol;14.0;0.7980440201809971;0.874941375347699;9.527428135620752;522.9340415463636;5.9928839937622085;0.01750213176047399;0.7823957313958061;[F2R, FASLG, JPH2, PTPRC, LCK, XCL1, CCR7, CCL19, CCR5]
GO:0030224;monocyte differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;69.52661413212034;7.004484905440688;0.0023269932051117304;0.6813299963962409;[MEF2C, JUN]
GO:0032765;positive regulation of mast cell cytokine production;9.0;1.0;0.896240625180289;9.628524252492122;311.82526325162985;8.67846133901236;0.010436510936514811;0.8400575416471059;[FCER1G]
GO:1900182;positive regulation of protein localization to nucleus;7.0;0.8436909121759173;0.7727648213451592;9.36615998802463;74.62336946219564;5.446340287394138;0.0024975770192273523;0.6294454608352614;[LRRK2, CDH1, AKT1, CCT3, CCT2, IFNG, PTGS2, FYN, CCT8, CCT7, CCT5, CCT4, TGFB1, JUP, MAPK14, CCT6A]
GO:0060397;JAK-STAT cascade involved in growth hormone signaling pathway;8.0;1.0;0.875;9.628524252492122;26.42836680105094;7.212124270218933;8.845336528452411E-4;0.7438283705770736;[LYN, GHR, GH1, PRL]
GO:1905875;negative regulation of postsynaptic density organization;8.0;1.0;0.875;9.628524252492122;179.1445802505115;9.777073627680469;0.005995807881329661;0.875;[LILRB2]
GO:0038066;p38MAPK cascade;11.0;1.0;0.9324289523296623;9.628524252492122;290.6144555783003;7.8311634786251565;0.009726604292176047;0.8329150168128974;[MAPK14]
GO:0060395;SMAD protein signal transduction;5.0;1.0;0.7902410118609202;9.628524252492122;23.17027026302992;5.734022359845919;7.75488093814194E-4;0.5834791820027497;[JUN, TGFB1, INHBA, FOS]
GO:0038061;NIK/NF-kappaB signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;6.8867018697843045;8.845336528452411E-4;0.6753065664753021;[CHUK, NFKB1, AKT1]
GO:0038063;collagen-activated tyrosine kinase receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;57.50475921673876;7.474488534686424;0.0019246325400609058;0.7572456912631272;[SYK]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[, HP, CXCL13, TNF, PYCARD, IGHG1, TRBC1, IL6R, SLC11A1, RNASE6, RNASE3, CLEC4D, SLPI, S100A8, SEH1L, C5AR1, KLRK1, NLRP3, S100A14, IGHA1, ELANE, DEFA4, PRG2, AZU1, DEFA1, PPBP, LYZ, IGKV3-20, MYD88, IGHM, CXCL6, HMGB2, CTSG, CD36, CAMP, HAVCR2, FCER1G, SYK, ANXA3, TLR1, FGR, IGHD, BPI, TLR6, TLR5, TLR4, LTF, TLR2, CEBPE, HIST1H2BK, NLRC4, IGKC, CCL20, CARD9, CD4]
GO:0030217;T cell differentiation;6.0;0.657518819034173;0.651879722107231;8.679443697794976;65.04859315339479;5.132682728539097;0.00217711787291102;0.5856059460217904;[ITK, CD3G, PTPN22, CD3E, CD3D, CCR9, CCR6, ANXA1, FCER1G, RUNX2, ZAP70, CLEC4D, LCK, KIT, BLM, NKX2-3, EGR1, TGFB1, BCL11B, FZD5, BMX, CD4, PTPRC, DNAJA3, CD28, GPR18, IL18R1]
GO:0010629;negative regulation of gene expression;6.0;0.471430776349301;0.558835700764795;6.738152494595957;59.04642522059629;2.349334787147576;0.001976230713800692;0.44326540286011196;[EHMT2, SLA2, AKT1, MEF2A, MEF2C, ATF3, IQGAP3, JUN, PKIG, EZH2, MMP12, FLNA, LGR4, GMNN, CTGF, FOXO1, NFKB1, CIITA, LRRK2, FASLG, HHEX, FYN, E2F7, EIF3E, UXT, MIF, KCNQ1, NAIP, PCBP3, CCR1, EGR1, MSR1, CD28, PTPRK, CD3E, CD36, BANK1, IL1B, CCNE1, CALCA, CAV1, HMGA1, MXD1, HMGB2, MYOCD, ELF3, FBP1, PHB2, MYB, HOXA7, HOXB4, HOXB3, PRDM16, ELANE, BARD1, NDFIP2, CDKN1A, HAVCR2, PAWR, PAX5, PAX2, AES, ENG, NR1H2, TNF, DACH1, MEN1, TLE4, MAP2K2, NACC2, WFS1, LSM5, LSM3, BCL6, CNOT3, PTPN22, CR1, RFC1, XCL1, NLRC4, RBBP8, ZNF503, KLF8, KLF5, DNAJA3, ZNF608, EDNRB, PPP2R1A, MAGOH, DPF3, IL1R2, RUNX2, BCL11A, IFNA2, XPO1, MLH1, ARID4A, BASP1, TGFB1, CBX4, EIF2S1, NR4A2, LIN28A, IFNG, PFDN5, MEIS2, RBMX]
GO:0031668;cellular response to extracellular stimulus;4.0;0.5452700253111464;0.5226350126555732;7.377232453885626;45.163559484697416;4.334655917158676;0.0015115836913881548;0.47167450518560927;[EHMT2, LAMP2, SKP2, SIK1, ATF3, SEH1L, ABCB4, FOXO1, GAS2L1, LYN, JUN, EIF2S1, NR4A2, CDKN1A, PLEKHF1, LRRK2, ASGR1, UPP1, AVPR1A, FOS, AES, PTGS2, FYN, SIPA1]
GO:0032757;positive regulation of interleukin-8 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.948432231191374;0.002183412136085803;0.6273234135236593;[TNF, PYCARD, FFAR2, CD58, ELANE, F2R, TLR1, CD2, IL1B, TLR8, TLR7, TLR5, TLR4, CD244, TLR2]
GO:0030218;erythrocyte differentiation;5.0;0.8436909121759173;0.712086467948879;9.117698628726131;22.675663695230284;5.885253329569843;7.589340571069517E-4;0.5912131408273906;[LYN, INHBA, KLF1, TGFBR3, KIT, ACIN1, TRIM10]
GO:0010989;negative regulation of low-density lipoprotein particle clearance;6.0;1.0;0.8231203125901445;9.628524252492122;57.61250424992052;8.16763571524637;0.0019282386693572648;0.7408135829017477;[CSK]
GO:0010507;negative regulation of autophagy;7.0;0.7436939687323844;0.7227663496233927;9.117698628726131;217.48068666745357;5.500407508664414;0.007278882862848883;0.6322104610454062;[LRRK2, PTPN22, AKT1, TSC2, PTK2]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[PID1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, IQGAP3, JUN, JAG1, JUP, AZU1, FOS, MMP12, PTAFR, STAT4, ATAD2, PSMC6, PSMC2, LGR4, CTGF, PKP3, BLM, FOXO1, NFKB1, CXCL10, MYD88, CIITA, HHEX, CCL5, E2F5, E2F7, POU2AF1, EIF3E, EIF3D, CCNH, TNFSF11, EGR1, EGR2, EGR3, CD28, BRCA2, CD3E, CD3D, CTSH, CD36, RGMA, IL1B, KIT, IL17A, CD86, CD80, ACTG2, CCNE1, CAV1, HMGA1, INHBA, TCF4, HMGB2, ARHGEF10L, NUP62, MYOCD, ACTA2, PSRC1, ELF3, CREB5, TAF9, EGF, MAPK14, CD4, RAN, EHF, MYB, HOXA3, HOXA7, HOXA5, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, NFE2, FZD5, PAWR, SERPINB9, PAX5, PAX2, ENG, EPCAM, GSN, NR1H2, GTF2H1, PLP1, PF4, PLXND1, TNF, CDH3, CDH1, MEN1, MAP2K2, F2R, ADAM2, COPS5, MAFF, PTPN22, LBH, RFC1, CHUK, SMARCD3, CEBPE, POLR2E, POLR2K, POLR2L, KLF1, KLF5, CHEK1, RPS6KA1, DPF3, SLC11A1, EBF1, FLT3LG, RUNX2, BEX1, NHLH2, BCL11B, IFNA2, PRL, RHOG, TLR6, TLR4, TLR2, LILRB1, GRHL2, CAMK4, ARID4A, HOXA11, HOXA10, HGS, ADRB2, STAP1, NLRP3, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, SLC40A1, CKAP2, DNM2, IFNG, DLL1, MEIS2, MEIS1, RBMX]
GO:0001913;T cell mediated cytotoxicity;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;37.17052405245288;7.292166977892469;0.001244063988735793;0.6960420709600095;[CTSH]
GO:0031663;lipopolysaccharide-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;6.343086423195323;8.87013979980389E-4;0.647506047256038;[PTAFR, LY96, PTPN22, TNF, CCL5, AKT1, CCL2, LYN, TGFB1, MAPK14, NFKBIA, HCK, CD6, IL1B, TLR4, TLR2]
GO:0072139;glomerular parietal epithelial cell differentiation;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;51.0109489693332;9.083926447120524;0.0017072905551300363;0.8154717862087246;[CD24]
GO:0032870;cellular response to hormone stimulus;5.0;0.6039883530135606;0.5922351883677006;7.932074963068391;80.94247679971589;3.9540277321974506;0.0027090718549867714;0.49245017396659174;[CYFIP1, PID1, AKT1, PRKACB, PTGDR, MEN1, GHSR, LHCGR, MEF2C, POR, ADCY9, PRKAR1B, SIK1, ABCB4, SLC30A10, FOXO1, PRKAR2B, IGFBP7, GAS2L1, JUN, TGFB1, CAV1, CDC6, INHBA, NFKB1, NR4A2, NR4A1, ROBO2, CTSS, GHR, CTSH, ANXA1, DUSP1, ARG1, GLP2R, AVPR1A, FOS, CEACAM1, KIT, PTGER2, P2RY6, PAK1, FYN, CSK, SORBS1, TSHR, RAMP1]
GO:0001915;negative regulation of T cell mediated cytotoxicity;9.0;0.8933024483968273;0.8428918493787028;9.557065288509976;365.562885098783;7.9853141584524145;0.012235060779019208;0.8046099625986299;[CEACAM1, PTPRC, LILRB1, FCGR2B]
GO:0010745;negative regulation of macrophage derived foam cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;114.21841186311113;7.212124270218933;0.0038227874551613377;0.6919486831672181;[ABCA1, NFKBIA, NR1H2]
GO:0016046;detection of fungus;6.0;0.8653626801206646;0.7558016526504768;9.474373572664863;96.01252026694556;9.777073627680469;0.0032134526476763577;0.8231203125901445;[TLR4]
GO:0032755;positive regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.94897299966192;5.395046993006588;0.0021737836760178982;0.5990232667078439;[TNF, PYCARD, CD36, IL6R, FCER1G, F2R, TLR1, IL1B, TLR8, TLR7, TLR6, TLR4, TLR2, PTAFR, HSPD1, CARD9, LILRB2, MYD88, IL17A]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[, AKT1, STK32B, MAP2K2, VRK1, PRKCQ, PLK2, LRRK2, MAP4K1, CHUK, SYK, SGK1, MAPK14, CAMK4, PKN1]
GO:0031666;positive regulation of lipopolysaccharide-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;344.2408759115043;7.697632086000634;0.011521432320083432;0.7445766281117727;[CD180, LY96, MIF]
GO:0032753;positive regulation of interleukin-4 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.94897299966192;6.686031174322154;0.0021737836760178982;0.665044257777226;[CD86, PRG2, CD3E, CD40LG, CD28, NLRP3, PRKCQ, HAVCR2]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[MYLK, LGALS3, C3AR1, AKT1, IL1R1, ACTN4, PFN1, FPR2, PLA2G7, EPB41L5, PDGFD, PDGFC, NCKAP1L, S100A14, PLCG1, ELANE, LYN, CCR1, JUN, TNFSF14, PLK2, PPBP, PTK2, NOX4, NRP1, NRP2, CTSH, CCR7, CCR6, CCR2, ANXA1, ANXA3, GAB1, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CCL20, PF4, SEMA5B, CXCL13, TNF, SLC8A1, CXCL16, PYCARD, IL6R, PDGFRB, F2R, ADAM9, CD274, CD151, C5AR1, CORO1A, TGFB1, CXCL10, CXCL11, CXCL12, PTPRC, DOCK5, CXCL6, CXCL9, TNFAIP6, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, MMP9, FGR, IFNG, XCL1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL1, EGF, SEMA4B, MAPK14, TEK]
GO:1903223;positive regulation of oxidative stress-induced neuron death;9.0;0.9326813400603323;0.8625812952104552;9.582004236857228;363.38011971363295;8.390779266560578;0.012162005585939545;0.8253454670833372;[TLR6, TLR4]
GO:0051591;response to cAMP;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;79.54904468548885;5.192106149009898;0.0026624349361310785;0.5886448625081389;[PTAFR, AQP9, SLC8A1, JUN, DUSP1, FOS, KCNQ1, NDUFS4, NOX4, SDC1, TEK, SLC26A3]
GO:0006468;protein phosphorylation;7.0;0.5708408884191841;0.6363398094667926;8.175090588534603;177.75756772840523;2.970244267288293;0.005949385820444992;0.5028177952168079;[, SLA2, MYLK, AKT1, PRKACB, MEF2A, MEF2C, PRKAR1B, PRKCQ, IQGAP3, LYN, PLK2, CDK14, ITK, DUSP6, CIT, HBEGF, IL12RB2, GTF2H1, PKN1, IL5RA, TNF, FGF5, GRAP2, STK32B, KCNH1, MEN1, MAP2K2, VRK1, NRBP1, MELK, BLK, PKMYT1, MAP2K6, BMX, NFKB1, LAT, LRRK2, CHUK, LCK, IL2RG, CCL8, CCL5, CCL2, FYN, CSK, TIE1, IL2RB, PTPN6, CCNH, CHEK1, RPS6KA1, TNFSF11, EPHB1, PAQR3, BTC, BTK, SIK1, ALPK2, EPHA3, PTK2, CTSH, CTSG, CCR5, SPTAN1, MAP4K1, SYK, HCK, IL1B, KIT, TLR7, SGK1, TLR4, TLR2, PAK1, PRKY, CAMK4, PDGFRB, CCNE1, CSF2RB, RASGRP4, SPTA1, TGFB1, EIF2S1, GHR, IRAK3, TGFBR3, FGR, ZAP70, NCAM1, BUB1, EGF, MAPK14, WEE1, TEK]
GO:0009615;response to virus;5.0;0.7436939687323844;0.6620879962271125;8.801845679307654;27.267803904038782;4.174954806800768;9.126288572378991E-4;0.503748394835965;[CHRM2, TNF, PYCARD, STMN1, IFNA14, IFNA16, RNASE6, RNASE2, IFNA10, NLRP3, IFNA21, HMGA1, AZU1, DEFA1, CXCL10, CXCL12, PTPRC, IFNA5, IFNA4, IFNA7, CXCL9, IFNA2, IFNA8, CHUK, IRAK3, MMP12, ACTA2, EEF1G, FGR, IFNG, PSMA2, TLR8, XCL1, TLR7, UNC93B1, CXCR4, SAMHD1, CCL8, CCL5, CCL4, CCL19, CCT5, CARD9, LILRB1, MAPK14]
GO:0006469;negative regulation of protein kinase activity;10.0;0.6835726970475526;0.7570273603846966;9.223059144383958;1097.0598301796;4.243684138952949;0.03671760522636433;0.6322632160784685;[PYCARD, PPP2R1A, AKT1, MEN1, PAQR3, TSC2, PRKAR1B, FLRT2, PRKAR2B, SFN, LYN, CAV1, PTPRC, PKIG, CDKN1A, LRRC4, TNFAIP3, PTPN22, HHEX, LRRTM4, NUP62, DUSP2, MYOCD, DUSP1, IRAK3, DUSP6, CEACAM1, IL1B, LRRC19, CDKN2C, PTPN6, PKN1]
GO:0042997;negative regulation of Golgi to plasma membrane protein transport;9.0;0.8933024483968273;0.8428918493787028;9.590783924509275;462.6485801827257;8.390779266560578;0.01548443162202583;0.8253454670833372;[GOPC, CSK]
GO:0032869;cellular response to insulin stimulus;8.0;1.0;0.875;9.628524252492122;462.69925393661634;5.334422371190153;0.015486127626965131;0.6478026081386739;[CYFIP1, AKT1, GHSR, CEACAM1, FOXO1, PAK1, SORBS1]
GO:0032507;maintenance of protein location in cell;5.0;0.6763753087927167;0.6284286662572787;8.412128928167629;43.86076268124676;5.4730085344763;0.0014679802548176633;0.5701309228349632;[AKT1, TLN1, BARD1, GSN, JUP, CAV1, CD4]
GO:0097421;liver regeneration;6.0;1.0;0.8231203125901445;9.628524252492122;47.21654787453615;6.250713103064308;0.0015802953652264606;0.6427820713687392;[PCNA, TGFB1, SULF2, NFKBIA, EZH2]
GO:0032868;response to insulin;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;4.800339885259895;0.0024778305216419678;0.5964089702280253;[CYFIP1, AKT1, GHSR, CEACAM1, TLR2, RETN, FOXO1, PAK1, PLN, LYN, EGR1, EGR2, SORT1, SORBS1]
GO:0009968;negative regulation of signal transduction;6.0;0.43649654099988644;0.5413685830900877;6.680044863788677;140.65047919891595;2.686163805600486;0.0047074449615745265;0.460490854527945;[, PID1, SLA2, PHB2, STMN1, AKT1, UBASH3A, PRKACB, PADI2, PRKCQ, ATF3, FLRT2, FIGNL1, PRDM16, LYN, EZH2, LRRC4, DUSP2, DUSP1, ARG1, FCRL3, PAWR, DUSP6, AES, MMP12, LRRC19, PTGS2, NR1H2, TMEM64, SULF2, LGR4, PF4, TNF, PYCARD, MEN1, TLE4, LY96, FOXO1, WFS1, TNFRSF10B, PTPRE, CXCL12, PTPRC, BCL6, CCDC22, LRRK2, FASLG, PTPN22, HHEX, LBH, PVRIG, CX3CR1, LRP1, LRP2, CCL5, FYN, CSK, TIE1, PTPN6, LGALS3, PPP2R1A, EPHB1, IL1R2, PAQR3, MIF, RUNX2, SIK1, EPHA3, APCDD1, PKHD1, INPP5D, EGR1, VNN1, NRP1, PTPRR, CD3E, CEACAM1, BANK1, IL1B, KIT, TLR6, TLR4, GNAI2, NLRP12, GRINA, RGS1, PDGFRB, TSC2, HGS, ADRB2, STAP1, NLRP3, TGFB1, CAV2, CAV1, NR4A2, NFKBIA, HMGB2, TNFAIP3, LRRTM4, NUP62, PTGIR, MYOCD, ARAP3, IRAK3, MMP9, DNM2, TGFBR3, NDUFS3, FBP1, PFDN5, LTF, BCL2A1, CLEC12B, TAF9, EGF, MAPK14, TEK]
GO:0030449;regulation of complement activation;8.0;0.6873818243518346;0.7186909121759173;9.298282565621545;245.7676390307622;5.076593261888053;0.008225621701844479;0.6346172154986847;[C5AR1, IGHG1, IGKC, CD19, IGLV1-44, C3AR1, CR2, CR1, IGKV3-20]
GO:0032747;positive regulation of interleukin-23 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.94897299966192;8.16763571524637;0.0021737836760178982;0.7408135829017477;[IFNG, MYD88, IL17A]
GO:0032740;positive regulation of interleukin-17 production;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;65.23665507211369;7.212124270218933;0.002183412136085803;0.6919486831672181;[TGFB1, PRKCQ, LY9, MYD88]
GO:0032741;positive regulation of interleukin-18 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.94897299966192;8.390779266560578;0.0021737836760178982;0.7522251544931926;[TLR2]
GO:0031532;actin cytoskeleton reorganization;6.0;1.0;0.8231203125901445;9.628524252492122;32.01253927882412;5.788089581116195;0.001071430880247358;0.6191234829421188;[NRP1, PAK1, FLNA, CXADR, ANXA1, GAB1, KIT]
GO:0060297;regulation of sarcomere organization;9.0;0.8933024483968273;0.8428918493787028;9.52844079393514;165.46881499726612;7.8311634786251565;0.005538092325693202;0.7967266896635242;[MEF2C]
GO:0045919;positive regulation of cytolysis;5.0;0.8436909121759173;0.712086467948879;9.377209824211215;41.08542638077049;7.379178354882098;0.0013750922464812324;0.6676125360964777;[LILRB1]
GO:1900086;positive regulation of peptidyl-tyrosine autophosphorylation;11.0;1.0;0.9324289523296623;9.628524252492122;1786.9389585583017;8.16763571524637;0.05980723880229299;0.8501222226412654;[ACE, SYK]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[SPIB, MEF2A, MEF2C, PADI4, ATF3, JUN, HACE1, EZH2, CHAF1B, FOS, STAT4, FLNA, ZNF467, ATAD2, PKN1, RUVBL1, FOXO1, NFKB1, CIITA, FASLG, HHEX, E2F5, E2F7, POU2AF1, CCNH, UXT, BTK, EGR1, EGR2, EGR3, HMGA1, MXD1, HMGB2, AFF3, NUP62, MYOCD, ELF3, CREB5, TAF9, MAPK14, EHF, PHB2, HOXA9, MYB, HOXA3, HOXA7, HOXA5, HOXA4, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, PRDM16, NKX2-3, NFE2, ZNF367, BRD2, PAWR, PAX5, PAX2, AES, GTF2H1, MEN1, TLE4, NACC2, MAP2K6, HOPX, COPS5, BCL6, CNOT3, MAFF, LBH, RFC1, SMARCD3, CEBPE, POLR2E, ZNF503, POLR2I, POLR2J, POLR2K, POLR2L, KLF1, KLF8, KLF5, MNDA, ZNF608, DPF3, EBF1, NHLH2, BCL11B, BCL11A, GRHL2, ARID4A, HOXA11, HOXA10, C5AR1, NLRP3, CBX4, NR4A2, KDM5D, LTF, MEIS2, MEIS1, RBMX]
GO:0006470;protein dephosphorylation;7.0;0.7586651285174919;0.7302519295159464;9.223059144383958;177.1697810635027;4.458953633836253;0.005929713129744359;0.5789504614541361;[PPP2R1A, PTPRE, PTPRC, PTPRR, PTPN22, PTPRK, DUSP2, DUSP1, DUSP6, LCK, TPTE, PPP1CA, PTPN6]
GO:0009743;response to carbohydrate;4.0;0.6347111282356054;0.5673555641178027;8.102467948997072;27.321196622860832;4.720827822332161;9.144158634865458E-4;0.49142335437501145;[SLC8A1, CTGF, MEN1, RMI1, PAX2, IL1B, CALCRL, PTGS2, MAP2K6, LYN, EGR1, EIF2B3, TGFB1, LIN28A, NOX4]
GO:0007202;activation of phospholipase C activity;9.0;1.0;0.896240625180289;9.628524252492122;83.73920694944017;6.444869117505266;0.0028026758962043192;0.7258315315665724;[ITK, C5AR1, AVPR1A, SELE, RASGRP4, PLCG1]
GO:0007565;female pregnancy;3.0;1.0;0.6981203125901445;9.628524252492122;32.8060485501291;5.299736813202263;0.0010979889214459554;0.4691490996802742;[PRL, TGFB1, FOS, CLDN4, PNOC]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[NUP107, SLA2, SPIB, AKT1, ATF3, JUN, JAG1, JUP, PKIG, CHAF1B, FOS, MMP12, PTAFR, ZNF467, ATAD2, PKN1, LGR4, GMNN, BLM, CIITA, HHEX, E2F5, E2F7, POU2AF1, SMARCAL1, TNFSF11, FBXO5, BTK, TGFA, PKHD1, EGR1, EGR2, EGR3, POLA1, SYK, IL1B, KIT, PCNA, NR3C2, CARD11, CAV1, TCF4, MXD1, TNFAIP3, MYOCD, NUP133, IRAK3, ELF3, FBP1, CD4, PHB2, PRKCQ, NUP85, PRDM16, NFE2, CDKN1A, ZNF367, EPCAM, NR1H2, ELP4, PF4, PLXND1, TNF, TLE4, MAP2K2, MAP2K6, COPS5, BCL6, CCDC22, SLC26A3, LBH, RFC1, XCL1, CEBPE, NLRC4, POLR2K, POLR2L, DNAJA3, PPIL4, PPP2R1A, RPS6KA1, FLT3LG, SIK1, AHCTF1, IFNA2, PRL, XPO1, MLF2, HCK, TLR6, TLR4, TLR2, GRHL2, CD40LG, HOXA11, HOXA10, NLRP3, CBX4, KDM5D, SLC40A1, DNM2, PFDN5, LTF, RBMX, PID1, EHMT2, MEF2A, MEF2C, PADI2, PADI4, HACE1, EZH2, PSMA6, STAT4, FLNA, USP9Y, PSMC6, PSMC2, RUVBL1, S100A8, MAZ, TNFRSF11A, FOXO1, NFKB1, CXCL10, MYD88, FASLG, LRP2, CCNH, UXT, TMPO, PCBP3, OR7D2, CD28, PTPRK, BRCA2, CD3D, CD36, RGMA, NLRP12, IL17A, CD86, CD80, CCNE1, CALCA, HMGA1, INHBA, HMGB2, ARHGEF10L, AFF3, NUP62, PSRC1, CREB5, TAF9, EGF, MAPK14, NUP35, RAN, EHF, HOXA9, MYB, HOXA3, HOXA7, HOXA5, HOXA4, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, ELANE, NKX2-3, FZD5, CDC6, HAVCR2, BRD2, ANXA3, NFAM1, PAWR, PAX5, PAX2, AES, ENG, GTF2H1, PYCARD, DACH1, CDH1, MEN1, F2R, NACC2, WFS1, HOPX, CNOT3, MAFF, CHUK, TRAF1, SMARCD3, RBBP8, ZNF503, KLF1, KLF8, KLF5, MNDA, ZNF608, EDNRB, CHEK1, DPF3, SLC11A1, EBF1, RUNX2, PFN1, BEX1, SP140, NHLH2, BCL11B, BCL11A, RHOG, SGK1, LILRB1, CAMK4, ARID4A, BASP1, ADRB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, JMY, TMEM100, CKAP2, TGFBR3, IFNG, DLL1, HSPD1, MEIS2, MEIS1]
GO:0072160;nephron tubule epithelial cell differentiation;6.0;0.8653626801206646;0.7558016526504768;9.310070521373587;49.624654608214016;9.083926447120524;0.0016608925304473024;0.7876727335416686;[MEF2C]
GO:0007204;positive regulation of cytosolic calcium ion concentration;11.0;0.6835726970475526;0.7742153008534385;9.097896001429952;290.3013502407617;4.174954806800768;0.00971612493830514;0.645936335304707;[CXCL13, SLC8A1, EDNRB, CCRL2, C3AR1, PROK2, PTGDR, F2R, AGTR1, CALCA, C5AR1, FPR1, FPR3, FPR2, CD19, HRH4, PLCG1, CCR10, CCR1, CAV1, CXCL10, CXCL11, PTPRC, CD24, GPR18, CXCL9, FASLG, JPH2, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, CD52, PTGIR, TRPC3, TRPC1, AVPR1A, LCK, IL1B, XCL1, CX3CR1, PTGER2, CXCR5, CXCR4, CXCR6, CXCR1, CXCR2, S1PR3, CCL1, CCL19, GPR157, GPR6, P2RX5, CD4, F2RL3]
GO:0030316;osteoclast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;47.07409398820286;6.375876246018314;0.0015755275618510598;0.6491829203200885;[TGFB1, FCER1G, TFRC, TREM2, TNFRSF11A, MAPK14, TNF, OSCAR, TNFSF11]
GO:0032735;positive regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.311337724880743;0.002183412136085803;0.6458824173477649;[HSPD1, CCR7, CD36, CCL19, MAPK14, CD40LG, IFNG, TLR4, TLR2]
GO:0030318;melanocyte differentiation;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;22.857985252022832;6.8867018697843045;7.650361955340501E-4;0.6424272657460779;[MEF2C, EDNRB, KIT]
GO:0098761;cellular response to interleukin-7;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;9.777073627680469;0.0027327542132076126;0.8231203125901445;[BTK]
GO:0032733;positive regulation of interleukin-10 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.375876246018314;0.002183412136085803;0.6491829203200885;[CD274, CD83, FCER1G, HSPD1, PYCARD, CD40LG, CD28, XCL1, TLR4, TLR2]
GO:0045409;negative regulation of interleukin-6 biosynthetic process;8.0;1.0;0.875;9.628524252492122;835.4451311618078;8.16763571524637;0.027961596688182013;0.7926932703116032;[GHSR, NLRP12, INPP5D]
GO:0090336;positive regulation of brown fat cell differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;143.10318807846457;7.57984905034425;0.004789534920478337;0.738553198190834;[PRDM16, PTGS2, MAPK14]
GO:0007252;I-kappaB phosphorylation;8.0;1.0;0.875;9.628524252492122;180.75330000196035;7.292166977892469;0.006049650283656873;0.747921758369865;[CHUK, TLR7, TLR4, TLR2]
GO:0007253;cytoplasmic sequestering of NF-kappaB;13.0;1.0;0.9625549647676366;9.628524252492122;578.6196231821564;7.8311634786251565;0.019365878064054164;0.8630410292508717;[NFKBIA, CCDC22]
GO:0007250;activation of NF-kappaB-inducing kinase activity;12.0;1.0;0.9481203125901445;9.628524252492122;1337.9940718610228;6.8867018697843045;0.04478145746870162;0.8003065664753022;[CHI3L1, TNFRSF10B, TLR6]
GO:0030031;cell projection assembly;4.0;0.6729672293956388;0.5864836146978194;8.124446855715847;35.515967283127445;3.9749552523034066;0.0011886874626708887;0.45327939645711923;[CYFIP1, MYLK, VCL, PKHD1, NUP85, NCKAP1L, NRP1, EMP1, KIT, RHOU, FGD4, FLNA, SH2B1, GSN, KLF5]
GO:0032570;response to progesterone;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;105.99106082751567;6.166155715036245;0.0035474254201351726;0.6384578026126634;[GABRB1, TGFB1, CAV1, PTGER2, FOS, CLDN4, TLR2]
GO:0045401;positive regulation of interleukin-3 biosynthetic process;8.0;1.0;0.875;9.628524252492122;833.6113263844036;9.777073627680469;0.027900220892599446;0.875;[SYK]
GO:0042495;detection of triacyl bacterial lipopeptide;8.0;1.0;0.875;9.628524252492122;192.9668546023468;9.083926447120524;0.006458426964646296;0.839552420951524;[TLR1, TLR2]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[CD86, CD80, SLA2, FGF5, IMPA2, PDGFRB, GAB1, BTC, LCK, KIT, HBEGF, CD19, FYN, ICOS, TRAT1, EGF, CD28]
GO:0007257;activation of JUN kinase activity;14.0;1.0;0.9759193652572005;9.628524252492122;8640.54909511404;6.088194173566533;0.2891914022241413;0.7872698984233759;[TNFSF11, CCL19, MAP4K1, SYK, CD40LG, PKN1]
GO:0090330;regulation of platelet aggregation;9.0;0.8259837884571596;0.8092325194088689;9.533214072687796;97.23557350837086;6.943860283624253;0.0032543871389904074;0.7513499630073597;[LYN, CEACAM1, SYK, PDPN, CD9, PRKCQ]
GO:0042496;detection of diacyl bacterial lipopeptide;8.0;1.0;0.875;9.628524252492122;192.9668546023468;9.083926447120524;0.006458426964646296;0.839552420951524;[TLR6, TLR2]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[TNF, PYCARD, TNFSF11, BTK, PRKCQ, S100A8, CARD11, TNFRSF11A, NLRP3, TGFB1, NFKB1, MYD88, CD36, CHUK, IRAK3, TRAF1, PSMA6, IL1B, TLR6, TLR4, LTF, TLR2, NLRC4, CD40LG]
GO:0045648;positive regulation of erythrocyte differentiation;8.0;0.9326813400603323;0.8413406700301662;9.582004236857228;358.80145150428314;6.409777797693995;0.012008761681506467;0.7027963346592216;[HMGB2, INHBA, MAPK14, INPP5D, NCKAP1L]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, CDH5, C3AR1, CTSH, GHSR, ANXA1, ANXA3, GAB1, IL1B, ADAM12, AGTR1, CHI3L1, ENG, CX3CR1, C5AR1, PTGS2, DLL1, CXCR2, PLCG1, JUP, PLK2, TNFSF12, LRG1, TEK]
GO:0045404;positive regulation of interleukin-4 biosynthetic process;8.0;1.0;0.875;9.628524252492122;833.6113263844036;9.083926447120524;0.027900220892599446;0.839552420951524;[CD86]
GO:0051090;regulation of DNA binding transcription factor activity;10.0;0.7192862368539868;0.7748841302879137;9.223059144383958;255.33763090554476;3.793137346993279;0.00854592071745993;0.6092222321850824;[PHB2, AKT1, TNFSF11, BTK, SIK1, PRKCQ, BEX1, PKHD1, NHLH2, JUN, JUP, EZH2, CD36, HAVCR2, SYK, ANXA3, NFAM1, FOS, PSMA6, HCK, IL1B, KIT, TLR6, SGK1, TLR4, TLR2, FLNA, NLRP12, CD40LG, TNF, PYCARD, MEN1, S100A8, CARD11, TNFRSF11A, NLRP3, TGFB1, WFS1, NFKB1, NFKBIA, COPS5, JMY, CCDC22, MYD88, TNFAIP3, MYOCD, CHUK, IRAK3, TRAF1, XCL1, LTF, NLRC4]
GO:0046856;phosphatidylinositol dephosphorylation;8.0;1.0;0.875;9.628524252492122;218.1540246804484;6.686031174322154;0.007301418880178951;0.7169239451870815;[INPP5D]
GO:0045646;regulation of erythrocyte differentiation;7.0;0.7980440201809971;0.7499413753476991;9.34084218004034;77.59787612007705;5.9928839937622085;0.002597131080184449;0.6573957313958061;[HMGB2, INPP5D, NCKAP1L, HOXA5, LYN, INHBA, MAPK14]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[PID1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, JUN, JAG1, JUP, FOS, MMP12, STAT4, ATAD2, PSMC6, PSMC2, LGR4, BLM, FOXO1, NFKB1, CXCL10, CIITA, HHEX, E2F5, E2F7, POU2AF1, CCNH, TNFSF11, EGR1, EGR2, EGR3, CD28, BRCA2, CD3D, RGMA, IL1B, IL17A, CD86, CD80, CCNE1, HMGA1, INHBA, TCF4, HMGB2, ARHGEF10L, NUP62, MYOCD, PSRC1, ELF3, CREB5, TAF9, EGF, MAPK14, CD4, RAN, EHF, MYB, HOXA3, HOXA7, HOXA5, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, NFE2, FZD5, PAX5, PAX2, ENG, EPCAM, NR1H2, GTF2H1, PF4, PLXND1, TNF, CDH1, MEN1, MAP2K2, F2R, COPS5, MAFF, LBH, RFC1, CHUK, SMARCD3, CEBPE, KLF1, KLF5, CHEK1, RPS6KA1, DPF3, SLC11A1, EBF1, FLT3LG, RUNX2, BEX1, NHLH2, BCL11B, IFNA2, PRL, RHOG, TLR4, TLR2, LILRB1, GRHL2, CAMK4, ARID4A, HOXA11, HOXA10, ADRB2, NLRP3, TGFB1, NR4A2, NFKBIA, NR4A1, SLC40A1, CKAP2, DNM2, DLL1, MEIS2, MEIS1, RBMX]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[TPM1, MSH2, EPB41L5, PLCG1, EIF2S2, MAFF, PTPRR, TMEM100, HHEX, TIE1]
GO:0001947;heart looping;7.0;1.0;0.8509193652572005;9.628524252492122;47.98143023837329;5.71663061713405;0.001605895289594654;0.6432681208679463;[DLL1, MEF2C, ENG]
GO:0032689;negative regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.343086423195323;0.002184000309729388;0.647506047256038;[CD274, CD96, LILRB1, INHBA, PDCD1LG2, XCL1, TLR4, HAVCR2]
GO:0031116;positive regulation of microtubule polymerization;10.0;0.8933024483968273;0.861892236059334;9.589303539338841;431.61701704611926;6.518977089658987;0.014445833130437288;0.7486218033895181;[PAK1, PSRC1]
GO:0065003;protein-containing complex assembly;4.0;0.45485133202666184;0.4774256660133309;6.058991556010752;36.471478728154885;2.4440506132939883;0.0012206675708314864;0.3749888620238313;[, NUP107, PRKACB, CLDN3, PADI4, PDGFC, ABCA1, JUP, HLA-DRB1, ARHGAP6, CHAF1B, CHAF1A, KCND2, ARG1, F5, SLC7A7, KCNA5, HLA-DMA, HLA-DMB, DMD, CENPK, CENPL, GOPC, KCNG2, GMNN, RUVBL1, OLFM4, BLM, LIN7A, CXCL12, HLA-DRA, LRRK2, ALAD, VBP1, NDUFC2, ACPP, NDUFB6, HM13, NDUFB4, NDUFB3, NDUFB2, NDUFB1, CCL5, EIF4H, NDUFA8, NDUFA6, NDUFA3, NDUFA2, IL2RB, CD247, EIF3D, CCNH, TCL1A, SNRPD2, SNRPD1, TNFSF11, FBXO5, SNRPD3, MIF, TGFA, PTK2, CD3G, CD3E, CD3D, CCT3, CCT2, FCER1G, MIS12, CCT8, GCH1, RPA1, RPA3, NDUFAB1, NDUFB10, NDUFB11, H1FX, CAV2, CAV1, HMGA1, NASP, TCF4, HMGB2, TNFAIP3, NUP62, NDUFS8, NDUFS7, NDUFS4, NDUFS3, NUP54, FBP1, TAF9, SAMHD1, EGF, TTC19, TEK, CDA, BIN2, NUP205, ACMSD, NCKAP1L, BRD2, GSN, GTF2H1, TNF, DACH1, MEN1, TLE4, SNRPG, SNRPE, SNRPF, NACC2, LSM3, HOPX, TRAF1, MCM2, NLGN1, NLRC4, PLN, RAD51, P2RX1, PPP2R1A, MCCC2, TLN1, MGST1, CD79B, CD79A, VASP, AHCTF1, RAD51C, UQCR10, NDUFA11, KNTC1, CHRNB4, ADRB2, NLRP3, MYH11, TGFB1, EIF2S1, DNM2, TGFBR3, COLEC12, HIST1H2BK, HSPD1, REPS2, RBMX]
GO:0030260;entry into host cell;6.0;0.7369933605727446;0.6916169928765168;8.68406264365127;26.98811751292015;5.212725436212633;9.032680054285688E-4;0.5896993338145817;[SCARB2, CD86, TFRC, CD80, CDH1, ANPEP, CLEC5A, ITGB6, CCR5, HAVCR1, CR2, CR1, CXADR, GYPA, CXCR4, DPP4, NCAM1, GPR15, CD4]
GO:0007265;Ras protein signal transduction;7.0;0.7586651285174919;0.7302519295159464;8.935377071932177;27.526979089716047;4.2636448815154875;9.213032174599934E-4;0.5689623627776663;[CYFIP1, CELSR1, EPS8, GRAP2, RAB32, DOK3, AGTR1, IQGAP3, JUN, HACE1, PLK2, DHCR24, BCL6, LAT, CDKN1A, ARHGAP6, CHUK, RHOG, RAB33B, RHOU, RAB21, PAK1, PDPN, EPS8L1]
GO:0045652;regulation of megakaryocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;68.9575807315309;5.845247994956144;0.0023079481692908138;0.6498456195510879;[HMGB2, NFE2, MEF2C, PRKCQ, MYL9, PF4]
GO:0045410;positive regulation of interleukin-6 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.3044735649636;7.8311634786251565;0.02792341990494083;0.7754860644832351;[TLR1, IL1B, PTAFR, TLR6]
GO:0045773;positive regulation of axon extension;11.0;0.8933024483968273;0.8790801765280758;9.582004236857228;1257.908905926367;6.113511981550823;0.04210107903683872;0.7450742393735527;[CYFIP1, NRP1, PAK1, CXCL12]
GO:0007266;Rho protein signal transduction;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;29.60642063139588;5.334422371190153;9.9090025448413E-4;0.6478026081386739;[CELSR1, ARHGAP6, EPS8, PAK1, PDPN, EPS8L1, CHUK, RHOG, BCL6, AGTR1, RHOU]
GO:0042267;natural killer cell mediated cytotoxicity;6.0;0.9326813400603323;0.7894609826203107;9.5544162803384;47.356962503066434;6.7325511899570465;0.001584994916478408;0.6674232935401965;[KLRK1, SLAMF7, KIR3DL1, PTPN6]
GO:0045416;positive regulation of interleukin-8 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.474488534686424;0.027942676825076673;0.7572456912631272;[TLR8, TLR7, TLR4, TNF, ELANE]
GO:0045779;negative regulation of bone resorption;7.0;1.0;0.8509193652572005;9.628524252492122;83.00611842489866;7.292166977892469;0.002778140083024753;0.7238411236270654;[CALCA, INPP5D, TNFAIP3, CSK]
GO:0046627;negative regulation of insulin receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;294.34753946768484;6.311337724880743;0.009851547250396369;0.6736814700148209;[PID1, TSC2, SLA2, PTPRE, IL1B, PRKCQ]
GO:0045659;negative regulation of neutrophil differentiation;10.0;1.0;0.9152410118609203;9.628524252492122;986.1244036487119;9.083926447120524;0.03300469633577752;0.8797934328124444;[INPP5D]
GO:0045656;negative regulation of monocyte differentiation;9.0;1.0;0.896240625180289;9.628524252492122;842.1281654798506;7.8311634786251565;0.028185271832466503;0.7967266896635242;[INPP5D, HOXA7]
GO:0045657;positive regulation of monocyte differentiation;9.0;1.0;0.896240625180289;9.628524252492122;840.3783565179247;7.57984905034425;0.02812670730123667;0.7838744581139225;[CD4, JUN, ACIN1]
GO:0001954;positive regulation of cell-matrix adhesion;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;50.25702962731741;5.926926025970411;0.0016820575532361247;0.6262235851885184;[NRP1, EPB41L5, CCR7, CD36, JUP, CEACAM6, TEK]
GO:0002922;positive regulation of humoral immune response;6.0;0.6997970393407541;0.6730188322605215;9.0306872517365;108.8065326900253;7.069023426578259;0.0036416567296131998;0.6846304993685643;[FCER2, CCR7, FCGR2B, TNF]
GO:0045780;positive regulation of bone resorption;7.0;1.0;0.8509193652572005;9.628524252492122;82.90338698468558;6.943860283624253;0.002774701754173115;0.7060287030842711;[TFRC, SYK, TNFSF11, TNFRSF11A, TMEM64]
GO:0043242;negative regulation of protein complex disassembly;6.0;0.7248374789738407;0.6855390520770648;8.83001655627435;65.72942481560547;5.572381008289503;0.002199904695936496;0.6080921364962873;[LMOD1, TNF, EPS8, SPTA1, SPTAN1, GSN, CKAP2, IRAK3]
GO:0002924;negative regulation of humoral immune response mediated by circulating immunoglobulin;10.0;0.8933024483968273;0.861892236059334;9.592156608321247;508.9965303178644;7.9853141584524145;0.017035655802601874;0.8236103492792612;[CR1, PTPN6, FCGR2B]
GO:0001836;release of cytochrome c from mitochondria;6.0;1.0;0.8231203125901445;9.628524252492122;22.134985108306864;6.686031174322154;7.408380313817617E-4;0.665044257777226;[JUN, BCL2A1, SFN]
GO:0014902;myotube differentiation;6.0;0.8653626801206646;0.7558016526504768;9.377209824211215;22.452520143917486;7.379178354882098;7.514656432606705E-4;0.7004918368257019;[MEF2C, SORT1, AVPR1A]
GO:0001959;regulation of cytokine-mediated signaling pathway;6.0;0.6108066114563391;0.628523618318314;8.112176763124033;55.1119710577094;4.759793790865545;0.0018445480737477274;0.5665363884080561;[TNF, PYCARD, IL1R1, IL1R2, PADI2, STAP1, CAV1, PTPRC, CD24, TNFAIP3, TREM2, CHUK, SYK, ARG1, IRAK3, TRAF1, MMP12, IFNG, CCL5, NR1H2, PTPN6]
GO:0034614;cellular response to reactive oxygen species;5.0;0.7671156992804218;0.6737988615011312;9.197741336399668;144.094088465717;5.076593261888053;0.004822699464687224;0.5498582273596049;[TNFAIP3, PTPRK, IL18RAP, MYB, AKT1, ANXA1, CHUK, ARG1, TPM1, FOS, MMP9, PAX2, DNM2, BTK, PCNA, FOXO1, PDGFD, JUN, EZH2]
GO:0010543;regulation of platelet activation;8.0;0.7866048967936545;0.7683024483968273;9.510741216835738;81.8829764000265;6.343086423195323;0.0027405495302144796;0.6993857346658935;[LYN, FCER1G, SYK, CEACAM1, PDPN, CD9, PRKCQ, TLR4]
GO:0031103;axon regeneration;7.0;0.8436909121759173;0.7727648213451592;9.427853557029971;96.50678923292918;6.832634648514029;0.00322999538515464;0.7003406189322132;[JUN, CHL1, JAM3]
GO:0071801;regulation of podosome assembly;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;64.45443428147517;7.069023426578259;0.002157231910176139;0.7124295520356204;[HCK, GSN, TNF]
GO:0045429;positive regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;658.6394256443023;6.166155715036245;0.02204406883931546;0.6903374900225189;[PTGS2, TNF, KLRK1, AKT1, CD36, AGXT2, DNM2, IFNG, IL1B, PTX3, TLR6, TLR4]
GO:0090314;positive regulation of protein targeting to membrane;10.0;0.9326813400603323;0.8815816818910864;9.587702257971866;497.0805077511855;6.343086423195323;0.016636837251019197;0.7396267465268138;[, ITGAM, PAK1, FYN]
GO:0038095;Fc-epsilon receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.989581884898423;0.002626513627734276;0.6301674496329921;[ITK, GRAP2, FCER1A, FCER1G, CHUK, SYK, FOS, LAT2, BTK, PRKCQ, LCP2, CARD11, PAK1, IGKC, IGLV1-44, PLCG1, LYN, JUN, NFKB1, IGKV3-20, LAT]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[GOLT1B, TNF, AKT1, TNFSF11, F2R, CARD11, NDFIP2, PLK2, TNFRSF10B, CCDC22, MYD88, FASLG, NUP62, CCR7, CD36, CHUK, ZDHHC17, IL1B, TLR6, LTF, FLNA, FYN, CCL19, CARD9, CD4, LTBR]
GO:0048812;neuron projection morphogenesis;7.0;0.6547035408479693;0.6782711356811852;8.502512989635898;62.99970935475633;4.360973225476049;0.002108543576046295;0.5739397388140403;[STMN1, EPHB1, MEF2A, SDC2, NCKAP1L, GP5, PTK2, NR4A2, LRFN4, OGN, NRP1, LRRK2, DCC, PAX2, DNM2, SGK1, DSCAML1, NLGN1, LRP2, PAK1, NTF3, SLITRK6, FYN, LINGO1, WEE1]
GO:0045786;negative regulation of cell cycle;5.0;0.5089359064165209;0.5447089650691808;7.0970975870692286;42.34575940812408;3.5270983854209863;0.0014172744586806725;0.47061698731819834;[EHMT2, SMC3, UXT, CHEK1, FBXO5, PRKACB, MIF, AURKAIP1, TP53BP2, SFN, BARD1, PLK2, CDC6, ZWINT, EZH2, CDKN1A, PTPRK, BRCA2, DUSP1, PCNA, PTGS2, GPNMB, CDKN2C, LILRB1, SIPA1, GMNN, TNF, KNTC1, MEN1, MSH6, MSH2, BLM, NACC2, NAE1, GAS2L1, MAP2K6, TGFB1, DHCR24, INHBA, NR4A1, BCL6, CNOT3, JMY, TNFAIP3, HHEX, TOPBP1, MYOCD, SMC1A, IFNG, RBBP8, CCL2, BUB1, E2F7, MAPK14, WEE1, RAD51]
GO:0097190;apoptotic signaling pathway;5.0;0.6954798709641801;0.6379809473430103;8.529911963824013;23.17027026302992;4.145861845859104;7.75488093814194E-4;0.5022605794604473;[TNF, PYCARD, IL6R, MSH6, MELK, MSH2, LGALS12, BTK, LY96, TNFRSF11A, TP53BP2, SFN, TGFB1, TNFSF12, CAV1, TNFRSF10C, TNFRSF10B, INHBA, JMY, CD28, CD24, CDKN1A, FASLG, BRCA2, CD3E, DCC, PAWR, TNFRSF1B, IFNG, IL1B, TLR4, BCL2A1, SORT1, G0S2, MLH1]
GO:0045666;positive regulation of neuron differentiation;8.0;0.6181399273706679;0.684069963685334;8.712233520617966;337.32148776029015;3.9481280100702625;0.011289846625707336;0.576907450041722;[SCARB2, CYFIP1, CPNE5, PLXND1, MEF2C, EPHA3, LYN, SYT2, CXCL12, LIN28A, BCL6, TCF4, EZH2, ROBO2, NRP1, NLGN1, RAB21, PAK1, CNR1, FYN]
GO:0038094;Fc-gamma receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.857092701852345;0.002626513627734276;0.6233919466506386;[CYFIP1, CD3G, IGHG1, FCGR3A, FCGRT, FCER1G, SYK, FGR, HCK, CLEC4D, PAK1, IGKC, IGLV1-44, NCKAP1L, FYN, PLCG1, LYN, PTK2, FCGR2A, CD247, FCGR2B, IGKV3-20]
GO:0045663;positive regulation of myoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.26328322821418;6.7325511899570465;0.00382428925936973;0.6674232935401965;[MEF2C, CXCL9, TNFSF14, FLT3LG, MAPK14]
GO:0097193;intrinsic apoptotic signaling pathway;6.0;0.7436939687323844;0.6949672969563367;9.0689084645567;50.98493142520191;4.74012102526684;0.0017064197713422317;0.5655303222604612;[TNF, PYCARD, MSH6, MELK, MSH2, LGALS12, TP53BP2, SFN, TNFRSF10B, JMY, CD24, CDKN1A, BRCA2, TNFRSF1B, BCL2A1, MLH1]
GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis;10.0;1.0;0.9152410118609203;9.628524252492122;384.64074149301706;4.886724499458715;0.01287357946357817;0.6651483300191682;[CYFIP1, CD3G, IGHG1, FCGR3A, SYK, FGR, HCK, PAK1, IGKC, IGLV1-44, NCKAP1L, FYN, PLCG1, LYN, PTK2, FCGR2A, CD247, FCGR2B, IGKV3-20]
GO:0045669;positive regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;169.86351353303945;5.734022359845919;0.005685178930713632;0.6163584827319739;[IL6R, MEF2C, JAG1, RUNX2, LTF]
GO:0046638;positive regulation of alpha-beta T cell differentiation;10.0;0.7671156992804218;0.7987988615011312;9.488762310116963;1285.3660192826185;5.970411137910149;0.04302004391107474;0.7205681151061569;[CD86, CD83, CD80, MYB, NLRP3, NCKAP1L, CCL19, IL12RB1, ANXA1, SYK, ZAP70, IFNG]
GO:0043129;surfactant homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;28.07196958697662;7.474488534686424;9.395435589437007E-4;0.7331650565203278;[CTSH]
GO:0045425;positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process;8.0;1.0;0.875;9.628524252492122;833.6113263844036;9.083926447120524;0.027900220892599446;0.839552420951524;[SYK, CD80]
GO:0038093;Fc receptor signaling pathway;7.0;0.8436909121759173;0.7727648213451592;9.474373572664863;77.78262967477835;4.556717802602145;0.0026033146153928975;0.5839501255913225;[CYFIP1, IGHG1, FCGRT, GRAP2, CLEC4D, BTK, PRKCQ, CARD11, IGLV1-44, NCKAP1L, PLCG1, LYN, JUN, PTK2, NFKB1, IGKV3-20, LAT, ITK, CD3G, FCGR3A, FCER1A, FCER1G, CHUK, SYK, FOS, LAT2, FGR, HCK, KIT, LCP2, PAK1, IGKC, FYN, FCGR1B, FCGR2A, CD247, FCGR2B]
GO:0048813;dendrite morphogenesis;8.0;0.8259837884571596;0.7879918942285797;9.485423408851448;64.60914726719044;6.063501560976162;0.0021624100145753813;0.6850877518099798;[MEF2A, NRP1, SDC2, FYN]
GO:0097067;cellular response to thyroid hormone stimulus;6.0;0.8933024483968273;0.7697715367885581;9.485423408851448;110.48347060425422;7.004484905440688;0.003697782332456301;0.6813299963962409;[GHSR, KIT, CTSH, GAS2L1, CTSS]
GO:0032308;positive regulation of prostaglandin secretion;10.0;0.8933024483968273;0.861892236059334;9.548481544818586;484.66648287468473;7.474488534686424;0.016221351010299763;0.7974867031240476;[IL1B, TNFSF11, TNFRSF11A, MIF, MAP2K6]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[NRP1, ITGAM, ITGB4, CTGF, ITGB6, FCER1G, SYK, FGR, HCK, CEACAM1, ADAM9, ITGA7, TLN1, PTK2, ZYX, PLP1, LAT]
GO:0034605;cellular response to heat;5.0;0.8436909121759173;0.712086467948879;9.260799472366804;50.43140892920004;5.666199763507158;0.0016878938715389536;0.5800107312719123;[CDKN1A, PTGS2, LYN, EIF2S1, CXCL10]
GO:0045672;positive regulation of osteoclast differentiation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;840.7838216260375;6.599019797332524;0.0281402778535103;0.7337148045016781;[CCR1, TMEM64, FOS, TNF, IFNG, TNFSF11, IL17A]
GO:0043372;positive regulation of CD4-positive, alpha-beta T cell differentiation;11.0;0.7980440201809971;0.8314509624201607;9.541512875502493;1782.7320683291834;6.409777797693995;0.0596664379722798;0.7602252869888839;[CD86, CD83, ANXA1, CD80, IFNG, MYB, NLRP3, NCKAP1L, CCL19, IL12RB1]
GO:0001920;negative regulation of receptor recycling;6.0;1.0;0.8231203125901445;9.628524252492122;203.33786122178435;8.390779266560578;0.006805535222898882;0.7522251544931926;[TRAT1]
GO:0046641;positive regulation of alpha-beta T cell proliferation;10.0;0.8653626801206646;0.8479223519212526;9.54628615425515;937.8544877713971;6.8867018697843045;0.03138914569146771;0.7674272657460779;[BLM, SYK, CD3E, ZAP70, CD28, XCL1, CCR2]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, FPR1, FLRT2, HLA-DQA1, HLA-DRB4, HLA-DRB1, CDKN1A, LRRC4, HLA-DPA1, ANXA1, FOS, FCER2, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL20, HLA-DPB1, PF4, CSF3R, F13A1, IL5RA, CXCL13, TNF, PYCARD, IGHG1, IL13RA2, IFNA14, IFNA16, IFNA10, TNFRSF11A, FOXO1, TNFRSF17, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, HLA-DRA, MYD88, CIITA, ITGAM, FASLG, TNFSF13B, CHUK, TNFRSF1B, XCL1, CX3CR1, IL2RG, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, FCGR1B, IL2RB, PTPN6, TNFSF11, ACSL1, IL1R1, IL1R2, FLT3LG, MIF, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, PPBP, SDC1, IFNA5, IFNA4, IFNA7, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, SYK, IL17RB, HCK, CEACAM1, IL1B, KIT, RHOU, CXCR5, CXCR4, CXCR6, CXCR1, CXCR2, CD40LG, IL18R1, IL17A, CD86, CD80, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, TGFB1, NFKBIA, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, GHR, LRRTM4, IRAK3, MMP9, IFNG, SAMHD1, NCAM1, CD4, LTBR]
GO:0045671;negative regulation of osteoclast differentiation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;842.5336305879634;6.481236761676141;0.028198842384740134;0.7276913745807394;[LILRB1, LILRB3, INPP5D, TLR4, LTF]
GO:0010759;positive regulation of macrophage chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;998.0472698001994;7.292166977892469;0.033403743935984914;0.7881627702307852;[CCL5, C5AR1, C3AR1, MAPK14]
GO:0010875;positive regulation of cholesterol efflux;9.0;1.0;0.896240625180289;9.628524252492122;184.0088741739662;7.069023426578259;0.0061586114213673755;0.757750811958709;[ABCA1, NFKBIA, LRP1, NR1H2]
GO:0001805;positive regulation of type III hypersensitivity;11.0;1.0;0.9324289523296623;9.628524252492122;1205.6585476054483;9.083926447120524;0.04035230656610712;0.8969813732811862;[FCER1G, BTK]
GO:0033630;positive regulation of cell adhesion mediated by integrin;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;34.61675044652454;6.943860283624253;0.0011585914843924019;0.6453503496879909;[SYK, CCL5, ADAM9, NCKAP1L, PTPN6, CXCL13]
GO:0010634;positive regulation of epithelial cell migration;8.0;0.7866048967936545;0.7683024483968273;9.383401794459138;242.52723865374625;4.901876304479318;0.00811716841739676;0.6256821821716325;[DOCK5, NRP1, NRP2, AKT1, CTSH, CCR6, ANXA1, ANXA3, MMP9, IFNG, ADAM9, PFN1, HBEGF, PTGS2, EPB41L5, PLCG1, JUN, TGFB1, PLK2, TEK]
GO:0048709;oligodendrocyte differentiation;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;23.145667324477426;6.518977089658987;7.746646556020492E-4;0.623621803389518;[CDKN2C, TSPAN2, CSK]
GO:0038083;peptidyl-tyrosine autophosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;522.6399477532146;5.905872616772578;0.017492288705884526;0.7172676121338334;[BLK, ITK, SLA2, GRAP2, FYN, CSK, LYN, SYK, BMX, PTK2, FGR, ZAP70, HCK, LCK, BTK]
GO:0043378;positive regulation of CD8-positive, alpha-beta T cell differentiation;11.0;1.0;0.9324289523296623;9.628524252492122;1779.8210772840882;8.390779266560578;0.05956900972172232;0.8615337942327104;[NCKAP1L]
GO:0048821;erythrocyte development;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;33.53950096943652;6.832634648514029;0.0011225369138558525;0.639662265535933;[ARID4A, BCL6, NCKAP1L]
GO:0043017;positive regulation of lymphotoxin A biosynthetic process;8.0;1.0;0.875;9.628524252492122;856.0759792352393;9.777073627680469;0.028652092606641942;0.875;[CD86]
GO:0007249;I-kappaB kinase/NF-kappaB signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;5.602686357784832;8.845336528452411E-4;0.6096419534788213;[TNF, AKT1, CHUK, BTK, TLR8, TLR7, TLR4, CARD11, LY96, CARD9, NFKB1, NFKBIA]
GO:0001932;regulation of protein phosphorylation;8.0;0.49565848909023646;0.6228292445451182;7.636094087801916;109.02632868365667;2.531418560085934;0.00364901310371649;0.5044568628857964;[, PID1, PHB2, AKT1, PROK2, ROPN1L, PRKACB, PRKAR1B, ATF3, FPR1, FPR2, SLC30A10, IQGAP3, FLRT2, PRKAR2B, PDGFD, PDGFC, SFN, NCKAP1L, ELANE, LYN, JUN, ACE, FZD5, CDC6, AZU1, NOX4, PKIG, EZH2, CDKN1A, LRRC4, HAVCR2, DUSP2, GPR37, DUSP1, FCRL3, DUSP6, HBEGF, ENG, CCL13, LRRC19, PTGS2, GPNMB, NTF3, DMD, CCL19, CCL18, CCL23, CDKN2C, CCL20, CARD9, GTF2H1, ELP4, PKN1, TNF, CTGF, PYCARD, MEN1, IFNA14, MAP2K2, IFNA16, F2R, ADAM9, IFNA10, BLM, TNFRSF11A, PKMYT1, FOXO1, DRD4, IFNA21, MAP2K6, TNFRSF10B, CXCL10, COPS5, PTPRC, CSPG4, LAT, LRRK2, TREM2, PTPN22, HHEX, XCL1, LCP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, CSK, TIE1, RAD50, PTPN6, FCGR2B, PPIL4, CCNH, TCL1A, EDNRB, PPP2R1A, TNFSF11, EPHB1, ACSL1, SLC11A1, PAQR3, FLT3LG, MIF, EPHA3, TGFA, PKHD1, CCR1, EGR1, PTK2, BST1, MARCO, CD24, IFNA5, IFNA4, NRP1, IFNA7, PTPRR, IFNA2, CD3E, IFNA8, CCR7, CD36, MAP4K1, SYK, CEACAM1, BANK1, IL1B, KIT, TLR8, TLR7, TLR6, TLR4, CXCR4, GNAI2, PAK1, NLRP12, CD40LG, CD80, IL6R, PDGFRB, TSC2, HGS, CCNE1, CALCA, C5AR1, ADRB2, HRH4, STAP1, TGFB1, CAV2, CAV1, INHBA, GH1, TNFAIP3, GHR, GRM5, LRRTM4, NUP62, MYOCD, IRAK3, MMP9, FGR, PSRC1, IFNG, NDUFS4, CHI3L1, LTF, EGF, MAPK14, CD4, LTBR, TEK]
GO:0070970;interleukin-2 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;8.67846133901236;0.004587596526932657;0.8590579283277371;[CARD11]
GO:0001812;positive regulation of type I hypersensitivity;11.0;1.0;0.9324289523296623;9.628524252492122;1109.5695898802176;9.083926447120524;0.0371362956254912;0.8969813732811862;[FCER1G, BTK]
GO:0016064;immunoglobulin mediated immune response;6.0;0.7586651285174919;0.7024528768488905;9.040737587590003;30.584352397600135;7.069023426578259;0.0010236307506175364;0.6846304993685643;[FCER1G, EXO1, INPP5D, TLR8, FCGR2B, IL13RA2, HLA-DQB1]
GO:0002902;regulation of B cell apoptotic process;9.0;0.7369933605727446;0.7647373054666613;9.117698628726131;22.875998380894767;6.8867018697843045;7.656390787466303E-4;0.7484268790654467;[LYN, MIF, BCL6, BTK]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[CXCL6, CCL13, CXCL9, CSF3R, C5AR1, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, LGALS3, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, PDE4B, CCL2, CCL1, NCKAP1L, CCL19, CCL18, CCL23, CXADR, FCER1G, SYK, CCL20, PPBP, CXCL10, CXCL11, IL1B, XCL1, S100A8, PF4]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[CSF3R, SIRPG, CXCL13, CXCL16, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, PRTN3, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, CORO1A, NUP85, INPP5D, IGLV1-44, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB1, GPR15, CAV1, TNFRSF10B, AZU1, DEFA1, PPBP, SELE, CXCL10, CXCL11, SDC1, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, CXCL1, SLC7A11, CXCL3, CXCL2, TREM1, CXCL5, PDE4B, OLR1, FFAR2, CCR7, CCR6, CCR5, CCR2, ANXA1, FCER1G, SYK, MMP9, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, IL1B, KIT, PECAM1, XCL1, CX3CR1, CCL13, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CCL23, CCL20, CD2, NLRP12, PTPN6, TEK, CD244, PF4]
GO:0010888;negative regulation of lipid storage;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;46.28121162512291;6.8867018697843045;0.001548990502706573;0.6753065664753021;[ABCA1, NR1H2, TNF, NFKBIA]
GO:0001938;positive regulation of endothelial cell proliferation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;87.3065775231622;5.277263957350204;0.0029220725788817177;0.6207988894539612;[NRP1, NRP2, HMGB2, AKT1, PLCG1, GHSR, JUN, EGR3, ARG1, CAV2, TNFSF12, NR4A1, LRG1, CXCL12, AGTR1, TEK]
GO:0035924;cellular response to vascular endothelial growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;62.59148538135601;6.599019797332524;0.00209488068703431;0.6605944919115335;[NR4A1, NRP1, EGR3, ANXA1, AKT1, MAPK14]
GO:0010524;positive regulation of calcium ion transport into cytosol;12.0;0.811012628672052;0.8536266269261705;9.4949928598676;446.85811756486936;5.825829909099042;0.01495593904869991;0.7460535250702665;[CXCL9, JPH2, CD19, PLCG1, TRPC3, CAV1, TRPC1, F2R, CXCL10, P2RX5, CD4, CXCL11, XCL1, F2RL3]
GO:0001818;negative regulation of cytokine production;5.0;0.5133656128089943;0.5469238182654175;7.031139619277432;44.35819177106142;4.304802954008995;0.0014846287587966433;0.5103888351227501;[CD83, TNF, PYCARD, CDH3, GHSR, CD96, LAG3, IL1R2, SLC11A1, BTK, CD274, INPP5D, NLRP3, NCKAP1L, ELANE, TGFB1, PRG2, INHBA, NFKB1, BCL6, CD24, GPR18, ORM1, IFNA2, TNFAIP3, PTPN22, HAVCR2, ANXA1, ARG1, IRAK3, PDCD1LG2, CEACAM1, IFNG, BANK1, TLR8, XCL1, BPI, TLR6, TLR4, LTF, DLL1, GPNMB, CSK, LILRB1, NLRP12, FCGR2B, LGR4]
GO:0010763;positive regulation of fibroblast migration;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;201.49065414776382;7.379178354882098;0.006743710864509851;0.7523715242355574;[PAK1, TGFB1, AKT1, SLC8A1]
GO:1905050;positive regulation of metallopeptidase activity;10.0;0.8933024483968273;0.861892236059334;9.59573442966913;498.63588947967594;7.8311634786251565;0.016688894477719096;0.8157270763441555;[MAPK14]
GO:0007050;cell cycle arrest;6.0;0.811012628672052;0.7286266269261705;9.292052015870908;55.61614271062087;4.7664383335842135;0.0018614222452456451;0.5668761906316916;[CDKN1A, DUSP1, MSH2, IFNG, GAS2L1, MAP2K6, BARD1, TGFB1, CDKN2C, DHCR24, INHBA, JMY]
GO:0007172;signal complex assembly;6.0;1.0;0.8231203125901445;9.628524252492122;86.36830501999869;7.697632086000634;0.002890669442591265;0.7167775754447168;[CD3E, PTK2]
GO:0043306;positive regulation of mast cell degranulation;11.0;0.8933024483968273;0.8790801765280758;9.584072489921288;1034.300036297698;7.212124270218933;0.03461709140528456;0.8012573229067359;[FGR, FCER1G, SYK]
GO:0031281;positive regulation of cyclase activity;5.0;0.8436909121759173;0.712086467948879;9.271849308553389;31.38454051727387;6.686031174322154;0.001050412326860463;0.6321649570480018;[LHCGR, GUCA1C, MAPK14, TSHR]
GO:0040036;regulation of fibroblast growth factor receptor signaling pathway;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;67.94038154209638;6.375876246018314;0.002273903427840277;0.6491829203200885;[RUNX2, DUSP6, SULF2]
GO:0032494;response to peptidoglycan;5.0;0.8653626801206646;0.7229223519212526;9.461470167828956;77.33766349313319;7.379178354882098;0.002588421997736798;0.6676125360964777;[C5AR1, CARD9, NLRP3, TREM2, IRAK3]
GO:0032495;response to muramyl dipeptide;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;59.66765988983927;7.004484905440688;0.0019970228791053504;0.6813299963962409;[JAG1, CARD9, TNFAIP3, PTPN22, MAPK14, NFKBIA]
GO:0007173;epidermal growth factor receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.040737587590003;32.38857880465376;5.788089581116195;0.0010840165847632744;0.6922437955322635;[TGFA, SLC30A10, EPS8, REPS2, AKT1, PLCG1, TGFB1, EGF, GAB1, PTK2, BTC, KIF16B, HBEGF]
GO:0061098;positive regulation of protein tyrosine kinase activity;11.0;0.8436909121759173;0.8542744084176208;9.55953138100517;2154.6219316186807;5.8650506222523235;0.07211325701743153;0.7323679139043926;[TGFA, GRM5, CCL5, STAP1, FYN, ACE, EGF, CD24]
GO:0007179;transforming growth factor beta receptor signaling pathway;8.0;0.7586651285174919;0.754332564258746;9.05316010758856;29.903672154863813;5.2552850506314295;0.0010008489954655988;0.6437555218850388;[PTPRK, CDH5, FOS, TGFBR3, ADAM9, JUN, TGFB1, USP9Y, PTK2, ZYX]
GO:0051051;negative regulation of transport;5.0;0.4195750255838234;0.500028524652832;5.863455660020639;25.979149802477615;3.6880287522336235;8.694987641720433E-4;0.47884697376102403;[, CYFIP1, PID1, LGALS3, AKT1, IL1R2, EPHA3, BARD1, NDFIP2, CYP4F2, PKIG, IFNA2, CD36, CCR2, ANXA1, RAB33B, CEACAM1, BANK1, IL1B, TLR8, TLR6, TLR2, KCNA5, PTGS2, GNAI2, GABRE, NR1H2, LILRB1, LILRB2, NLRP12, GOPC, LGR4, TNF, IL13RA2, GHSR, F2R, GEM, PRTN3, KCNE3, CORO1A, NLRP3, DRD4, TGFB1, CAV1, INHBA, NFKB1, MCTP1, LRRK2, PTPN22, MMP9, PLN, CNR1, CSK, TRAT1, EGF, FCGR2B]
GO:0007178;transmembrane receptor protein serine/threonine kinase signaling pathway;7.0;0.6393367784920305;0.6705877545032157;8.124446855715847;28.111912685638995;4.641275190630208;9.408804185094754E-4;0.5882743943473984;[PTPRK, TMEM100, CDH5, FOS, RUNX2, RGMA, TGFBR3, ADAM9, ENG, EGR1, JUN, TGFB1, USP9Y, INHBA, MAPK14, PTK2, ZYX]
GO:0043303;mast cell degranulation;9.0;1.0;0.896240625180289;9.628524252492122;196.3355458728175;7.138016298065211;0.006571174029843636;0.7612791106150483;[LAT2, KIT, LAT]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[LLGL2, RACGAP1, NCKAP1L, JUN, EZH2, DENND1B, NRP1, ARHGAP6, CCR7, RHOG, CCL13, NTF3, CCL19, CCL18, RANBP2, RANBP1, CCL23, CCL20, SIPA1, CXCL13, RGS1, F2R, TSC2, ACAP1, PRTN3, ADAP2, EVI5, CAV2, TBCK, LRRK2, TBC1D9, ARAP3, ALDH1A1, XCL1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1]
GO:0043304;regulation of mast cell degranulation;10.0;0.7980440201809971;0.8142630219514189;9.523163736834295;224.79395709788088;6.409777797693995;0.007523651442639206;0.7430373465201421;[LYN, FCER1G, SYK, STXBP2, FGR, IL13RA2]
GO:1990441;negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress;13.0;1.0;0.9625549647676366;9.628524252492122;2405.9170544431627;8.390779266560578;0.08052387862743936;0.8916598066706847;[JUN]
GO:0051289;protein homotetramerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;5.433268205826786;0.002859955186148837;0.6287769539759931;[CDA, ACPP, FBP1, HM13, SAMHD1, CD79A, VASP, CD247]
GO:0001865;NK T cell differentiation;8.0;1.0;0.875;9.628524252492122;92.19446145895849;8.67846133901236;0.0030856656554028718;0.8188169164668168;[ITK, BMX]
GO:0031397;negative regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;529.4632463014641;5.572381008289503;0.01772065836772442;0.7002128357670632;[TNFAIP3, AKT1, FBXO5, FYN, CAV1]
GO:0010694;positive regulation of alkaline phosphatase activity;10.0;1.0;0.9152410118609203;9.628524252492122;315.71736046966464;7.9853141584524145;0.01056677592774235;0.8236103492792612;[MEF2C]
GO:1905232;cellular response to L-glutamate;7.0;1.0;0.8509193652572005;9.628524252492122;543.0623632319648;8.390779266560578;0.01817580857297763;0.7800242071602487;[ABCB4, FYN]
GO:0045859;regulation of protein kinase activity;9.0;0.5608425510848448;0.6766619007227115;8.333797084897721;159.5555227474585;3.0974744418360864;0.005340179755709658;0.5546456121830788;[, AKT1, PROK2, PRKACB, PRKAR1B, FPR1, IQGAP3, FLRT2, PRKAR2B, PDGFD, PDGFC, SFN, NCKAP1L, ELANE, LYN, ACE, FZD5, CDC6, AZU1, NOX4, PKIG, EZH2, CDKN1A, LRRC4, DUSP2, DUSP1, DUSP6, LRRC19, NTF3, CCL19, CDKN2C, GTF2H1, ELP4, PKN1, TNF, PYCARD, MEN1, MAP2K2, F2R, ADAM9, BLM, TNFRSF11A, PKMYT1, DRD4, MAP2K6, TNFRSF10B, CXCL10, PTPRC, CSPG4, LAT, LRRK2, PTPN22, HHEX, LCP2, CCL5, FYN, CSK, PTPN6, CCNH, TCL1A, PPP2R1A, TNFSF11, ACSL1, SLC11A1, PAQR3, MIF, TGFA, EGR1, PTK2, CD24, CCR7, MAP4K1, SYK, CEACAM1, IL1B, KIT, TLR6, TLR4, CXCR4, PAK1, CD40LG, IL6R, PDGFRB, TSC2, HGS, CCNE1, CALCA, C5AR1, ADRB2, STAP1, TGFB1, CAV1, GH1, TNFAIP3, GHR, GRM5, LRRTM4, NUP62, MYOCD, IRAK3, FGR, PSRC1, IFNG, CHI3L1, LTF, EGF, MAPK14, CD4]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[MRGPRF, EDNRB, GPR171, C3AR1, AKT1, PROK2, PRKACB, PTGDR, TAS2R10, TAS2R13, TAAR2, TRHR, ADCY9, AGTR1, FPR1, FPR3, FPR2, OR7D2, CCR10, CCR1, ABCA1, GPR15, FZD5, OR2J2, AZU1, NMBR, PPBP, MARCO, PNOC, OR7C2, GPR18, GPR19, GPR25, GABRB1, GRIK3, CD3E, CCR9, FFAR2, CCR7, CCR6, CCR5, CCR2, GPR37, ANXA1, RHOG, GPBAR1, TACR3, AGTRAP, PTH2R, AVPR1A, SORCS3, MC3R, CCL13, PTGER2, PTAFR, CXCR5, CXCR4, CXCR6, GNAI1, GNAI2, FGD4, CXCR1, CXCR2, FLNA, CCL19, GABRE, CCL18, GPR157, P2RY13, GABBR1, CCL23, SORT1, GABRA5, CCL20, P2RY14, GPR6, RAMP1, LGR4, F2RL3, PF4, CHRM2, CHRM1, CELSR1, CXCL13, CXCL16, RGS1, CCRL2, PDGFRB, CD97, GHSR, LHCGR, F2R, NPY1R, DGKZ, SPNS1, OR2C3, CALCA, SUCNR1, CALCRL, GPR87, C5AR1, GPR85, GPR84, ADRB2, GPR82, HRH4, DRD4, HTR1E, CAV1, GPR98, CXCL10, CXCL11, CXCL12, GNB2, OR7E24, TAS2R7, CXCL6, CXCL9, OR1G1, CXCL1, CXCL3, CXCL2, CXCL5, GRM5, PDE4B, PTGIR, GLP2R, OR2H1, XCL1, CX3CR1, LRP1, OR1E1, P2RY6, CCL8, PLN, CCL7, CNR1, P2RY2, OR2W1, CCL5, CCL4, CCL2, S1PR3, OR12D3, CCL1, S1PR5, TSHR, OR11A1, PTPN6]
GO:0030183;B cell differentiation;6.0;0.7307253602413294;0.6884829927108091;9.022388448921806;64.35544597283358;5.2552850506314295;0.0021539188605695985;0.5918758344751833;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, HHEX, BLNK, TPD52, CR2, IFNA14, IFNA16, NFAM1, MSH2, KIT, CARD11, IFNA10, DLL1, CD79B, CD79A, NKX2-3, IFNA21, CD40LG, BCL6, FCGR2B, ITM2A]
GO:0031274;positive regulation of pseudopodium assembly;9.0;0.9326813400603323;0.8625812952104552;9.571365838652174;200.71212349518538;7.212124270218933;0.006717654144200148;0.7650689957573628;[KIT, CCR7]
GO:0030182;neuron differentiation;4.0;0.5833093054345528;0.5416546527172764;7.212610474191073;21.066225782797595;4.296434704338478;7.050676185779127E-4;0.4697198705845162;[MEF2C, RUNX2, JAG1, BCL11B, FZD5, INHBA, USH2A, NR4A2, ITM2C]
GO:0032481;positive regulation of type I interferon production;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;65.23665507211369;5.618190544320798;0.002183412136085803;0.610434838299289;[HMGB2, PTPN22, CHUK, SYK, MMP12, TLR8, TLR7, TLR4, TLR2, HSPD1, NFKB1, MYD88]
GO:0043552;positive regulation of phosphatidylinositol 3-kinase activity;11.0;0.9326813400603323;0.8987696223598284;9.597752593825367;732.6859750532908;6.375876246018314;0.024522340210466318;0.7584915600596062;[LYN, PDGFRB, TGFB1, FPR2, PTK2, FGR, KIT, CCR7, TEK, CCL19]
GO:0042100;B cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;50.60132884827668;6.166155715036245;0.00169358093831245;0.6384578026126634;[IFNA5, IFNA4, IFNA7, MEF2C, CR2, IFNA14, IFNA16, IFNA2, CD180, IFNA8, HSPD1, CD79A, CD40LG, PTPRC, MS4A1, CARD11, IFNA21, IFNA10]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, C3AR1, RNASE3, RNASE2, BIN2, PADI2, FPR1, FPR2, NCKAP1L, ELANE, JUP, AZU1, LYZ, TCN1, SIGLEC9, PYGL, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, PTAFR, ALOX5, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, BRI3, HVCN1, GPR84, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, ITGAM, FCAR, ALAD, FCGR3B, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, TTR, FCGR2A, P2RX1, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CCT2, FCER1G, MME, RHOG, CEACAM1, CEACAM6, TLR2, LILRA3, CXCR1, CXCR2, CD58, CCT8, LILRB2, LILRB3, QPCT, CD68, CD97, CHRNB4, CD93, OSCAR, DOK3, PRTN3, VCL, PSMD14, C5AR1, MGAM, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[CD86, TFRC, CD80, CD3E, TNFSF13B, PYCARD, IL6R, ICOSLG, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, PDCD1LG2, ZAP70, IL1B, XCL1, PRKCQ, CARD11, CD274, BLM, HHLA2, CORO1A, HLA-DMB, CCL5, NCKAP1L, CCL19, IL12RB1, LILRB2, CD4, CD40LG, PTPRC, CD6, DNAJA3, CD28, HLA-DPB1, CD24]
GO:0043555;regulation of translation in response to stress;8.0;0.6519675769143192;0.7009837884571596;9.143016436710422;244.8151792676207;7.004484905440688;0.008193743730730268;0.7332096838060964;[EIF2S1, PPP1CA, RPS6KA1]
GO:0043313;regulation of neutrophil degranulation;10.0;0.8933024483968273;0.861892236059334;9.537552474286395;150.84516981286367;7.8311634786251565;0.005048652081797471;0.8157270763441555;[ITGAM, SYK, PTAFR, CD177]
GO:0097062;dendritic spine maintenance;7.0;1.0;0.8509193652572005;9.628524252492122;53.70815772734724;7.474488534686424;0.0017975637049304797;0.7331650565203278;[FYN]
GO:0042104;positive regulation of activated T cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;649.8896198547563;6.599019797332524;0.021751220713853325;0.7527151911823093;[HHLA2, PYCARD, CD24, IL12RB1, IL6R, ICOSLG]
GO:2000727;positive regulation of cardiac muscle cell differentiation;9.0;0.8436909121759173;0.8180860812682478;9.4949928598676;667.9527156383532;6.8867018697843045;0.02235577627399952;0.7484268790654467;[MEF2C, MYOCD, TGFB1]
GO:0033209;tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;30.19135422731818;5.395046993006588;0.00101047745553359;0.6268223193749;[TNFRSF13B, TNF, TNFSF13B, PYCARD, TNFSF11, CHUK, TNFRSF1B, TNFRSF11A, TNFRSF17, TNFSF14, TNFSF12, TNFRSF10C, TNFRSF10B, NFKBIA, CD40LG, LTBR]
GO:0002721;regulation of B cell cytokine production;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;107.63791932510406;9.777073627680469;0.003602544291973033;0.875;[BTK]
GO:0042590;antigen processing and presentation of exogenous peptide antigen via MHC class I;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;32.556158890958;6.409777797693995;0.0010896253394395913;0.618037346520142;[CD36, FCGR1B, FCER1G, CHUK]
GO:0019395;fatty acid oxidation;8.0;0.7763722522362496;0.7631861261181248;9.283683766200392;147.7937623067202;5.446340287394138;0.004946524218655313;0.6535260955780609;[ETFA, ACADM, HIBCH, POR, SLC27A2, HSD17B4, MAPK14]
GO:0045860;positive regulation of protein kinase activity;10.0;0.6281612110245125;0.7293216173731766;9.003430535177193;1094.9224192180604;3.5309668621989068;0.03664606800502658;0.5958148214005239;[, CCNH, TCL1A, AKT1, PROK2, TNFSF11, PRKACB, ACSL1, SLC11A1, MIF, PRKAR1B, FPR1, TGFA, IQGAP3, PRKAR2B, PDGFD, PDGFC, NCKAP1L, ELANE, EGR1, ACE, FZD5, CDC6, AZU1, PTK2, NOX4, CD24, EZH2, CDKN1A, CCR7, MAP4K1, SYK, DUSP6, IL1B, KIT, TLR6, TLR4, CXCR4, PAK1, NTF3, CCL19, CD40LG, PKN1, TNF, IL6R, PDGFRB, MAP2K2, F2R, ADAM9, CALCA, C5AR1, TNFRSF11A, ADRB2, STAP1, DRD4, MAP2K6, TGFB1, TNFRSF10B, GH1, PTPRC, CSPG4, LAT, LRRK2, GHR, GRM5, PSRC1, IFNG, CHI3L1, LCP2, LTF, CCL5, FYN, CSK, EGF, MAPK14, CD4]
GO:0035509;negative regulation of myosin-light-chain-phosphatase activity;11.0;1.0;0.9324289523296623;9.628524252492122;1252.1557676251311;8.16763571524637;0.04190852667538468;0.8501222226412654;[NCKAP1L, TNF]
GO:0002606;positive regulation of dendritic cell antigen processing and presentation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;55.28681003950749;7.8311634786251565;0.0018503997771236419;0.7236063770733796;[SLC11A1, CCR7, CCL19]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[BRCA2, CTGF, PDGFRB, GHSR, ANXA1, DUSP1, TACR3, IL1B, PCNA, ABCB4, PTGS2, RBBP8, TGFB1, GH1, CD4, EZH2]
GO:0032597;B cell receptor transport into membrane raft;11.0;0.9326813400603323;0.8987696223598284;9.59462270081644;336.41565742558566;9.777073627680469;0.011259529299599152;0.9324289523296623;[CD24]
GO:0030177;positive regulation of Wnt signaling pathway;7.0;0.7307253602413294;0.7162820453778652;9.040737587590003;188.4547261984632;4.948759890378168;0.006307410087620234;0.6039991761920099;[LRRK2, TNFAIP3, HHEX, RUVBL1, NAIP, TLR2, JUP, EGF, CAV1, NFKB1, SULF2, LGR4]
GO:0035984;cellular response to trichostatin A;6.0;1.0;0.8231203125901445;9.628524252492122;367.2586666355552;8.390779266560578;0.012291817060950673;0.7522251544931926;[MEF2C, EZH2]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[SCARB2, CD86, TFRC, CD80, ANPEP, CLEC5A, ITGB6, HAVCR1, CR2, CR1, CXADR, GYPA, DPP4, NCAM1, GPR15]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[CYFIP1, PLXND1, EPS8, TPM1, VRK1, CORO1A, SPTA1, MYH14, PTK2, ANXA1, RHOG, ARAP3, FGR, HCK, KIT, ITGA7, RHOU, CCL13, FGD4, CCL7, PDPN, CCL2, FYN]
GO:0090630;activation of GTPase activity;7.0;1.0;0.8509193652572005;9.628524252492122;49.337455126924546;5.2552850506314295;0.0016512802222712962;0.6196748871422394;[CXCL13, NTF3, CCR7, EVI5, RHOG, TBC1D9, TBCK]
GO:0043200;response to amino acid;5.0;0.6441938053840475;0.612337914552944;8.412128928167629;56.712201515420396;5.104244793218563;0.0018981063470534028;0.5512723279577749;[TNF, CTGF, ALAD, CHUK, ARG1, NAIP, PCNA, ABCB4, PDGFD, PDGFC, FYN, LYN]
GO:0046710;GDP metabolic process;10.0;0.8933024483968273;0.861892236059334;9.574457031221845;1314.1926939491284;7.138016298065211;0.04398484676983994;0.7802794972956796;[MPP1, CARD11]
GO:0045740;positive regulation of DNA replication;8.0;0.7671156992804218;0.7585578496402109;9.427853557029971;747.3070825002359;6.166155715036245;0.025011695518573164;0.6903374900225189;[JUN, PCNA, DBF4, E2F7]
GO:0045746;negative regulation of Notch signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.56398573135455;188.1075192762445;6.193554689224359;0.006295789384399518;0.6676580400938822;[EGF, NFKBIA, BCL6]
GO:0001960;negative regulation of cytokine-mediated signaling pathway;7.0;0.7140352122741334;0.7079369713942671;8.965230035081857;244.80256319284138;5.8067817141283475;0.008193321482061134;0.6478784521606894;[CCL5, STAP1, ARG1, NR1H2, IL1R2, CAV1, IRAK3, MMP12, PTPRC, PADI2]
GO:0097022;lymphocyte migration into lymph node;8.0;1.0;0.875;9.628524252492122;30.235634434558513;9.777073627680469;0.001011959474220325;0.875;[CCR7]
GO:0097029;mature conventional dendritic cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;70.62522642078902;8.390779266560578;0.002363762769726602;0.7522251544931926;[PRTN3, CCR7, CCL19]
GO:0043330;response to exogenous dsRNA;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;30.956451235720028;5.970411137910149;0.0010360845638621964;0.6284474158353811;[IFNA5, COLEC12, IFNA4, IFNA7, IFNA14, IFNA16, CAV1, IFNA2, CARD9, IRAK3, IFNA8, NFKBIA, IFNA21, IFNA10]
GO:0097028;dendritic cell differentiation;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;22.452520143917486;6.343086423195323;7.514656432606705E-4;0.6146267465268138;[LYN, TGFB1, TREM2, LILRB1, CAMK4, PRTN3, CCR7, LTBR, CCL19]
GO:0035855;megakaryocyte development;5.0;1.0;0.7902410118609202;9.628524252492122;66.38585475831493;7.069023426578259;0.0022218748153703875;0.6517511986393402;[MEIS1, KIT, PTPN6]
GO:0033673;negative regulation of kinase activity;9.0;0.6519675769143192;0.7222244136374487;8.892817457513381;266.5566888017255;4.174954806800768;0.008921412488748512;0.6097480081553338;[PYCARD, PPP2R1A, AKT1, MEN1, PAQR3, TSC2, PRKAR1B, FLRT2, PRKAR2B, SFN, LYN, CAV1, PTPRC, PKIG, CDKN1A, LRRC4, TNFAIP3, PTPN22, HHEX, LRRTM4, NUP62, DUSP2, MYOCD, DUSP1, IRAK3, DUSP6, CEACAM1, IL1B, LRRC19, CSK, CDKN2C, PTPN6, PKN1]
GO:0010572;positive regulation of platelet activation;9.0;0.8933024483968273;0.8428918493787028;9.592156608321247;334.5200598726648;8.16763571524637;0.011196085355429928;0.8139338954918922;[PDPN, TLR4]
GO:0070935;3'-UTR-mediated mRNA stabilization;11.0;1.0;0.9324289523296623;9.628524252492122;1969.4104306254499;6.8867018697843045;0.06591439475871723;0.7846152062148197;[MAPK14, MYD88]
GO:0045638;negative regulation of myeloid cell differentiation;7.0;0.7307253602413294;0.7162820453778652;9.186691500213083;279.0827475916144;5.4730085344763;0.00934064840372507;0.6308092762312435;[HOXA9, GPR171, HOXA7, HOXA5, CEACAM1, TLR4, LTF, DLL1, INPP5D, LYN, LILRB1, INHBA, LILRB3, MEIS2, NFKBIA, MEIS1, PF4]
GO:0090400;stress-induced premature senescence;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;55.82928668984125;7.697632086000634;0.0018685559824130236;0.6838982747154925;[CDKN1A, MAPK14]
GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway;7.0;0.579397892394798;0.6406183114545996;7.564831067780425;28.111912685638995;3.5644675319289507;9.408804185094754E-4;0.533206400604739;[CYFIP1, SLA2, EPS8, STMN1, AKT1, EPHB1, BTC, BTK, EPHA3, SDC2, TGFA, SLC30A10, FLRT2, PDGFD, PDGFC, NCKAP1L, PLCG1, PAG1, LYN, PTK2, NRP1, ITK, PTPRR, NRP2, CD3E, SYK, GAB1, HCK, KIT, HBEGF, PAK1, NTF3, SORT1, SORBS1, SULF2, NCF4, CTGF, FGF5, GRAP2, AP2M1, PDGFRB, TSC2, KIF16B, BLK, RASGRP4, FOXO1, STAP1, TGFB1, CAV2, CRIM1, BMX, GH1, CSPG4, GHR, BLNK, MMP9, FGR, ZAP70, LCK, ESRP1, LCP2, REPS2, POLR2E, FYN, CSK, POLR2I, POLR2J, POLR2K, POLR2L, TRAT1, EGF, MAPK14, CD4, CD7, TEK]
GO:0045630;positive regulation of T-helper 2 cell differentiation;13.0;1.0;0.9625549647676366;9.628524252492122;2538.1941708228874;7.8311634786251565;0.08495107467099283;0.8630410292508717;[CD86, NLRP3]
GO:0045879;negative regulation of smoothened signaling pathway;7.0;0.8653626801206646;0.7836007053175329;9.446202695698167;188.1075192762445;6.444869117505266;0.006295789384399518;0.6805102716434839;[CD3E, RUNX2, PRKACB]
GO:0019370;leukotriene biosynthetic process;8.0;0.8653626801206646;0.8076813400603323;9.488762310116963;324.40599840797483;6.781341354126479;0.010857576820271119;0.7217981122146513;[SYK, ALOX5]
GO:2000987;positive regulation of behavioral fear response;7.0;1.0;0.8509193652572005;9.628524252492122;209.702758470375;8.16763571524637;0.007018562605773582;0.7686126355688037;[MEF2C]
GO:0042130;negative regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;581.9323154417883;5.734022359845919;0.01947675089275457;0.6894787953221185;[CD86, CD274, CD80, GPNMB, CTLA4, HAVCR2, TGFB1, ARG1, PAWR, LILRB1, PDCD1LG2, LILRB2, XCL1, PTPN6]
GO:0032212;positive regulation of telomere maintenance via telomerase;10.0;1.0;0.9152410118609203;9.628524252492122;1624.1830741800397;6.250713103064308;0.054359945822938814;0.734902770639515;[CCT8, CCT7, CCT5, CCT4, CCT3, CCT2, CCT6A, PRKCQ]
GO:0035723;interleukin-15-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.212124270218933;0.00101047745553359;0.7197477358342742;[IL2RG, CD4, IL2RB]
GO:0032695;negative regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;7.004484905440688;0.002184000309729388;0.6813299963962409;[LILRB1, IRAK3, NFKB1, TLR8]
GO:2000502;negative regulation of natural killer cell chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;1002.759017369874;9.083926447120524;0.03356144188684441;0.8969813732811862;[KLRK1, CCL2]
GO:0030279;negative regulation of ossification;5.0;0.8436909121759173;0.712086467948879;9.377209824211215;41.83246312675316;5.500407508664414;0.0014000948940798496;0.571532107649126;[CALCA, TNF, MEN1, CCR1, MEF2C, TGFB1, TMEM64]
GO:0050718;positive regulation of interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;998.8167007681584;6.518977089658987;0.033429496098039586;0.7658097438582601;[ORM1, FZD5, PYCARD, NLRP12, TLR8, NLRP3, CCL19, TLR4]
GO:0009395;phospholipid catabolic process;6.0;0.7248374789738407;0.6855390520770648;9.05316010758856;279.93785671288197;6.343086423195323;0.00936926813646565;0.647506047256038;[PNPLA8, ABHD12, PNPLA6, PLCG1]
GO:1901741;positive regulation of myoblast fusion;9.0;1.0;0.896240625180289;9.628524252492122;353.2013099653272;6.8867018697843045;0.011821329983997786;0.7484268790654467;[CXCL9, TNFSF14, FLT3LG, MAPK14]
GO:0048754;branching morphogenesis of an epithelial tube;6.0;0.7436939687323844;0.6949672969563367;8.8813098506619;51.7127811195946;4.956792062075433;0.0017307802455913577;0.5766108891590862;[NRP1, PLXND1, PHB2, HOXA11, HHEX, HOXA5, PAX2, ENG, PAK1, TGFB1, EGF, PPP1CA]
GO:1902951;negative regulation of dendritic spine maintenance;8.0;1.0;0.875;9.628524252492122;176.1829454725938;8.67846133901236;0.005896684630611009;0.8188169164668168;[FYN]
GO:1902715;positive regulation of interferon-gamma secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.5029195149353;7.8311634786251565;0.02521906460756386;0.8157270763441555;[CD2, PTPN22, CD244]
GO:0002762;negative regulation of myeloid leukocyte differentiation;8.0;0.7671156992804218;0.7585578496402109;9.352270875863963;700.1468303315412;5.948432231191374;0.02343328431995837;0.6792031009335148;[INPP5D, HOXA7, LYN, LILRB1, INHBA, LILRB3, CEACAM1, TLR4, LTF]
GO:0002634;regulation of germinal center formation;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;44.47967864407596;7.57984905034425;0.0014886948151053528;0.738553198190834;[MEF2C, BCL6, TNFAIP3, PKN1, TNFSF13B]
GO:0002755;MyD88-dependent toll-like receptor signaling pathway;12.0;0.8933024483968273;0.8947715367885583;9.5544162803384;412.6549923027037;6.280566066213989;0.013811191226989502;0.7693087532925187;[LY96, HSPD1, CD36, IRAK3, TLR1, BTK, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, MYD88, TLR2]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[PHB2, SLC8A1, MYB, AKT1, ACTN4, ATP1B1, CLDN3, ABCB4, PSEN2, DPP4, EGR1, TGFB1, CAV1, NR4A2, CXCL12, NOX4, CD24, ALAD, MYOCD, KCND2, AGTRAP, TGFBR3, IL1B, TLR2, CXCR4, KCNA5, PTGS2, PAK1, TEK]
GO:0002758;innate immune response-activating signal transduction;9.0;0.6324783794010864;0.7124798148808322;8.79372655486915;406.8866713069129;4.647174912757396;0.013618130714412242;0.6338973663344365;[ICAM2, PRKACB, CD180, CLEC4D, BTK, S100A8, CARD11, LY96, KLRK1, CLEC7A, S100A14, MAP2K6, LYN, NFKB1, NFKBIA, MARCO, MYD88, ITGAM, TNFAIP3, CTSS, FFAR2, MUC15, CD36, HAVCR2, FCER1G, CHUK, SYK, IRAK3, TLR1, HCK, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, COLEC12, UNC93B1, HSPD1, PAK1, FYN, CARD9]
GO:2000510;positive regulation of dendritic cell chemotaxis;10.0;0.9326813400603323;0.8815816818910864;9.593432932680852;509.141903474748;7.697632086000634;0.01704052131133542;0.8088982747154926;[CCR7, CCR6]
GO:0050715;positive regulation of cytokine secretion;9.0;0.6913464685778243;0.7419138594692012;9.0689084645567;549.4808578036607;5.03214149931722;0.0183906298100222;0.6535845754738829;[ORM1, LRRK2, PTPN22, TNF, PYCARD, CLEC5A, FFAR2, HAVCR2, CHUK, SYK, F2R, MIF, IL17RB, MMP12, TLR1, FGR, IL1B, IGHD, TLR8, TLR4, TLR2, CD274, NLRP3, CD58, CCL19, FZD5, MAPK14, CD2, NLRP12, CD244, IL17A]
GO:0032289;central nervous system myelin formation;6.0;1.0;0.8231203125901445;9.628524252492122;33.54444455821997;8.67846133901236;0.0011227023713234936;0.7669372290569613;[TLR2]
GO:0051926;negative regulation of calcium ion transport;8.0;0.7140352122741334;0.7320176061370667;8.890925309361343;69.46225493434336;5.666199763507158;0.0023248391606816524;0.6647697194109919;[PTGS2, PLN, DRD4, TGFB1, LILRB1, LILRB2, GEM]
GO:0070207;protein homotrimerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;6.444869117505266;0.002859955186148837;0.6805102716434839;[ARG1, MGST1, MIF, TCL1A, CD247]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[AKT1, MEF2A, MEF2C, PRKAR1B, AGTR1, FPR1, FPR2, IQGAP3, PRKAR2B, SFN, LYN, ABCA1, JUN, HACE1, AZU1, ARHGAP6, DUSP1, DUSP6, PTAFR, STAT4, DMD, PKN1, LGR4, CTGF, KCNH1, MSH6, MSH2, BLK, LY96, TNFRSF10B, BMX, CORO2A, NFKB1, LRRK2, TNFRSF1B, LCP2, IL2RG, CCL5, CCL2, FYN, E2F7, SH2B1, IL2RB, PTPN6, TNFSF11, PAQR3, MIF, BTC, BTK, RACGAP1, PAG1, CCR1, PTK2, RGL4, CD24, RGL1, BRCA2, CCR9, CTSH, CCR7, CCR6, CD36, CCR5, SPTAN1, CCR2, LAT2, MC3R, IL1B, KIT, PCNA, GNAI2, PAK1, RAMP1, CD80, CELSR1, CCRL2, PDGFRB, DOK3, CARD11, CALCA, PSEN2, RASGRP4, SPTA1, GH1, TNFAIP3, GHR, GRM5, IRAK3, NDUFS4, BCL2A1, EPS8L1, EGF, MAPK14, TEK, CYFIP1, EPS8, STMN1, ADCY9, LGALS12, PRKCQ, PLCG1, PLK2, ITK, CDKN1A, NFAM1, PAX2, CIT, HBEGF, GSN, CCL20, CARD9, IL5RA, TNF, SLC8A1, FGF5, PYCARD, GRAP2, STK32B, MEN1, LHCGR, MAP2K2, DGKZ, NRBP1, RAB32, MELK, CALCRL, MAP2K6, DHCR24, BCL6, CNOT3, CSPG4, LAT, TREM1, CHUK, CX3CR1, RAB21, PLN, DNAJA3, EDNRB, PPP2R1A, CHEK1, RPS6KA1, PTGDR, SIK1, INPP5D, TP53BP2, CCR10, PRL, RALGPS2, MAP4K1, RHOG, AVPR1A, RAB33B, TLR8, TLR7, RHOU, SGK1, TLR4, PTGER2, CXCR5, CXCR4, CXCR6, CXCR1, CXCR2, PDPN, MLH1, CAMK4, SIPA1, SIRPG, TSC2, ATP1B1, CSF2RB, ADRB2, TGFB1, SELE, NFKBIA, JMY, DOCK5, MCTP1, CXCL1, TMEM100, BLNK, PTGIR, TGFBR3, ZAP70, NCAM1, TSHR]
GO:0050830;defense response to Gram-positive bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.334422371190153;0.0023911797157970473;0.6237219733958743;[SEH1L, HIST1H2BK, C5AR1, HMGB2, TNF, KLRK1, NLRP3, CD36, CAMP, HAVCR2, DEFA4, CARD9, RNASE6, RNASE3, DEFA1, LYZ, FGR, MYD88, TLR2]
GO:0070447;positive regulation of oligodendrocyte progenitor proliferation;9.0;1.0;0.896240625180289;9.628524252492122;486.0421787932986;8.67846133901236;0.016267394314649825;0.8400575416471059;[LYN, LRP2]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, TNF, TCL1A, AKT1, IFNA14, IFNA16, MIF, IFNG, IFNA10, PTGS2, PAK1, NTF3, IFNA21, TGFB1, CAV1]
GO:0050849;negative regulation of calcium-mediated signaling;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;240.2984816065916;6.518977089658987;0.008042573924779611;0.7083807915285978;[SLA2]
GO:0050729;positive regulation of inflammatory response;7.0;0.657518819034173;0.679678774774287;8.587070377663961;125.85203775116636;4.973052582947213;0.0042121544440509905;0.6052415056197167;[TNF, TNFSF11, FFAR2, CCR7, CCR2, FCER1G, IL17RB, IL1B, BTK, AGTR1, TLR10, TLR7, TLR6, TLR4, S100A8, TLR2, SUCNR1, TNFRSF11A, PTGS2, PLA2G7, CNR1, CCL4, CCL18, CCL23, NFKBIA, NLRP12, CD6, CD28, MYD88, IL17A]
GO:0060998;regulation of dendritic spine development;10.0;0.8259837884571596;0.8282329060895002;9.517298617381897;87.62706980140223;5.572381008289503;0.002932799167010087;0.7002128357670632;[NLGN1, LRRK2, MEF2C, PLK2]
GO:1902961;positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process;11.0;1.0;0.9324289523296623;9.628524252492122;1348.57412674769;7.9853141584524145;0.04513556238432715;0.8407982897480031;[LYN]
GO:0002764;immune response-regulating signaling pathway;5.0;0.5860072649471136;0.5832446443344771;7.893923197104016;48.795248251786205;3.532906727016733;0.0016331330461149228;0.4709140261775204;[, CYFIP1, ICAM2, SLA2, TRBC1, C3AR1, PRKACB, ICOSLG, MEF2C, BTK, PRKCQ, HHLA2, FPR1, FPR3, FPR2, CD79B, CD79A, KLRK1, CD19, INPP5D, NCKAP1L, S100A14, PLCG1, IGHA1, HLA-DQA1, PAG1, LYN, JUN, HLA-DRB4, PTK2, MARCO, CD28, CD24, HLA-DRB1, IGHM, DENND1B, ITK, CD3G, CD3E, CD3D, CTSS, FCER1A, CTSH, CTLA4, FFAR2, MUC15, CD36, HLA-DPA1, HAVCR2, FCER1G, SYK, FOS, LIME1, LAT2, TLR1, HCK, KIT, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, HLA-DQB1, TLR2, PAK1, IGKC, CARD9, LILRB1, LILRB2, HLA-DPB1, TRAC, IGHG1, FCGRT, GRAP2, CD180, THEMIS, CLEC4D, S100A8, CARD11, BLK, C5AR1, LY96, KIR2DL1, CLEC7A, IGLV1-44, MAP2K6, EIF2B3, BMX, NFKB1, NFKBIA, PTPRC, HLA-DRA, IGKV3-20, LAT, MYD88, ITGAM, TNFAIP3, PTPN22, FCGR3A, PDE4B, CR2, CR1, CHUK, IRAK3, FGR, ZAP70, LCK, LCP2, COLEC12, UNC93B1, CLEC12B, HSPD1, FYN, CSK, FCGR1B, TRAT1, CD4, FCGR2A, PTPN6, MNDA, CD247, FCGR2B]
GO:0002885;positive regulation of hypersensitivity;10.0;0.7980440201809971;0.8142630219514189;9.439282252853593;636.6186907884354;8.16763571524637;0.021307054661064313;0.8329342821725234;[FCER1G, BTK, CCR7]
GO:0002522;leukocyte migration involved in immune response;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;38.08781428465786;9.083926447120524;0.0012747648673000812;0.7876727335416686;[HCK]
GO:0001798;positive regulation of type IIa hypersensitivity;12.0;0.9326813400603323;0.9144609826203107;9.606051396640064;1378.0251110012991;9.083926447120524;0.04612126032313042;0.9126727335416687;[FCER1G]
GO:2000525;positive regulation of T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;265.86994678880865;9.083926447120524;0.008898427851603871;0.8607930461318132;[CCR7]
GO:2000526;positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation;9.0;1.0;0.896240625180289;9.628524252492122;733.9494972534095;9.777073627680469;0.024564629161408138;0.896240625180289;[CCR7]
GO:0001558;regulation of cell growth;5.0;0.5833093054345528;0.5818956645781967;7.6590836060266145;26.25041167864861;3.793137346993279;8.785776550476476E-4;0.4842222321850823;[CDA, CYFIP1, CPNE5, PPP2R1A, RPS6KA1, AKT1, AGTR1, PRKCQ, SFN, NRP1, CDKN1A, ESM1, AVPR1A, IL17RB, CEACAM1, SGK1, HBEGF, PAK1, CDKN2C, SIPA1, SEMA5B, CTGF, CXCL16, TNR, S100A8, IGFBP7, TGFB1, SYT2, CRIM1, INHBA, CXCL12, BCL6, TCHP, MYOCD, DCC, DNM2, PSRC1, NDUFS3, FBP1, TAF9, RAB21, SEMA4B]
GO:0070431;nucleotide-binding oligomerization domain containing 2 signaling pathway;13.0;1.0;0.9625549647676366;9.628524252492122;488.61025226297863;7.8311634786251565;0.01635334542256394;0.8630410292508717;[NFKBIA]
GO:0002768;immune response-regulating cell surface receptor signaling pathway;6.0;0.6835726970475526;0.6649066611139208;8.807543700422292;76.39633531366081;3.743987405881668;0.0025569165907102184;0.5145880026401528;[, CYFIP1, ICAM2, SLA2, TRBC1, C3AR1, PRKACB, ICOSLG, MEF2C, BTK, PRKCQ, HHLA2, FPR1, FPR3, FPR2, CD79B, CD79A, KLRK1, CD19, INPP5D, NCKAP1L, PLCG1, IGHA1, HLA-DQA1, PAG1, LYN, JUN, HLA-DRB4, PTK2, CD28, CD24, HLA-DRB1, IGHM, DENND1B, ITK, CD3G, CD3E, CD3D, FCER1A, CTLA4, FFAR2, MUC15, HLA-DPA1, FCER1G, SYK, FOS, LIME1, LAT2, HCK, KIT, IGHD, HLA-DQB1, PAK1, IGKC, CARD9, LILRB1, LILRB2, HLA-DPB1, TRAC, IGHG1, FCGRT, GRAP2, THEMIS, CLEC4D, CARD11, BLK, C5AR1, KIR2DL1, IGLV1-44, EIF2B3, BMX, NFKB1, PTPRC, HLA-DRA, IGKV3-20, LAT, PTPN22, FCGR3A, PDE4B, CR2, CR1, CHUK, FGR, ZAP70, LCK, LCP2, CLEC12B, FYN, CSK, FCGR1B, TRAT1, CD4, FCGR2A, PTPN6, MNDA, CD247, FCGR2B]
GO:2000768;positive regulation of nephron tubule epithelial cell differentiation;8.0;1.0;0.875;9.628524252492122;415.05780765516636;8.67846133901236;0.013891611294443005;0.8188169164668168;[CD24]
GO:2000648;positive regulation of stem cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;63.968874315823136;6.250713103064308;0.002140980655101363;0.6427820713687392;[CX3CR1, SMARCD3, LTBP3, PTPRC, EPCAM]
GO:0002408;myeloid dendritic cell chemotaxis;8.0;0.9326813400603323;0.8413406700301662;9.56398573135455;125.05555036753341;8.67846133901236;0.004185496728112903;0.8188169164668168;[CCR7, CCL19]
GO:2000522;positive regulation of immunological synapse formation;8.0;1.0;0.875;9.628524252492122;159.40900365360346;9.777073627680469;0.005335275893496953;0.875;[CCR7]
GO:0050727;regulation of inflammatory response;6.0;0.5272636092234699;0.5867521172018795;7.400047131651798;31.586589572713706;3.8007227183825356;0.00105717472691369;0.517489449159909;[EDNRB, C3AR1, TNFSF11, IL1R1, IL1R2, BTK, AGTR1, PLA2G7, CD19, ELANE, LYN, BST1, CD28, FFAR2, CCR7, CCR2, ANXA1, FCER1G, IL17RB, PSMA6, HCK, IL1B, TLR10, TLR7, TLR6, TLR4, TLR2, PTGS2, NT5E, IGKC, CCL18, CCL23, NLRP12, ZYX, IL17A, TNF, CDH5, IGHG1, GHSR, S100A8, SUCNR1, CALCRL, C5AR1, TNFRSF11A, IGLV1-44, NLRP3, SELE, NFKB1, NFKBIA, BCL6, IGKV3-20, MYD88, TNFAIP6, TNFAIP3, CR2, CR1, TNFRSF1B, XCL1, CNR1, CCL5, CCL4, MAPK14, CD6, TEK, FCGR2B]
GO:0035548;negative regulation of interferon-beta secretion;10.0;1.0;0.9152410118609203;9.628524252492122;774.9330078742448;9.777073627680469;0.025936310379122567;0.9152410118609203;[LILRB1]
GO:0050966;detection of mechanical stimulus involved in sensory perception of pain;6.0;1.0;0.8231203125901445;9.628524252492122;71.50580126066325;7.379178354882098;0.0023932348171512878;0.7004918368257019;[CXCL12, FYN, SCN1A]
GO:0035307;positive regulation of protein dephosphorylation;9.0;0.811012628672052;0.801746939516315;9.464221201200845;660.9024749708963;6.063501560976162;0.022119811063664396;0.706328376990269;[PDGFRB, TGFB1, FCRL3, LILRB2]
GO:0070433;negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;403.9920680879125;8.67846133901236;0.013521250949646067;0.8400575416471059;[TNFAIP3, PTPN22]
GO:0072610;interleukin-12 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;9.083926447120524;0.004587596526932657;0.8797934328124444;[CCR7, CCL19]
GO:0071407;cellular response to organic cyclic compound;5.0;0.5310727365277519;0.5557773801247963;7.0299582842316;63.0333181336412;3.907776714546695;0.0021096684316296343;0.4900848947730398;[AQP9, AKT1, MEF2C, KCNQ1, ABCB4, ABCA1, EGR1, JUP, NOX4, EZH2, GABRB1, ANXA1, ARG1, IL1B, PTAFR, PTGS2, GNAI1, P2RY13, TNF, SLC8A1, CDH1, BLM, FOXO1, OSBPL7, TGFB1, CAV1, INHBA, NFKB1, NFKBIA, ALPL, SLC26A3, LRRK2, PDE4B, DNM2, COLEC12, P2RY6, CCL5, CCL2, RAD51, KLF5]
GO:0071404;cellular response to low-density lipoprotein particle stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;56.74958382123113;7.004484905440688;0.0018993574991869968;0.6813299963962409;[ABCA1, FCER1G, SYK, CD9, CD36]
GO:0035666;TRIF-dependent toll-like receptor signaling pathway;13.0;0.9326813400603323;0.9288956347978027;9.592156608321247;413.3481394832653;6.599019797332524;0.013834390239330937;0.8000291440890255;[CHUK, LY96, TLR6, TLR4]
GO:0032270;positive regulation of cellular protein metabolic process;7.0;0.47017759384120705;0.586008162177804;7.412950536487706;288.49227156764;2.455885070940991;0.00965557670318086;0.47651344199545814;[, AKT1, PRKACB, PRKAR1B, AGTR1, FPR1, FPR2, SLC30A10, IQGAP3, PRKAR2B, PDGFD, PDGFC, LYN, JUN, AZU1, NOX4, EZH2, GPR37, DUSP6, PTAFR, PTGS2, NTF3, PSMC6, PSMC2, PKN1, CTGF, IFNA14, IFNA16, S100A8, IFNA10, TNFRSF11A, IFNA21, TNFRSF10B, PTPRC, LRRK2, FASLG, TNFRSF1B, LCP2, LRP1, LRP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, TIE1, EIF3E, FCGR2B, EIF3D, CCNH, TCL1A, TNFSF11, EPHB1, MIF, EPHA3, TGFA, CCR1, EGR1, PTK2, CD28, CD24, NRP1, CD3E, CTSH, CCR7, CD36, SYK, BANK1, IL1B, KIT, GNAI2, PAK1, NLRP12, RAMP1, CD80, IL6R, PDGFRB, CALCA, PSMD14, CAV2, CAV1, INHBA, GH1, TNFAIP3, GHR, GRM5, MMP9, PSRC1, CHI3L1, EGF, MAPK14, CD4, TEK, PHB2, MYB, PROK2, NCKAP1L, ELANE, NDFIP2, ACE, FZD5, PLK2, CDC6, CDKN1A, HAVCR2, FCRL3, HBEGF, ENG, CCL13, GPNMB, CCL19, CCL18, CCL23, GSN, CCL20, NR1H2, CARD9, TNF, PYCARD, MAP2K2, F2R, ADAM9, DRD4, MAP2K6, OSBPL7, WFS1, BCL6, CSPG4, CCDC22, LAT, TREM2, PTPN22, CR1, LCK, XCL1, NLRC4, CSK, RAD50, P2RX1, EDNRB, SKP2, ACSL1, SLC11A1, FLT3LG, AURKAIP1, MARCO, IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, MAP4K1, TLR6, TLR4, CXCR4, LILRB2, CD40LG, C5AR1, ADRB2, STAP1, NLRP3, TGFB1, NFKBIA, LIN28A, IFNG, LTF, HSPD1, HSPE1, LTBR]
GO:0060420;regulation of heart growth;6.0;0.7586651285174919;0.7024528768488905;9.260799472366804;65.94608890727007;5.75172193694532;0.0022071562480994867;0.6172636399279519;[MEF2C, MAPK14, DUSP6, TGFBR3, PAK1, MEIS1, BASP1]
GO:0034695;response to prostaglandin E;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;134.30653146733928;6.599019797332524;0.004495118740180942;0.6883935445785896;[PTGER2, TGFBR3, P2RY6, AKT1, CCR7, CCL19, PTGDR]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[SPINT2, PHB2, EPHB1, MEF2C, SPINT1, BTK, INPP5D, SFN, LYN, JUN, BCL11B, FZD5, CDC6, NOX4, CDKN1A, TNFRSF13B, PRL, PTPRK, BRCA2, CTLA4, CD33, HAVCR2, DUSP1, ARG1, PAWR, PDCD1LG2, CEACAM1, IL1B, TLR2, PTGS2, PAK1, GPNMB, PDPN, CCL23, CDKN2C, LILRB1, LILRB2, PKN1, CD86, CD80, SIRPG, TNF, CDH5, DACH1, MEN1, F2R, TPM1, TSC2, HGS, CD274, NACC2, IGFBP7, TGFB1, RARRES3, CAV2, CAV1, HMGA1, DHCR24, INHBA, BCL6, OGN, TNFAIP3, CXCL1, NUP62, PTGIR, MYOCD, TGFBR3, IFNG, XCL1, DLL1, CCL8, CCL2, ZNF503, CSK, E2F7, MEIS1, DNAJA3, CD9, PTPN6, MNDA, FCGR2B]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MEF2C, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, IQGAP3, PDGFD, PDGFC, NCKAP1L, PLCG1, ELANE, LYN, JUN, CDC6, CDKN1A, HLA-DPA1, HAVCR2, ANXA1, ARG1, FCRL3, PAX2, MMP12, HBEGF, PTAFR, KCNA5, PTGS2, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, LRG1, HLA-DPB1, CHRM1, TNF, CTGF, FGF5, PYCARD, CDH3, F2R, MSH6, CD274, BLM, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, BCL6, FASLG, TNFSF13B, LBH, XCL1, CX3CR1, SMARCD3, LRP2, CCL5, KLF5, DNAJA3, PTPN6, TCL1A, EDNRB, SKP2, ICOSLG, FLT3LG, MIF, RUNX2, BTC, TGFA, PKHD1, EGR1, EGR3, TNFSF12, PTK2, BST1, CD28, CD24, CD320, NRP1, NRP2, PRL, CD3E, ESM1, CTSH, CCR2, SYK, RHOG, PDCD1LG2, AVPR1A, HCK, CEACAM6, IL1B, KIT, GNAI2, PAK1, CXCR2, LILRB2, CD40LG, CD86, CD80, SIRPG, IL6R, PDGFRB, GHSR, CCNE1, PRTN3, CARD11, C5AR1, LTBP3, DPP4, TGFB1, CAV2, NR4A1, LIN28A, HMGB2, TNFAIP3, LAMC2, CXCL5, MYOCD, GLP2R, MMP9, TGFBR3, ZAP70, IFNG, NDUFS4, LTF, DLL1, S1PR3, EGF, MAPK14, MEIS2, TSHR, CD4, CD6, TEK]
GO:0046598;positive regulation of viral entry into host cell;8.0;0.9326813400603323;0.8413406700301662;9.548481544818586;85.02443603688559;7.57984905034425;0.0028456913571300335;0.7626338329336335;[CD4]
GO:0001890;placenta development;4.0;1.0;0.75;9.628524252492122;49.86610466882393;6.193554689224359;0.0016689736466849693;0.5667386748366816;[ABCB4, MAPK14, PTK2, E2F7]
GO:0048539;bone marrow development;5.0;1.0;0.7902410118609202;9.628524252492122;32.5184652959493;7.697632086000634;0.001088363768736683;0.6838982747154925;[PTPRC, HOXB4]
GO:0002740;negative regulation of cytokine secretion involved in immune response;10.0;1.0;0.9152410118609203;9.628524252492122;981.2960148552594;7.9853141584524145;0.03284309450812846;0.8236103492792612;[LILRB1, TNF]
GO:0050850;positive regulation of calcium-mediated signaling;8.0;0.7763722522362496;0.7631861261181248;9.283683766200392;239.92176968958296;6.039404009397101;0.008029965715936047;0.6838554019015759;[TREM2, CD3E, TNF, JPH2, CCL4, SYK, TRAT1, ZAP70, P2RX5, CD4]
GO:0050851;antigen receptor-mediated signaling pathway;9.0;0.8653626801206646;0.8289219652406215;9.533214072687796;218.73839564357212;4.31748811353631;0.007320977250414979;0.6170371680902661;[, TRAC, SLA2, IGHG1, GRAP2, TRBC1, ICOSLG, MEF2C, THEMIS, BTK, PRKCQ, CARD11, BLK, HHLA2, CD79B, CD79A, CD19, INPP5D, NCKAP1L, PLCG1, IGHA1, HLA-DQA1, PAG1, LYN, EIF2B3, HLA-DRB4, BMX, NFKB1, PTPRC, CD28, HLA-DRA, LAT, HLA-DRB1, IGHM, DENND1B, ITK, CD3G, PTPN22, CD3E, CD3D, PDE4B, CTLA4, HLA-DPA1, CHUK, SYK, LIME1, LAT2, ZAP70, LCK, IGHD, LCP2, HLA-DQB1, PAK1, IGKC, FYN, CSK, TRAT1, CD4, HLA-DPB1, PTPN6, MNDA, CD247]
GO:0019064;fusion of virus membrane with host plasma membrane;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;56.73089801191601;7.8311634786251565;0.0018987321019653565;0.7514054297404357;[CD4, CXCR4, CCR5]
GO:0001649;osteoblast differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[FBL, AKT1, MEF2C, RUNX2, HSD17B4, GPNMB, FIGNL1, HSPE1, PSMC2, ALPL, RBMX, LGR4]
GO:0032147;activation of protein kinase activity;11.0;0.6799073451904818;0.7723826249249031;9.164951513576677;1096.8683293671154;4.034070439870987;0.03671119586651001;0.6387315022281249;[, TNF, AKT1, PROK2, TNFSF11, PRKACB, MAP2K2, SLC11A1, F2R, PRKAR1B, ADAM9, CALCA, C5AR1, FPR1, TGFA, ADRB2, IQGAP3, PRKAR2B, PDGFC, NCKAP1L, DRD4, MAP2K6, TNFRSF10B, CSPG4, LRRK2, GHR, MAP4K1, SYK, DUSP6, IL1B, KIT, CHI3L1, TLR6, TLR4, CXCR4, PAK1, NTF3, CCL19, EGF, MAPK14, CD40LG, PKN1]
GO:0050859;negative regulation of B cell receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;309.61561130321576;7.9853141584524145;0.010362555874359037;0.7833693374183408;[FCRL3, PTPN6]
GO:0014835;myoblast differentiation involved in skeletal muscle regeneration;5.0;1.0;0.7902410118609202;9.628524252492122;21.75937296335754;9.083926447120524;7.282666309192915E-4;0.7547934328124444;[MAPK14]
GO:0072643;interferon-gamma secretion;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;7.8311634786251565;0.004587596526932657;0.8157270763441555;[LILRB1]
GO:0050857;positive regulation of antigen receptor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.52844079393514;294.8408907598327;6.7325511899570465;0.00986805927415722;0.6952223462072524;[LYN, TRAT1, NFAM1, PTPRC, LCK, STAP1, CCR7]
GO:0034329;cell junction assembly;4.0;0.7140352122741334;0.6070176061370667;8.529911963824013;35.00514165935835;4.7018998124466425;0.0011715905887565515;0.49045537506922354;[ITGB4, LAMC2, PTPRK, ARHGAP6, CDH5, CDH3, CDH1, TNS1, ACTN1, LSR, ACTN4, CLDN3, PKP3, TLN1, VCL, CD151, LAMA3, GJC1, FLNA, VASP, JUP, LAMB3, SORBS1, GRHL2, GJB2, CD9]
GO:0050855;regulation of B cell receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;68.86251036091213;6.686031174322154;0.0023047662495439825;0.692843310444282;[BLK, LYN, FCRL3, NFAM1, PTPN22, PAX5, STAP1, PTPN6]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[DENND1B, ITK, TRAC, CD3G, PTPN22, CD3E, CD3D, GRAP2, TRBC1, PDE4B, ICOSLG, HLA-DPA1, CHUK, THEMIS, LIME1, ZAP70, LCK, BTK, PRKCQ, LCP2, CARD11, HLA-DQB1, HHLA2, PAK1, INPP5D, FYN, CSK, PLCG1, HLA-DQA1, PAG1, EIF2B3, HLA-DRB4, TRAT1, BMX, NFKB1, CD4, PTPRC, CD28, HLA-DPB1, HLA-DRA, CD247, LAT, HLA-DRB1]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[NRP1, CD80, IFNA2, TREM2, CD3E, GHR, GRM5, CD36, IL6R, SYK, MIF, IFNG, BANK1, KIT, HBEGF, TGFA, CCL5, NTF3, STAP1, FYN, LYN, TGFB1, ACE, EGF, GH1, CD4, CSPG4, CD24]
GO:0050853;B cell receptor signaling pathway;10.0;0.9326813400603323;0.8815816818910864;9.582004236857228;219.43154282413207;4.948759890378168;0.007344176262756358;0.6683208227957298;[, BLK, IGHM, ITK, CD79B, CD79A, IGHG1, IGKC, CD19, TRBC1, CTLA4, NCKAP1L, IGHA1, LYN, MEF2C, SYK, BMX, LIME1, LAT2, PTPRC, LCK, BTK, IGHD, PTPN6, MNDA]
GO:0070228;regulation of lymphocyte apoptotic process;8.0;0.6441938053840475;0.6970969026920237;8.449869256150476;21.26656046846411;5.75172193694532;7.117726402176593E-4;0.6691433273378073;[CD274, BLM, SLC46A2, CD3G, LGALS3, CCL5, LYN, MIF, BCL6, BTK, PRKCQ]
GO:0050732;negative regulation of peptidyl-tyrosine phosphorylation;10.0;0.7980440201809971;0.8142630219514189;9.446202695698167;781.0212663083519;5.926926025970411;0.02614007890983527;0.7183442844592942;[PPP2R1A, NTF3, CAV1, PTPN6]
GO:2000670;positive regulation of dendritic cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;128.63842847306384;8.67846133901236;0.004305412433924055;0.8400575416471059;[LYN]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD86, CD274, HHLA2, CD80, CD3E, TNFSF13B, DPP4, PAK1, KLRK1, GRAP2, BTLA, AKT1, CTLA4, FYN, CSK, CCL19, ICOS, ICOSLG, LYN, TNFSF14, CAV1, PDCD1LG2, CD40LG, LCK, CD28, PTPN6, CD24, CARD11]
GO:0060536;cartilage morphogenesis;4.0;0.8436909121759173;0.6718454560879586;9.158520623246385;27.732136419115502;6.481236761676141;9.281696486453839E-4;0.5814507494004503;[MEF2C, HOXA5]
GO:0048667;cell morphogenesis involved in neuron differentiation;6.0;0.811012628672052;0.7286266269261705;9.223059144383958;47.452274261266446;7.212124270218933;0.0015881849152503491;0.6919486831672181;[MEF2C, SLITRK6, SLC1A3]
GO:1902741;positive regulation of interferon-alpha secretion;10.0;1.0;0.9152410118609203;9.628524252492122;774.0580298608876;7.8311634786251565;0.025907025652444588;0.8157270763441555;[MMP12, CHUK]
GO:0048666;neuron development;4.0;0.6696747006330769;0.5848373503165385;8.088079211544972;32.15320660831846;4.814228997420562;0.001076138889173156;0.4961998948126311;[ROBO2, GABRB1, MEF2C, GABRA5, SLC4A7, UQCRQ]
GO:0001782;B cell homeostasis;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;22.00128503895464;6.599019797332524;7.363632103827933E-4;0.6883935445785896;[LYN, MEF2C, TNFRSF13B, TNFAIP3, TNFSF13B, NCKAP1L, PKN1]
GO:0001661;conditioned taste aversion;8.0;1.0;0.875;9.628524252492122;32.407272069964435;8.16763571524637;0.001084642231530376;0.7926932703116032;[FOS]
GO:1900449;regulation of glutamate receptor signaling pathway;6.0;0.7763722522362496;0.7113064387082693;9.143016436710422;41.8512380110395;5.970411137910149;0.0014007232725606145;0.6284474158353811;[MEF2C, NLGN1, ADRB2, FYN]
GO:0050861;positive regulation of B cell receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;365.0896954818653;7.8311634786251565;0.01221922354838398;0.7754860644832351;[LYN, NFAM1, STAP1]
GO:0002741;positive regulation of cytokine secretion involved in immune response;10.0;1.0;0.9152410118609203;9.628524252492122;980.5172466015069;7.9853141584524145;0.03281702983552129;0.8236103492792612;[MAPK14]
GO:0050862;positive regulation of T cell receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;365.0896954818653;7.212124270218933;0.01221922354838398;0.7438283705770736;[TRAT1, LCK, CCR7]
GO:0001774;microglial cell activation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;31.19674186509269;6.8867018697843045;0.001044126874979773;0.6753065664753021;[CX3CR1, JUN, ITGAM, TLR8, TLR7, FPR2, AZU1, TLR6, TLR2]
GO:0050860;negative regulation of T cell receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.57973408832269;309.61561130321576;6.8867018697843045;0.010362555874359037;0.7271862538851576;[LGALS3, CEACAM1, PVRIG, PAWR, PTPN22, PTPN6, UBASH3A]
GO:2000547;regulation of dendritic cell dendrite assembly;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;51.76168527241457;8.67846133901236;0.001732417023575362;0.8188169164668168;[CCR7, CCL19]
GO:0002503;peptide antigen assembly with MHC class II protein complex;7.0;1.0;0.8509193652572005;9.628524252492122;45.61567929762514;8.67846133901236;0.0015267157346454312;0.7947362817240173;[HLA-DMA, HLA-DMB, HLA-DRA]
GO:2000669;negative regulation of dendritic cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;128.74299079791163;7.8311634786251565;0.004308912040836728;0.7967266896635242;[CXCL12, LILRB1, CCR7, CCL19]
GO:0071300;cellular response to retinoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;200.602279209425;5.54296712308321;0.006713977754809188;0.606587909038952;[LYN, ABCA1, PHB2, PAX2, MYB, EPHA3]
GO:0048311;mitochondrion distribution;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;32.547621880228036;6.943860283624253;0.00108933961337327;0.6453503496879909;[MEF2A, LRRK2]
GO:0002506;polysaccharide assembly with MHC class II protein complex;6.0;1.0;0.8231203125901445;9.628524252492122;58.63041707748974;9.083926447120524;0.0019623072956339374;0.7876727335416686;[HLA-DRA, HLA-DRB1]
GO:0050869;negative regulation of B cell activation;8.0;0.7586651285174919;0.754332564258746;9.158520623246385;160.49678057359853;6.375876246018314;0.005371682808073518;0.701062607729944;[TNFRSF13B, TNFAIP3, SLA2, INPP5D, CTLA4, LYN, PAWR, INHBA, BCL6, BANK1, BTK, MNDA, PKN1, FCGR2B]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[CD86, CD80, CXCL13, PYCARD, EDNRB, GHSR, CD96, MEF2C, SLC11A1, CD180, F2R, KMO, SLPI, ADAM9, S100A8, CD274, ABCB4, C5AR1, MGST1, LY96, CSF2RB, TNFRSF11A, KLRK1, STAP1, NLRP3, S100A14, ELANE, ABCA1, JUN, DEFA4, TNFRSF10C, TNFRSF10B, DEFA1, PPBP, SELE, NFKB1, CXCL10, CXCL11, ALPL, CXCL6, CXCL9, HMGB2, TNFAIP3, CXCL1, TREM2, FASLG, PTPN22, CXCL3, CXCL2, CXCL5, ALAD, PDE4B, CTSG, CCR7, CD36, CCR5, HAVCR2, PTGIR, CHUK, ARG1, IRAK3, PDCD1LG2, FOS, TNFRSF1B, IL1B, TLR4, CX3CR1, CEBPE, PTGER2, PTGS2, CNR1, CCL2, IL12RB2, GCH1, CCL20, NR1H2, LILRB1, LILRB2, MAPK14, CD6, LTBR, PF4]
GO:0050868;negative regulation of T cell activation;8.0;0.6393367784920305;0.6946683892460153;8.866384200445225;233.2008977034727;5.132682728539097;0.007805024178953029;0.6374856334316459;[CD86, CD80, IFNA2, PTPN22, LGALS3, CTLA4, HAVCR2, LAG3, ANXA1, ARG1, PAWR, PDCD1LG2, CEACAM1, XCL1, CD274, GPNMB, PAG1, TGFB1, LILRB1, LILRB2, BCL6, PTPN6, FCGR2B]
GO:0032497;detection of lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;150.00497270670016;8.390779266560578;0.005020531440782482;0.7522251544931926;[LY96, TREM2, TLR4]
GO:0035644;phosphoanandamide dephosphorylation;6.0;1.0;0.8231203125901445;9.628524252492122;26.015028339229886;9.777073627680469;8.706995865085551E-4;0.8231203125901445;[PTPN22]
GO:0072709;cellular response to sorbitol;6.0;1.0;0.8231203125901445;9.628524252492122;152.1977355403849;8.67846133901236;0.005093921239467482;0.7669372290569613;[MAP2K6]
GO:0034150;toll-like receptor 6 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;9.777073627680469;0.013811191226989502;0.9481203125901445;[TLR6]
GO:0034154;toll-like receptor 7 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;8.390779266560578;0.013811191226989502;0.8772251544931927;[UNC93B1, TLR7, HAVCR2]
GO:0055012;ventricular cardiac muscle cell differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;47.302935560632505;8.16763571524637;0.001583186683336236;0.7686126355688037;[MEF2C, MYOCD]
GO:0042177;negative regulation of protein catabolic process;7.0;0.7140352122741334;0.7079369713942671;9.105276108727574;231.8232476428224;5.040875179285974;0.007758915471227624;0.6087099563505541;[ALAD, IRAK3, TAF9, FLNA, FYN]
GO:0046777;protein autophosphorylation;8.0;0.7763722522362496;0.7631861261181248;9.31486669363708;180.75330000196035;4.488806596985934;0.006049650283656873;0.604557778120715;[SLA2, GRAP2, AKT1, EPHB1, PDGFRB, MAP2K2, VRK1, MELK, BTK, SIK1, BLK, LYN, BMX, EIF2S1, PTK2, ITK, LRRK2, MAP4K1, SYK, IRAK3, FGR, ZAP70, HCK, LCK, KIT, PAK1, FYN, CSK, CAMK4, TEK]
GO:0023014;signal transduction by protein phosphorylation;8.0;0.7248374789738407;0.7374187394869203;9.153100555777048;203.92357026499027;3.9689311377000256;0.006825138377471068;0.5779713229561524;[, IL5RA, TNF, FGF5, TNFSF11, KCNH1, MEN1, PDGFRB, MEF2A, MEF2C, MAP2K2, PAQR3, BTC, CSF2RB, IQGAP3, RASGRP4, SPTA1, MAP2K6, LYN, TGFB1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, MAP4K1, CHUK, DUSP6, IL1B, KIT, HBEGF, IL2RG, PAK1, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, IL2RB, TEK]
GO:0048714;positive regulation of oligodendrocyte differentiation;10.0;1.0;0.9152410118609203;9.628524252492122;471.693664190925;6.943860283624253;0.01578716244373315;0.7703503496879909;[CXCR4, TLR2]
GO:0043029;T cell homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;22.00128503895464;6.444869117505266;7.363632103827933E-4;0.6805102716434839;[TGFB1, SLC46A2, TNFSF14, CACNA1F, CORO1A, SIT1, NCKAP1L]
GO:0002554;serotonin secretion by platelet;10.0;1.0;0.9152410118609203;9.628524252492122;131.6544252072528;8.67846133901236;0.0044063551303965215;0.8590579283277371;[FCER1G, SYK, P2RX1]
GO:2000318;positive regulation of T-helper 17 type immune response;8.0;0.8933024483968273;0.8216512241984136;9.56398573135455;171.5773823021682;7.474488534686424;0.005742540576034618;0.7572456912631272;[NLRP3, PRKCQ, IL12RB1]
GO:0043392;negative regulation of DNA binding;5.0;0.7586651285174919;0.6695735761196662;8.866384200445225;32.533753988449135;5.788089581116195;0.0010888754675157227;0.5862441822128946;[JUN, NFKBIA]
GO:0006914;autophagy;4.0;0.6729672293956388;0.5864836146978194;8.39638057119949;37.75222312160081;4.39717627414001;0.001263532933085;0.4748717991491287;[LAMP2, HGS, S100A8, FOXO1, PLEKHF1, ITGB4, LRRK2, PTPN22, VPS41]
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.8653626801206646;0.8808016526504769;9.556203590912496;734.4861809891323;5.277263957350204;0.024582591483058774;0.7179998367869053;[RPS6KA1, AKT1, SERPINB9, TNFRSF1B, MMP9, PAX2, POR, NAIP, NLRC4, PTGS2, SFN, TNFSF14, TNFRSF10C, TNFRSF10B, DHCR24]
GO:0060729;intestinal epithelial structure maintenance;8.0;1.0;0.875;9.628524252492122;27.01847773359651;8.390779266560578;9.042841346921817E-4;0.8041048419030481;[TLR4]
GO:0043032;positive regulation of macrophage activation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;126.59742726208806;6.641579411751319;0.004237101960174532;0.6905700452391912;[ITGAM, LRRK2, HSPD1, STAP1, TLR6, TLR4, HAVCR2]
GO:2000311;regulation of AMPA receptor activity;9.0;0.8933024483968273;0.8428918493787028;9.541512875502493;200.74624271324296;6.558197802812269;0.006718796083723233;0.7316271658034954;[MEF2C, NLGN1, ADRB2]
GO:2000310;regulation of NMDA receptor activity;9.0;0.8933024483968273;0.8428918493787028;9.541512875502493;200.74624271324296;6.8867018697843045;0.006718796083723233;0.7484268790654467;[MEF2C, NLGN1]
GO:0006919;activation of cysteine-type endopeptidase activity involved in apoptotic process;13.0;0.9326813400603323;0.9288956347978027;9.604426700913061;734.4853933519539;5.322726331426962;0.024582565121551242;0.7347594368888992;[FASLG, TNF, PYCARD, CTSH, F2R, LCK, S100A8, NLRC4, HSPD1, NLRP3, TNFRSF10B, HSPE1, NLRP12, P2RX1]
GO:0071731;response to nitric oxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;66.42530163189308;6.832634648514029;0.0022231950667291668;0.639662265535933;[FOXO1, DNM2, CCR7, CCL19]
GO:0055005;ventricular cardiac myofibril assembly;9.0;1.0;0.896240625180289;9.628524252492122;126.15714848640395;8.67846133901236;0.004222366225777558;0.8400575416471059;[MEF2A]
GO:0034146;toll-like receptor 5 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;9.777073627680469;0.013811191226989502;0.9481203125901445;[TLR5]
GO:0014898;cardiac muscle hypertrophy in response to stress;7.0;1.0;0.8509193652572005;9.628524252492122;75.67165931027915;7.138016298065211;0.002532662337043095;0.7159578506919597;[MEF2C, EZH2]
GO:0034141;positive regulation of toll-like receptor 3 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;505.2767808384828;7.8311634786251565;0.01691115913508416;0.7967266896635242;[CAV1, PTPN22]
GO:0071727;cellular response to triacyl bacterial lipopeptide;8.0;1.0;0.875;9.628524252492122;168.80270344913424;8.67846133901236;0.005649674571872418;0.8188169164668168;[TLR1, TLR2]
GO:2000570;positive regulation of T-helper 2 cell activation;11.0;1.0;0.9324289523296623;9.628524252492122;326.26765218285163;9.777073627680469;0.010919884696736623;0.9324289523296623;[PRKCQ]
GO:0034260;negative regulation of GTPase activity;6.0;1.0;0.8231203125901445;9.628524252492122;61.14468506277762;5.970411137910149;0.0020464575824072424;0.6284474158353811;[LRRK2, KLRK1, PDE6D]
GO:0034145;positive regulation of toll-like receptor 4 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;505.2767808384828;7.474488534686424;0.01691115913508416;0.7784863164434164;[PTPN22, LTF]
GO:0090025;regulation of monocyte chemotaxis;9.0;0.8933024483968273;0.8428918493787028;9.510741216835738;137.5287080193099;6.641579411751319;0.004602962089604771;0.7358913051622797;[LYN, CCR1, CXCL10, CXCL12, CCL5, CCL1, FPR2, S100A14, PLA2G7, CCR2]
GO:0032088;negative regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.61713652769816;5.420364800990877;0.009358533920496976;0.725318020585559;[TNFAIP3, PYCARD, HAVCR2, CHUK, IRAK3, PKHD1, NLRP3, NFKBIA, NLRP12, CCDC22]
GO:0034144;negative regulation of toll-like receptor 4 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;354.70667396235325;7.697632086000634;0.011871713162238609;0.7898978880348613;[LYN, TNFAIP3]
GO:0090023;positive regulation of neutrophil chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;945.710466239641;6.343086423195323;0.03165207822087823;0.7568146869955557;[CXCL6, C5AR1, CXCL1, PPBP, CXCL3, CXCL2, CXCL5, IL1B, CXCR2, C3AR1, XCL1, CCR7, NCKAP1L, CCL19, PF4]
GO:0034142;toll-like receptor 4 signaling pathway;12.0;0.8436909121759173;0.8699657686781033;9.485423408851448;412.6549923027037;6.943860283624253;0.013811191226989502;0.8032296504172152;[ITGAM, LY96, NFKBIA, S100A14, TLR4]
GO:0045577;regulation of B cell differentiation;8.0;0.7369933605727446;0.7434966802863723;9.223059144383958;130.3775146173893;6.518977089658987;0.004363618082098712;0.7083807915285978;[SYK, FCRL3, NFAM1, INHBA, INPP5D, BTK, NCKAP1L, PTPN6, CARD11]
GO:0045579;positive regulation of B cell differentiation;9.0;0.8436909121759173;0.8180860812682478;9.503361109538115;803.2041625246294;7.212124270218933;0.026882520482883615;0.7650689957573628;[SYK, INPP5D, BTK, NCKAP1L]
GO:0045580;regulation of T cell differentiation;8.0;0.5976175254657065;0.6738087627328533;8.663443356448536;131.165971977755;4.909539177224887;0.004390007040384596;0.626074061840201;[CD86, CD83, SLC46A2, CD80, IFNA2, MYB, CTLA4, HLA-DOA, CR1, ANXA1, SYK, ZAP70, IFNG, IL1B, CARD11, CLPTM1, NLRP3, NCKAP1L, CCL19, IL12RB1, TGFB1, EGR3, LILRB2, CD2, VNN1, BCL6, CAMK4, CD28]
GO:0000390;spliceosomal complex disassembly;6.0;1.0;0.8231203125901445;9.628524252492122;58.04709595168642;8.390779266560578;0.0019427840625082307;0.7522251544931926;[LIME1]
GO:0034137;positive regulation of toll-like receptor 2 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;505.2767808384828;8.16763571524637;0.01691115913508416;0.8139338954918922;[TLR1]
GO:0034136;negative regulation of toll-like receptor 2 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;354.70667396235325;8.390779266560578;0.011871713162238609;0.8253454670833372;[LYN, TNFAIP3, TLR6]
GO:0071726;cellular response to diacyl bacterial lipopeptide;8.0;1.0;0.875;9.628524252492122;168.80270344913424;8.390779266560578;0.005649674571872418;0.8041048419030481;[CD36, TLR6, TLR2]
GO:0034130;toll-like receptor 1 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;9.777073627680469;0.013811191226989502;0.9481203125901445;[TLR1]
GO:0090237;regulation of arachidonic acid secretion;9.0;0.8933024483968273;0.8428918493787028;9.485423408851448;83.13942816732954;7.9853141584524145;0.0027826018401329354;0.8046099625986299;[SYK, MIF]
GO:0033280;response to vitamin D;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;74.55580141320215;6.375876246018314;0.002495315577434836;0.6769819729871445;[TGFB1, ABCB4, PTGS2, CXCL10, CD4, IL1B, ALPL]
GO:0034134;toll-like receptor 2 signaling pathway;12.0;0.9326813400603323;0.9144609826203107;9.590783924509275;412.6549923027037;8.16763571524637;0.013811191226989502;0.8658135829017477;[TLR2]
GO:0045588;positive regulation of gamma-delta T cell differentiation;10.0;1.0;0.9152410118609203;9.628524252492122;1283.265958453736;8.67846133901236;0.04294975676506408;0.8590579283277371;[SYK, NCKAP1L]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[EHMT2, SLA2, MYB, HOXA7, MEF2A, MEF2C, HOXB4, HOXB3, ATF3, PRDM16, ELANE, JUN, PKIG, EZH2, PAWR, PAX5, AES, MMP12, NR1H2, TNF, DACH1, MEN1, TLE4, FOXO1, NACC2, WFS1, NFKB1, BCL6, CIITA, FASLG, HHEX, RFC1, RBBP8, E2F7, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, PCBP3, EGR1, BCL11A, XPO1, CD36, IL1B, CCNE1, TGFB1, CBX4, CAV1, NR4A2, MXD1, MYOCD, IFNG, FBP1, MEIS2]
GO:0002774;Fc receptor mediated inhibitory signaling pathway;8.0;1.0;0.875;9.628524252492122;130.16139686502353;8.67846133901236;0.004356384815420379;0.8188169164668168;[LYN, LILRB1, LILRB2]
GO:0045591;positive regulation of regulatory T cell differentiation;10.0;0.8933024483968273;0.861892236059334;9.60254876608886;997.8066164740876;7.292166977892469;0.03339568948573388;0.7881627702307852;[TGFB1, BCL6, IFNG, LILRB2]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[EEF1B2, ALAD, CLDN3, IL1B, CLDN7, S100A8, PSMD14, CCL7, CNR1, FYN, GSN]
GO:0045590;negative regulation of regulatory T cell differentiation;10.0;0.8933024483968273;0.861892236059334;9.60254876608886;1015.6316661848598;8.67846133901236;0.03399227785805019;0.8590579283277371;[CTLA4]
GO:0070423;nucleotide-binding oligomerization domain containing signaling pathway;12.0;0.8933024483968273;0.8947715367885583;9.56183287799345;487.9171050824184;6.481236761676141;0.016330146410222554;0.7795710619905949;[TNFAIP3, NFKBIA, MAP2K6]
GO:0070542;response to fatty acid;5.0;0.6696747006330769;0.6250783621774587;8.578702127993445;43.78950961223322;5.382624473008031;0.0014655954787213788;0.5655086777281872;[PID1, CTGF, ALAD, AKT1, FFAR2, CCR7, CD36, PTGDR, DGAT2, ACSL1, TGFBR3, IL1B, TLR2, PTGER2, PTAFR, PTGS2, P2RY6, CCL19]
GO:0070427;nucleotide-binding oligomerization domain containing 1 signaling pathway;13.0;1.0;0.9625549647676366;9.628524252492122;488.61025226297863;9.083926447120524;0.01635334542256394;0.9271073857191605;[NFKBIA]
GO:0035335;peptidyl-tyrosine dephosphorylation;8.0;0.8933024483968273;0.8216512241984136;9.52844079393514;179.24922260518233;5.181953777545879;0.005999310166768488;0.6400053571691908;[PTPRR, PTPN22, PTPRK, DUSP2, DUSP1, DUSP6, TPTE, PTPRE, PTPRC, PTPN6]
GO:0010034;response to acetate;4.0;0.9326813400603323;0.7163406700301662;9.4949928598676;53.293729952816655;9.777073627680469;0.0017836931802777236;0.75;[CHUK]
GO:0070304;positive regulation of stress-activated protein kinase signaling cascade;8.0;0.7866048967936545;0.7683024483968273;9.394909401310617;268.25740884697916;4.746635706288034;0.008978334058114483;0.6177431707607042;[TNF, CTGF, PYCARD, TNFSF11, CCR7, MAP4K1, SYK, IL1B, TLR6, TNFRSF11A, PAK1, CCL19, LYN, FZD5, CARD9, CD40LG, PKN1, LTBR, FCGR2B]
GO:0070667;negative regulation of mast cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;83.65590509736859;9.777073627680469;0.0027998878581822827;0.8509193652572005;[LYN]
GO:0034128;negative regulation of MyD88-independent toll-like receptor signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;354.70667396235325;7.8311634786251565;0.011871713162238609;0.7967266896635242;[LY96, TLR4]
GO:0070668;positive regulation of mast cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;83.5280859103553;9.777073627680469;0.002795609865022748;0.8509193652572005;[LYN]
GO:0034123;positive regulation of toll-like receptor signaling pathway;8.0;0.7140352122741334;0.7320176061370667;9.09300601613576;411.4409909120541;6.781341354126479;0.013770559692974778;0.7217981122146513;[CAV1, PTPN22, TLR1, TLR5, LTF, TLR2]
GO:0050829;defense response to Gram-negative bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.407625775213448;0.0023911797157970473;0.627465598881932;[IGHM, HIST1H2BK, HMGB2, PYCARD, CTSG, IL6R, CAMP, DEFA4, SLC11A1, RNASE6, RNASE3, AZU1, DEFA1, LYZ, CD4, BPI, TLR4, LTF]
GO:0035690;cellular response to drug;4.0;0.5629771490299041;0.531488574514952;7.020557509946895;41.90713853914268;4.145861845859104;0.0014025942129290189;0.462019567599527;[TFRC, TNF, SLC8A1, IL18RAP, CDH1, MYB, MEF2C, KCNQ1, BLM, ABCB4, FOXO1, PDGFD, EGR1, TGFB1, JUP, NFKB1, EZH2, LRRK2, TNFAIP3, PTPN22, PDE4B, MAP4K1, ANXA1, ARG1, PAX2, DNM2, IL1B, FBP1, PCNA, PTAFR, PTGS2, GNAI1, CCL7, FYN, RAD51, CD69]
GO:0034122;negative regulation of toll-like receptor signaling pathway;8.0;0.7140352122741334;0.7320176061370667;9.0094850440859;260.8137256220838;6.166155715036245;0.00872920067945721;0.6903374900225189;[LYN, LY96, TNFAIP3, IRAK3, TLR6, TLR4, LGR4]
GO:0031098;stress-activated protein kinase signaling cascade;6.0;0.7980440201809971;0.722142322680643;9.193206181234276;55.4262366053078;5.142344639450834;0.0018550662588052154;0.5861000565951415;[TNF, CHUK, MAP2K6, MAPK14, NFKB1]
GO:0050706;regulation of interleukin-1 beta secretion;10.0;0.8933024483968273;0.861892236059334;9.533214072687796;155.12756668048587;6.166155715036245;0.005191980051049822;0.7305785018834392;[ORM1, PYCARD, NLRP3, CCR7, CCL19, FZD5, NLRP12, TLR8, TLR4]
GO:0050707;regulation of cytokine secretion;8.0;0.5887823193610073;0.6693911596805037;8.358061706897352;114.42085987655861;4.647174912757396;0.003829563207980042;0.6126567411541474;[TNF, PYCARD, CLEC5A, GHSR, IL1R2, F2R, MIF, CD274, NLRP3, LYN, FZD5, ORM1, LRRK2, IFNA2, PTPN22, FFAR2, CCR7, HAVCR2, ANXA1, CHUK, SYK, IL17RB, MMP12, TLR1, FGR, BANK1, IL1B, IGHD, TLR8, TLR10, TLR6, TLR5, TLR4, TLR2, CD58, CCL19, LILRB1, MAPK14, CD2, NLRP12, FCGR2B, LGR4, CD244, IL17A]
GO:0043299;leukocyte degranulation;8.0;0.811012628672052;0.780506314336026;9.223059144383958;48.80626136022181;3.5624655292582776;0.0016335016449431083;0.5571846528378576;[CDA, CYFIP1, ABCA13, C3AR1, RNASE3, RNASE2, BIN2, PADI2, FPR1, FPR2, NCKAP1L, ELANE, JUP, AZU1, LYZ, TCN1, SIGLEC9, PYGL, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, PTAFR, ALOX5, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, BRI3, HVCN1, GPR84, CORO1A, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, LAT, ITGAM, FCAR, ALAD, FCGR3B, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, TTR, FCGR2A, P2RX1, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CCT2, FCER1G, MME, RHOG, LAT2, HCK, CEACAM1, CEACAM6, KIT, TLR2, LILRA3, CXCR1, CXCR2, CD58, CCT8, LILRB2, LILRB3, QPCT, CD68, CD97, CHRNB4, CD93, OSCAR, DOK3, PRTN3, VCL, PSMD14, C5AR1, MGAM, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0046326;positive regulation of glucose import;8.0;0.9326813400603323;0.8413406700301662;9.548481544818586;84.68372616907679;5.970411137910149;0.0028342881044734467;0.6803271032452366;[PAK1, AKT1, MEF2A, SORBS1, MAPK14]
GO:0045597;positive regulation of cell differentiation;5.0;0.4493394816318884;0.5149107526768645;6.573475401781711;82.53300662006848;2.970244267288293;0.0027623054566900678;0.44213944182052767;[CYFIP1, MYB, AKT1, HOXA5, MEF2A, MEF2C, SPINT1, AGTR1, HOXB4, EPB41L5, PRDM16, SFN, NCKAP1L, LYN, JUN, JAG1, EZH2, ANXA1, FOS, PAX2, ENG, PTGS2, FLNA, CCL19, IL12RB1, TMEM64, PF4, PLXND1, TNF, CTGF, CDH5, OLFM4, TACSTD2, NFKB1, CXCL12, BCL6, ADAMTS20, CX3CR1, NLGN1, SMARCD3, LRP2, RAB21, FYN, KLF5, CPNE5, RPS6KA1, TNFSF11, FLT3LG, RUNX2, BTC, POR, BTK, EPHA3, INPP5D, CCR1, MSR1, EGR3, TNFSF14, VNN1, CD24, ROBO2, NRP1, CD36, CCR2, SYK, CEACAM1, IL1B, KIT, TLR2, CXCR4, PAK1, PDPN, LILRB2, IL17A, SCARB2, CD86, CD83, CD80, HOXA11, IL6R, LTBP3, NLRP3, TGFB1, SYT2, INHBA, LIN28A, TCF4, DOCK5, CXCL9, HMGB2, TMEM100, MYOCD, DNM2, ZAP70, IFNG, LTF, CNR1, MAPK14, CD4, ACIN1]
GO:0045356;positive regulation of interferon-alpha biosynthetic process;8.0;1.0;0.875;9.628524252492122;855.4349480558234;8.390779266560578;0.0286306378699575;0.8041048419030481;[TLR8, TLR7]
GO:0048864;stem cell development;4.0;0.8436909121759173;0.6718454560879586;9.34084218004034;32.15320660831846;6.375876246018314;0.001076138889173156;0.576062607729944;[JAG1, PTPRC]
GO:0046209;nitric oxide metabolic process;5.0;0.8933024483968273;0.736892236059334;9.474373572664863;82.70267162507076;6.943860283624253;0.002767983991718903;0.6453503496879909;[POR, GCH1, AKT1, TLR6, TLR2]
GO:0002431;Fc receptor mediated stimulatory signaling pathway;9.0;0.8933024483968273;0.8428918493787028;9.533214072687796;218.73839564357212;4.87179884924204;0.007320977250414979;0.6453846448923425;[CYFIP1, CD3G, IGHG1, FCGR3A, FCER1G, SYK, FGR, HCK, PAK1, IGKC, IGLV1-44, NCKAP1L, FYN, PLCG1, LYN, PTK2, FCGR2A, CD247, FCGR2B, IGKV3-20]
GO:0045359;positive regulation of interferon-beta biosynthetic process;8.0;1.0;0.875;9.628524252492122;855.4349480558234;7.8311634786251565;0.0286306378699575;0.7754860644832351;[TLR8, TLR7]
GO:0002553;histamine secretion by mast cell;10.0;1.0;0.9152410118609203;9.628524252492122;188.83492405524427;8.67846133901236;0.006320134967730841;0.8590579283277371;[LYN, BTK]
GO:0002666;positive regulation of T cell tolerance induction;7.0;0.8653626801206646;0.7836007053175329;9.4949928598676;165.82106058012107;7.8311634786251565;0.005549881668350914;0.7514054297404357;[LILRB2, CD3E]
GO:0002669;positive regulation of T cell anergy;8.0;1.0;0.875;9.628524252492122;417.44285307459876;8.67846133901236;0.013971436618229886;0.8188169164668168;[CD3E]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[PHB2, AKT1, PROK2, MEF2C, CLDN7, PRKCQ, SLC30A10, FIGNL1, SFN, NCKAP1L, BARD1, JUN, PLK2, AZU1, CDKN1A, CHL1, ANXA1, DUSP1, ANXA5, SERPINB9, PAX2, PTGS2, UNG, NTF3, FLNA, CCL19, GABRA5, PF4, TNF, CLEC5A, F2R, MSH2, BLM, CORO1A, FOXO1, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, CXCL12, COPS5, BCL6, MYD88, LRRK2, FASLG, TNFRSF1B, ADAMTS20, CX3CR1, LRP1, NLRC4, CCL5, CCL2, FYN, TIE1, IL2RB, SLC46A2, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB1, FLT3LG, MIF, BTC, POR, EPHA3, NAIP, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, CD28, NRP1, CTSH, CCR7, CCR5, FCER1G, HCK, CEACAM6, IL1B, KIT, GNAI2, CXCR2, PDPN, LILRB1, CD40LG, GRINA, PDGFRB, GHSR, C5AR1, PSEN2, CBX4, CAV1, NR4A2, NFKBIA, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, MMP9, NDUFS3, LTF, BCL2A1, TAF9, DLL1, HSPD1, TEK]
GO:0046330;positive regulation of JNK cascade;12.0;0.8436909121759173;0.8699657686781033;9.567899630675686;1762.0380321839782;4.909539177224887;0.058973827205923174;0.6991943744303455;[TNF, CTGF, PYCARD, TNFSF11, CCR7, MAP4K1, SYK, IL1B, TLR6, TNFRSF11A, PAK1, CCL19, FZD5, CARD9, CD40LG, PKN1, LTBR, FCGR2B]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[MYB, AKT1, HOXA5, MEF2C, ATF3, SFN, PLCG1, BARD1, LYN, JUN, NOX4, CTLA4, ANXA1, DUSP1, PAWR, DUSP6, AES, PTGS2, FGD4, GSN, BIK, G0S2, TNF, CTGF, PYCARD, F2R, MELK, MAL, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, PLEKHF1, FASLG, LCK, NLRC4, CCL5, CCL2, P2RX1, MNDA, PPP2R1A, SIK1, INPP5D, TP53BP2, TNFSF12, ITM2C, CTSH, IL1B, CXCR2, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, PDGFRB, NLRP3, TGFB1, CAV1, INHBA, EIF2S1, JMY, UBE2M, MMP9, DNM2, IFNG, BCL2A1, HSPD1, CNR1, HSPE1, LTBR]
GO:0071864;positive regulation of cell proliferation in bone marrow;6.0;1.0;0.8231203125901445;9.628524252492122;63.05258358394898;7.9853141584524145;0.0021103132289136558;0.7314896500084853;[MEF2C, FLT3LG]
GO:0033148;positive regulation of intracellular estrogen receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;233.77170011230152;7.379178354882098;0.007824128421887714;0.7523715242355574;[, PAK1, SKP2]
GO:0002309;T cell proliferation involved in immune response;7.0;0.8653626801206646;0.7836007053175329;9.517298617381897;137.0826054799011;8.390779266560578;0.004588031439076979;0.7800242071602487;[SLC11A1, LILRB1]
GO:0033026;negative regulation of mast cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;301.33162323320204;9.777073627680469;0.010085298248760914;0.896240625180289;[FCER1G]
GO:0050702;interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;137.76275822249997;7.697632086000634;0.004610795539274035;0.8260862151842345;[ABCA1, NLRC4, CD36, TLR6, TLR4]
GO:0070417;cellular response to cold;5.0;0.8436909121759173;0.712086467948879;9.427853557029971;50.719091001651144;7.697632086000634;0.0016975223316068359;0.6838982747154925;[NFKBIA, FOXO1]
